General Information of Disease (ID: DIS655KI)

Disease Name Myocardial infarction
Synonyms infarction (MI), myocardial; myocardial infarction; MI, myocardial infarction; myocardial infarct; myocardial infarction, (MI); MI; heart attack; myocardial infarction (disease)
Disease Class BA41-BA43: Myocardial infarction
Definition Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.
Disease Hierarchy
DISRYD6K: Myocardial disease
DIS655KI: Myocardial infarction
ICD Code
ICD-11
ICD-11: BA41-BA43
Disease Identifiers
MONDO ID
MONDO_0005068
MESH ID
D009203
UMLS CUI
C0027051
MedGen ID
10150
HPO ID
HP:0001658
SNOMED CT ID
22298006

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 21 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
111In-imciromab pentetate DMF95QX Approved Monoclonal antibody [1]
Aspirin DM672AH Approved Small molecular drug [2]
Atenolol DMNKG1Z Approved Small molecular drug [3]
Brilinta DMBR01X Approved Small molecular drug [4]
Clopidogrel DMOL54H Approved Small molecular drug [5]
Dicumarol DMFQCB1 Approved Small molecular drug [6]
Fondaparinux sodium DMWS3FH Approved Small molecular drug [7]
Gadoversetamide DMAT54G Approved Small molecular drug [1]
Lisinopril DMUOK4C Approved Small molecular drug [8]
Metoprolol DMOJ0V6 Approved Small molecular drug [9]
Nateplase DMO6N8L Approved NA [1]
Perfluorochemical emulsion DMN0RYF Approved NA [1]
Phenprocoumon DMDO279 Approved Small molecular drug [10]
Salicyclic acid DM2F8XZ Approved Small molecular drug [11]
Sodium nitrite DMS9J43 Approved Small molecular drug [12]
Sparsentan DMMP51W Approved Small molecular drug [13]
Tenecteplase DMJYN25 Approved NA [14]
Ticlopidine DMO946V Approved Small molecular drug [15]
Urokinase DM0GOUD Approved NA [2]
Vorapaxar DMA16BR Approved Small molecular drug [16]
Ximelegatran DMU8ANS Approved Small molecular drug [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 21 Drug(s)
This Disease is Treated as An Indication in 25 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Amediplase DM4FPM3 Phase 3 Small molecular drug [17]
Tilarginine acetate DMZBGI8 Phase 3 Small molecular drug [18]
Autologous myoblast cell therapy DMMCSJL Phase 2 NA [19]
BAY 1142524 DMHKTGX Phase 2 Small molecular drug [20]
CAP-1002 DMJ2Y1C Phase 2 NA [21]
EFEGATRAN SULFATE HYDRATE DMX4RSD Phase 2 Small molecular drug [22]
FDY-5301 DM5NJU1 Phase 2 NA [23]
LB-30870 DM0OHX3 Phase 2 NA [24]
PP-099 DMCX6TO Phase 2 Small molecular drug [25]
Revascor DM8ER6I Phase 2 NA [26]
RGN-352 DM6ZNX4 Phase 2 Peptide [27]
Superoxide dismutase DMSWPA6 Phase 2 NA [28]
Tiprelestat DM1SB94 Phase 2 NA [29]
Troplasminogen alfa DMR8Y4F Phase 2 NA [30]
TY-51924 DMSAGVN Phase 2 NA [31]
X-22 DM7C0FT Phase 2 NA [32]
BL-1040 DM8SSSH Phase 1/2 NA [33]
TG100-115 DMON4IL Phase 1/2 Small molecular drug [34]
VMD-30283 DMID90T Phase 1/2 NA [35]
Adipose stem cell therapy DMXL6Z9 Phase 1 NA [36]
APN01 DMHPL66 Phase 1 NA [37]
BVI-007 DM43GPX Phase 1 NA [38]
CPI-003 DM4P4Z2 Phase 1 NA [39]
Elinogrel DMA4BRV Phase 1 Small molecular drug [40]
Myoblast cell transplantation DM3JGSQ Phase 1 NA [41]
------------------------------------------------------------------------------------
⏷ Show the Full List of 25 Drug(s)
This Disease is Treated as An Indication in 14 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
BMS-200980 DM4SVE0 Discontinued in Preregistration NA [42]
DG051 DM3I0GS Discontinued in Phase 2 Small molecular drug [43]
INOGATRAN DM6HDO3 Discontinued in Phase 2 Small molecular drug [44]
Napsagatran DM8L4Z0 Discontinued in Phase 2 Small molecular drug [45]
PG-530742 DMELXBQ Discontinued in Phase 2 Small molecular drug [46]
SSR-182289 DMN7BM3 Discontinued in Phase 2 NA [47]
Vasoflux DMHCOFM Discontinued in Phase 2 NA [48]
CVS-1123 DMDRFZV Discontinued in Phase 1 NA [49]
S-18326 DMX59E8 Discontinued in Phase 1 NA [50]
UK-156406 DMGFPIY Discontinued in Phase 1 Small molecular drug [51]
BMS-189664 DMV3B5Y Terminated Small molecular drug [52]
CVS-995 DMMDO3X Terminated NA [53]
EP-3533 DMVLKKC Terminated NA [54]
LXR-017 DM7D5S3 Terminated NA [55]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Drug(s)
This Disease is Treated as An Indication in 13 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Annexin A5 DM75FM1 Investigative NA [56]
BIIB-513 DML4DQ3 Investigative Small molecular drug [57]
C3BS-GQR-1 DMIKEPF Investigative NA [56]
Cyclin A2 DMBN2X2 Investigative NA [56]
EDP-15 DMSO3SG Investigative NA [56]
HO-4038 DM6B0SP Investigative NA [56]
IMD-1622 DMWL747 Investigative Small molecular drug [56]
KR-33889 DMC4YGT Investigative NA [58]
MGN-1374 DMB9F9M Investigative NA [56]
Nanofibers DMZ5PK7 Investigative NA [56]
Recombinant human pro-urokinase DMVJLR3 Investigative NA [59]
Rimeporide DM59G40 Investigative Small molecular drug [60]
Vasonex DMW1JX4 Investigative NA [56]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 449 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ABCA1 TTJW1GN Limited Biomarker [61]
ACE2 TTUI5H7 Limited Biomarker [62]
ACVR1B TTPKHTZ Limited Biomarker [63]
ADM2 TTM642F Limited Biomarker [64]
ADORA1 TTK25J1 Limited Therapeutic [65]
ADORA3 TTJFY5U Limited Therapeutic [66]
ALOX12 TT12ABZ Limited Biomarker [67]
ALOX15 TTN9T81 Limited Biomarker [67]
ANGPT1 TTWNQ1T Limited Biomarker [68]
ANGPTL3 TT59GO7 Limited Altered Expression [69]
ANPEP TTPHMWB Limited Genetic Variation [70]
APOL1 TTDB8PW Limited Genetic Variation [71]
AQP9 TTQEI32 Limited Biomarker [72]
ARSA TTYQANR Limited Biomarker [73]
ATG7 TTLVB9Z Limited Biomarker [74]
ATP1A1 TTWK8D0 Limited Therapeutic [75]
AVPR1A TT4TFGN Limited Biomarker [76]
BAK1 TTFM7V0 Limited Biomarker [77]
BIRC5 TTTPU1G Limited Biomarker [78]
BRS3 TTKYEPM Limited Altered Expression [79]
C5 TTKANGO Limited Biomarker [80]
C5AR1 TTHXFA1 Limited Biomarker [80]
CCN2 TTIL516 Limited Biomarker [81]
CCNA2 TTAMQ62 Limited Biomarker [82]
CCR3 TTD3XFU Limited Biomarker [83]
CREB1 TTH4AN3 Limited Biomarker [84]
CSNK2A1 TTER6YH Limited Biomarker [85]
CTSD TTPT2QI Limited Biomarker [86]
CTSG TTQAJF1 Limited Biomarker [87]
CTSK TTDZN01 Limited Biomarker [88]
CYBB TT5T8MR Limited Biomarker [89]
CYP11B1 TTIQUX7 Limited Biomarker [90]
CYP1A2 TTS1DTU Limited Genetic Variation [91]
DAG1 TT4X7PG Limited Therapeutic [92]
DCN TTB3XAN Limited Biomarker [93]
DGKZ TTSBBXL Limited Therapeutic [94]
EBI3 TTJF68X Limited Altered Expression [95]
EDN1 TTJR60Z Limited Altered Expression [96]
EDN2 TTMR0OP Limited Biomarker [97]
ELANE TTPLTSQ Limited Biomarker [98]
ENTPD1 TTYM8DJ Limited Biomarker [99]
EPAS1 TTWPA54 Limited Biomarker [100]
EPOR TTAUX24 Limited Biomarker [101]
F11 TTDM4ZU Limited Altered Expression [102]
F13B TTAXGIP Limited Genetic Variation [103]
FGF1 TTMY81X Limited Biomarker [104]
FPR2 TTOJ1NF Limited Biomarker [105]
FUS TTKGYZ9 Limited Biomarker [106]
G6PD TTKN8W0 Limited Therapeutic [107]
GAP43 TTSGLN5 Limited Altered Expression [108]
GGT1 TTZVT7O Limited Biomarker [109]
GJA5 TTFQKZ7 Limited Therapeutic [110]
GPER1 TTDSB34 Limited Biomarker [111]
GRK2 TTAZ3MN Limited Altered Expression [112]
GSR TTEP6RV Limited Therapeutic [113]
HIF1A TTSN6QU Limited Biomarker [114]
HMOX1 TTI6V2A Limited Biomarker [115]
HSPA5 TTW26OG Limited Biomarker [116]
IFNA2 TTSIUJ9 Limited Biomarker [117]
IGF1 TTT6LOU Limited Biomarker [118]
IGF2R TTPNE41 Limited Biomarker [119]
IL4R TTDWHC3 Limited Biomarker [120]
ILK TT7ALZG Limited Biomarker [121]
ITGAM TTB69FJ Limited Biomarker [122]
JAK2 TTRMX3V Limited Genetic Variation [123]
KCNJ2 TTH7UO3 Limited Therapeutic [124]
KCNQ1 TT846HF Limited Altered Expression [125]
KDM3A TTKXS4A Limited Biomarker [126]
KLF4 TTTI53X Limited Altered Expression [127]
KNG1 TTDJ4MY Limited Altered Expression [102]
LBP TTVQJLY Limited Biomarker [128]
LCAT TTGZ91P Limited Biomarker [129]
LDHA TTW76JE Limited Biomarker [130]
LIFR TTID542 Limited Altered Expression [131]
LIPG TTHSZXO Limited Genetic Variation [132]
LPL TTOF3WZ Limited Genetic Variation [133]
MAP3K5 TTOQCD8 Limited Therapeutic [134]
MAPK1 TT4TQBX Limited Altered Expression [135]
MCAM TTHRE05 Limited Biomarker [136]
MIA TT5HNVS Limited Biomarker [137]
MME TT5TKPM Limited Biomarker [138]
MTAP TTDBX7N Limited Genetic Variation [139]
NES TTHZ752 Limited Altered Expression [140]
NFE2L2 TTA6ZN2 Limited Biomarker [141]
NOS2 TTF10I9 Limited Genetic Variation [142]
NPPB TTY63XT Limited Altered Expression [143]
NPR1 TTM9IYA Limited Genetic Variation [144]
NPR3 TTWVLS6 Limited Biomarker [145]
NR1H3 TTECBXN Limited Biomarker [146]
NRG1 TTEH395 Limited Biomarker [147]
OLR1 TTKSND3 Limited Biomarker [148]
OPRD1 TT27RFC Limited Biomarker [149]
OPRK1 TTQW87Y Limited Biomarker [149]
PADI4 TTQHAXM Limited Biomarker [150]
PCSK1 TTED9LZ Limited Biomarker [151]
PDE3A TT06AWU Limited Biomarker [84]
PDE4D TTSKMI8 Limited Genetic Variation [152]
PDGFD TTSN0GA Limited Biomarker [153]
PDX1 TT8SGZK Limited Biomarker [154]
PEBP1 TT1BGU8 Limited Biomarker [155]
PF4 TTSG7Q5 Limited Biomarker [156]
PIM1 TTTN5QW Limited Biomarker [157]
PLCB1 TTLPGU7 Limited Biomarker [158]
PTN TTA9EJK Limited Biomarker [159]
RPS6KB1 TTG0U4H Limited Biomarker [160]
S100A8 TT4AF6N Limited Altered Expression [161]
SCARB1 TTRE324 Limited Genetic Variation [162]
SEMA3A TTVKD3S Limited Altered Expression [163]
SERPINC1 TT4QPUL Limited Altered Expression [164]
SERPINF1 TTR59S1 Limited Altered Expression [165]
SHH TTIENCJ Limited Therapeutic [166]
SIRT1 TTUF2HO Limited Altered Expression [167]
SIRT3 TTVZLIJ Limited Biomarker [168]
SLC2A9 TTIF3GB Limited Genetic Variation [169]
SMAD1 TT9GR53 Limited Biomarker [170]
SMN1 TT8QL6X Limited Altered Expression [95]
SOD1 TTP9K3Q Limited Altered Expression [171]
SREBF2 TTRQ4AP Limited Genetic Variation [172]
SSTR4 TTAE1BR Limited Altered Expression [79]
TEK TT9VGXW Limited Biomarker [173]
TGFB2 TTI0KH6 Limited Biomarker [174]
TGFBR2 TTZE3P7 Limited Biomarker [175]
TMSB4X TTMVAIU Limited Altered Expression [176]
TNFRSF12A TTKPS7V Limited Biomarker [177]
TNFRSF14 TTWGTC1 Limited Biomarker [178]
TREM1 TTHZQP0 Limited Biomarker [179]
TRPA1 TTELV3W Limited Genetic Variation [180]
TXNRD1 TTR7UJ3 Limited Biomarker [181]
TXNRD3 TTDYFVB Limited Genetic Variation [182]
UTRN TTNO1VA Limited Biomarker [183]
UTS2R TTW5UDX Limited Biomarker [184]
VDAC1 TTAMKGB Limited Biomarker [185]
VDAC2 TTM1I7L Limited Therapeutic [186]
XPO1 TTCJUR4 Limited Biomarker [187]
SLC5A2 TTF8JAT Disputed Biomarker [188]
ADRB1 TTR6W5O moderate Altered Expression [189]
ANGPT2 TTKLQTJ moderate Biomarker [190]
ARG1 TT7ZQEV moderate Biomarker [191]
ATXN2 TTPQJ7P moderate Genetic Variation [192]
BGN TT0JPVF moderate Biomarker [193]
C3 TTJGY7A moderate Biomarker [194]
CCL11 TTCF05Y moderate Genetic Variation [195]
CD59 TTBGTEJ moderate Biomarker [196]
CYP11B2 TT9MNE2 moderate Genetic Variation [197]
FAP TTGPQ0F moderate Altered Expression [198]
FER TTRA9G0 moderate Genetic Variation [199]
FES TTLBY21 moderate Genetic Variation [192]
FN1 TTPJ921 moderate Biomarker [200]
ITGA1 TTPERWV moderate Genetic Variation [180]
PDE5A TTJ0IQB moderate Biomarker [201]
PDGFA TTSM78N moderate Genetic Variation [202]
POSTN TT8ALTZ moderate Altered Expression [203]
SH2B3 TT36N7Z moderate Biomarker [204]
SMAD3 TTHQZV7 moderate Altered Expression [96]
TNC TTUCPMY moderate Biomarker [205]
TNFRSF4 TTL31H0 moderate Genetic Variation [206]
ABCC1 TTOI92F Strong Genetic Variation [207]
ABCG1 TTMWDGU Strong Posttranslational Modification [208]
ABCG5 TTKZ7WY Strong Genetic Variation [209]
ACACB TTY84UG Strong Genetic Variation [210]
ADAMTS1 TTS2TEI Strong Genetic Variation [211]
ADAMTS13 TTUREBK Strong Altered Expression [212]
ADGRL3 TTQST3U Strong Genetic Variation [213]
ADM TTV14YH Strong Genetic Variation [214]
ADORA2B TTNE7KG Strong Biomarker [215]
ADRA2B TTWM4TY Strong Genetic Variation [216]
AGRP TT4DE1O Strong Biomarker [217]
AGTR2 TTQVOEI Strong Biomarker [218]
AHSG TTKF4WV Strong Genetic Variation [219]
AIMP2 TTXWHGF Strong Altered Expression [135]
ANG TTURHFP Strong Altered Expression [220]
ANXA1 TTUCK4B Strong Biomarker [221]
ANXA5 TT2Z83I Strong Biomarker [222]
AOC1 TTM3B5R Strong Biomarker [223]
AOC3 TT7HC21 Strong Genetic Variation [224]
APLN TT87D3J Strong Biomarker [225]
APLNR TTJ8E43 Strong Altered Expression [226]
APOA4 TTNC3WS Strong Genetic Variation [227]
APOH TT2OUI9 Strong Biomarker [228]
ASPA TT6TLZP Strong Biomarker [194]
ATM TTKBM7V Strong Genetic Variation [229]
BACH1 TT2ME4S Strong Biomarker [230]
BAX TTQ57WJ Strong Altered Expression [167]
BCHE TT3MSAO Strong Biomarker [231]
BCL2 TTFOUV4 Strong Biomarker [232]
BCL2L1 TTRE6AX Strong Biomarker [233]
BDKRB1 TTG5QIA Strong Altered Expression [234]
BDKRB2 TTGY8IW Strong Altered Expression [234]
BECN1 TT5M7LN Strong Biomarker [235]
BMP6 TT07RIB Strong Biomarker [236]
CALR TTUZ7OA Strong Biomarker [237]
CARM1 TTIZQFJ Strong Biomarker [238]
CASP1 TTCQIBE Strong Biomarker [239]
CASP3 TTPF2QI Strong Altered Expression [240]
CASP7 TTM7Y45 Strong Biomarker [241]
CASR TTBUYHA Strong Biomarker [242]
CAT TTPS279 Strong Altered Expression [243]
CAV1 TTXUBN2 Strong Genetic Variation [244]
CBS TTVZJ7G Strong Genetic Variation [245]
CCR5 TTJIH8Q Strong Genetic Variation [246]
CD27 TTDO1MV Strong Biomarker [247]
CD34 TTZAVYN Strong Biomarker [248]
CD69 TTPQE9F Strong Altered Expression [249]
CDH11 TTRGWZC Strong Biomarker [250]
CDKN1B TTLGFVW Strong Biomarker [251]
CEACAM1 TTA9CK4 Strong Altered Expression [252]
CEACAM3 TTPX7I5 Strong Genetic Variation [253]
CFB TTA0P7K Strong Genetic Variation [254]
CFTR TTRLZHP Strong Biomarker [255]
CHAT TTKYFSB Strong Biomarker [256]
CHRM3 TTQ13Z5 Strong Biomarker [257]
CHRNA5 TTH2QRX Strong Genetic Variation [258]
CHUK TT1F8OQ Strong Biomarker [259]
CLEC6A TTQ02HK Strong Biomarker [260]
CNP TT71P0H Strong Biomarker [261]
CNR2 TTMSFAW Strong Genetic Variation [262]
CPB2 TTP18AY Strong Genetic Variation [263]
CR1 TTEA8OW Strong Genetic Variation [264]
CRK TTFEUYR Strong Altered Expression [135]
CRY2 TTAO58M Strong Genetic Variation [265]
CTSB TTF2LRI Strong Biomarker [266]
CXCL12 TT4UGTF Strong Biomarker [267]
CXCR1 TTMWT8Z Strong Genetic Variation [268]
CXCR4 TTBID49 Strong Biomarker [269]
CYP17A1 TTRA5BZ Strong Genetic Variation [270]
DDIT4 TTVEOY6 Strong Biomarker [271]
DLK1 TTF4AVB Strong Genetic Variation [272]
DNASE1 TTYWGOJ Strong Biomarker [273]
DOT1L TTSZ8T1 Strong Genetic Variation [274]
DYRK1A TTSBVFO Strong Biomarker [275]
ECE1 TTQ9RYT Strong Altered Expression [276]
EDNRB TT3ZTGU Strong Biomarker [277]
EGLN1 TT9ISBX Strong Biomarker [278]
EHMT1 TTOFXD7 Strong Genetic Variation [279]
EIF2AK1 TTRUJBV Strong Genetic Variation [207]
EIF2AK4 TT9U4EP Strong Biomarker [280]
ENG TTB30LE Strong Biomarker [281]
ENPEP TT9PBIL Strong Biomarker [282]
ENPP1 TTZTIWS Strong Genetic Variation [283]
EPHB4 TTI4ZX2 Strong Biomarker [284]
EPHX2 TT7WVHI Strong Biomarker [285]
ESRRA TTPNQAC Strong Biomarker [286]
F10 TTCIHJA Strong Genetic Variation [287]
F13A1 TTXI2RA Strong Genetic Variation [288]
F2R TTL935N Strong Biomarker [289]
F7 TTF0EGX Strong Genetic Variation [290]
FABP2 TTS4YLO Strong Genetic Variation [154]
FABP3 TT3TGLR Strong Biomarker [291]
FGF18 TT6ICRA Strong Genetic Variation [292]
FGF23 TT2IZ4K Strong Biomarker [293]
FLT1 TT1VAUK Strong Altered Expression [294]
FOLR2 TTT54CI Strong Genetic Variation [295]
FOS TTOM5AU Strong Biomarker [296]
FPR1 TT5Y4EM Strong Biomarker [297]
FTO TTFW3BT Strong Altered Expression [298]
FYN TT2B9KF Strong Biomarker [299]
FZD7 TTUQMO5 Strong Biomarker [300]
GATA4 TT1VDN2 Strong Altered Expression [301]
GCG TT6Y4PN Strong Altered Expression [302]
GCGR TT9O6WS Strong Biomarker [303]
GCH1 TTLSWP6 Strong Biomarker [304]
GCLM TTNFESW Strong Genetic Variation [305]
GDF15 TT4MXVG Strong Biomarker [306]
GIPR TTYMKBE Strong Genetic Variation [307]
GJA4 TTQO1VY Strong Genetic Variation [308]
GJC1 TTEP7OC Strong Biomarker [309]
GLA TTIS03D Strong Biomarker [310]
GLO1 TTV9A7R Strong Altered Expression [311]
GLP1R TTVIMDE Strong Altered Expression [312]
GP1BA TTVB0Q9 Strong Genetic Variation [313]
GPNMB TT7315J Strong Biomarker [314]
GPR17 TTMPART Strong Biomarker [315]
GPRC6A TTI1PRE Strong Altered Expression [79]
GRB2 TTEYRJ9 Strong Biomarker [316]
GRIA1 TTVPQTF Strong Altered Expression [317]
GSK3B TTRSMW9 Strong Biomarker [318]
GSN TTUH7OM Strong Biomarker [319]
GSTO1 TTWO3SH Strong Altered Expression [320]
GUCY1B1 TTLBYH1 Strong Biomarker [321]
HBEGF TT15SL0 Strong Biomarker [322]
HDAC7 TTMUEK1 Strong Biomarker [323]
HLA-B TTGS10J Strong Genetic Variation [324]
HMGB2 TTA78JQ Strong Biomarker [325]
HP TTLC8E1 Strong Biomarker [326]
HSD11B1 TTN7BL9 Strong Biomarker [327]
HSD11B2 TT9H85R Strong Biomarker [328]
HSPA12B TTAI9ZQ Strong Biomarker [329]
HSPB3 TTLH8WG Strong Genetic Variation [330]
HSPD1 TT9HL5R Strong Altered Expression [232]
ID2 TTW8A5N Strong Genetic Variation [331]
IFNAR1 TTSYFMA Strong Biomarker [332]
IGF1R TTQFBMY Strong Biomarker [333]
IL19 TT87RWS Strong Biomarker [334]
INHBA TTVB30D Strong Altered Expression [335]
IRF3 TTYR7OH Strong Altered Expression [332]
IRF8 TTHUBNK Strong Biomarker [336]
ITGA6 TT165T3 Strong Biomarker [337]
ITGB1 TTBVIQC Strong Therapeutic [338]
KCNMA1 TTE87WJ Strong Biomarker [339]
KCNN4 TT7M9I6 Strong Genetic Variation [340]
KLK1 TT5T3P6 Strong Biomarker [341]
KLK4 TT4319X Strong Biomarker [342]
KLKB1 TTN0PCX Strong Genetic Variation [102]
LAIR1 TTSI7A8 Strong Biomarker [343]
LAMP2 TTULDG7 Strong Biomarker [74]
LCN2 TTKTLAI Strong Altered Expression [344]
LCT TTA0OSE Strong Genetic Variation [345]
LGALS3 TTFPQV7 Strong Altered Expression [346]
LIPE TTLUQ8E Strong Biomarker [347]
LRP6 TTSXOWE Strong Genetic Variation [348]
LTA4H TTXZEAJ Strong Biomarker [349]
LTC4S TTW7OTG Strong Biomarker [350]
LYN TT1RWNJ Strong Biomarker [351]
LYVE1 TTG8DNU Strong Biomarker [352]
MAG TT9XFON Strong Genetic Variation [353]
MAP3K3 TTJZNIG Strong Biomarker [354]
MAP4 TT0VFPN Strong Biomarker [355]
MAPK10 TT056SO Strong Biomarker [356]
MAPK14 TTQBR95 Strong Altered Expression [135]
MAPKAP1 TTWDKCL Strong Genetic Variation [357]
MAPKAPK5 TT3UJ7Z Strong Biomarker [358]
MARK2 TTAJ45Y Strong Biomarker [359]
MAS1 TTOISYB Strong Biomarker [360]
MBL2 TTMQDZ5 Strong Altered Expression [361]
MDK TTV8UE7 Strong Biomarker [362]
MGLL TTZ963I Strong Altered Expression [363]
MIF TT6804T Strong Altered Expression [364]
MMP12 TTXZ0KQ Strong Biomarker [365]
MMP13 TTHY57M Strong Genetic Variation [366]
MMP2 TTLM12X Strong Biomarker [367]
MRGPRX1 TTIX6PK Strong Altered Expression [79]
MSTN TTM8I2X Strong Biomarker [368]
MTOR TTCJG29 Strong Biomarker [369]
MTR TTUTO39 Strong Genetic Variation [370]
MUC17 TTVO0JU Strong Genetic Variation [213]
MYH7 TTNIMDP Strong Biomarker [85]
NFKBIA TTSHAEB Strong Genetic Variation [371]
NLRP3 TT4EN8X Strong Biomarker [372]
NOX4 TTQRBSJ Strong Biomarker [344]
NPPC TTRK0B9 Strong Biomarker [145]
NT5E TTK0O6Y Strong Biomarker [373]
NTN1 TT0AH4L Strong Altered Expression [374]
OPA1 TTTU49Q Strong Genetic Variation [375]
OSM TTIVXSE Strong Biomarker [376]
OXER1 TT7WBSV Strong Altered Expression [79]
P2RY1 TTA93TL Strong Genetic Variation [377]
P2RY2 TTOZHQC Strong Genetic Variation [378]
PAM TTF4ZPC Strong Biomarker [223]
PCSK2 TT46F0P Strong Genetic Variation [379]
PECAM1 TT4EZB2 Strong Biomarker [114]
PGF TT48I1Y Strong Biomarker [380]
PHGDH TT8DRCK Strong Biomarker [381]
PKN1 TTSL41O Strong Biomarker [382]
PLA2G7 TTDNFMT Strong Biomarker [383]
PLAU TTGY7WI Strong Biomarker [384]
PLAUR TTNOSTX Strong Biomarker [384]
PLD1 TT3T17P Strong Altered Expression [385]
PLG TTP86E2 Strong Altered Expression [386]
PLN TTMCVJF Strong Altered Expression [387]
PML TTLH9NY Strong Genetic Variation [207]
PNMT TT0NZIC Strong Biomarker [388]
PPIA TTL2ADK Strong Genetic Variation [389]
PRKCE TT57MT2 Strong Altered Expression [390]
PRKD1 TTSLUMT Strong Altered Expression [391]
PROC TTZUXYS Strong Altered Expression [392]
PSMD10 TT2H4LN Strong Altered Expression [320]
PTGER2 TT1ZAVI Strong Genetic Variation [393]
PTGER4 TT79WV3 Strong Altered Expression [394]
PTGS1 TT8NGED Strong Biomarker [395]
PTK2B TTTEFBV Strong Biomarker [396]
REG4 TTVZEHU Strong Biomarker [397]
RGS12 TTP9AV7 Strong Genetic Variation [207]
RHBDF2 TTH1ZOP Strong Biomarker [398]
ROS1 TTSZ6Y3 Strong Altered Expression [399]
RPGR TTHBDA9 Strong Biomarker [400]
S100A4 TTPR5SX Strong Biomarker [401]
S100A9 TT0TMQG Strong Biomarker [402]
S100B TTQ0V86 Strong Biomarker [403]
S1PR1 TT9JZCK Strong Altered Expression [404]
S1PR3 TTDYP7I Strong Biomarker [405]
SAA1 TTY0DN9 Strong Genetic Variation [406]
SDC1 TTYDSVG Strong Biomarker [407]
SELL TT2IYXF Strong Genetic Variation [408]
SLC25A1 TTTD730 Strong Biomarker [409]
SLC2A4 TTP6MT5 Strong Altered Expression [410]
SLC33A1 TTL69WB Strong Biomarker [411]
SLC5A1 TT2UE56 Strong Genetic Variation [412]
SLC6A4 TT3ROYC Strong Genetic Variation [413]
SLCO1B1 TTFGXEB Strong Biomarker [414]
SMARCA4 TTVQEZS Strong Altered Expression [415]
SMPD2 TTE5VI6 Strong Biomarker [416]
SMPD4 TTZSJIV Strong Biomarker [416]
SOCS1 TT8COJM Strong Biomarker [417]
SOD2 TT9O4C5 Strong Altered Expression [418]
SORT1 TTRX9AV Strong Genetic Variation [419]
SPARC TTBQFM7 Strong Biomarker [420]
SSTR2 TTZ6T9E Strong Biomarker [421]
STAB1 TTJFEOC Strong Biomarker [422]
SUV39H1 TTUWQTK Strong Biomarker [423]
TBXAS1 TTKNWZ4 Strong Genetic Variation [424]
TFF1 TTNOJIZ Strong Genetic Variation [207]
TFPI TT068JH Strong Therapeutic [425]
TGFB1 TTR9XHZ Strong Altered Expression [426]
TGFB3 TTWOMY8 Strong Altered Expression [427]
TGFBR1 TTP4520 Strong Biomarker [428]
TH TTUHP71 Strong Biomarker [296]
THBD TTAPV67 Strong Genetic Variation [429]
THPO TTCG5PE Strong Biomarker [430]
TM6SF2 TTE1OHM Strong Biomarker [431]
TNFRSF11B TT2CJ75 Strong Biomarker [432]
TNFRSF1B TT63WSF Strong Biomarker [433]
TNFSF4 TTBW580 Strong Genetic Variation [434]
TNNI3 TTNLDK6 Strong Biomarker [435]
TNNT2 TTWAS18 Strong Biomarker [436]
TRPC3 TTNVC34 Strong Biomarker [437]
TRPC4 TTX0H5W Strong Genetic Variation [438]
TRPM4 TTJ2HKA Strong Biomarker [439]
TRPM6 TTV76RD Strong Biomarker [440]
TRPM8 TTXDKTO Strong Altered Expression [441]
TRPV1 TTMI6F5 Strong Biomarker [442]
TRPV2 TTBECWA Strong Altered Expression [443]
TSPO TTPTXIN Strong Biomarker [257]
TTR TTPOYU7 Strong Biomarker [196]
TXN TTZJ5U9 Strong Altered Expression [444]
UTS2 TTERU0T Strong Genetic Variation [154]
VCAM1 TTHCEF6 Strong Altered Expression [96]
VEGFB TTPJQHE Strong Biomarker [445]
WWP2 TT6TU05 Strong Genetic Variation [446]
ABCC9 TTEF5MJ Definitive Genetic Variation [447]
ADRB3 TTMXGCW Definitive Genetic Variation [448]
APOA2 TTGQA9W Definitive Genetic Variation [449]
BPI TTXCSDR Definitive Genetic Variation [450]
C3AR1 TTI6B3F Definitive Biomarker [451]
CA3 TTXUK5D Definitive Biomarker [452]
CTSE TTLXC4Q Definitive Genetic Variation [453]
DBH TTYIP79 Definitive Altered Expression [454]
FCAR TTGUJAO Definitive Genetic Variation [455]
GLRX2 TTESHRV Definitive Biomarker [456]
HTR1D TT6MSOK Definitive Biomarker [457]
KCNJ11 TT329V4 Definitive Genetic Variation [458]
LTB TTHQ6US Definitive Biomarker [459]
MTTP TTUS1RD Definitive Genetic Variation [460]
SCAP TTL6U2P Definitive Genetic Variation [461]
SELPLG TTS5K8U Definitive Genetic Variation [462]
SERPIND1 TT8XSKJ Definitive Altered Expression [463]
SLC26A4 TT7X02I Definitive Genetic Variation [464]
TBXA2R TT2O84V Definitive Biomarker [465]
UCP3 TT12RJK Definitive Genetic Variation [448]
ZNF202 TTD9R62 Definitive Biomarker [466]
------------------------------------------------------------------------------------
⏷ Show the Full List of 449 DTT(s)
This Disease Is Related to 17 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC25A37 DTLBGTZ Limited Biomarker [467]
SLC27A1 DTKDTML Limited Biomarker [468]
SLC27A6 DTG4CWJ Limited Biomarker [468]
SLC2A6 DTS4MKQ Limited Genetic Variation [169]
SLC52A1 DT7NOKR Limited Biomarker [67]
SLC7A9 DTP7AEQ moderate Genetic Variation [469]
ABCC11 DTWN7FC Strong Altered Expression [470]
ATP2B1 DTJWQ1L Strong Genetic Variation [192]
KCNK2 DTENHUP Strong Biomarker [471]
SLC25A20 DTQOUM4 Strong Biomarker [472]
SLC30A6 DTKPRIL Strong Biomarker [473]
SLC35A1 DTVZIRG Strong Altered Expression [474]
SLC4A4 DTWDEIL Strong Altered Expression [475]
SLC5A3 DT8ACN1 Strong Genetic Variation [476]
SLC6A18 DTGQ7FH Strong Genetic Variation [477]
SLC6A6 DTHWCVA Strong Altered Expression [478]
SLC7A8 DTJF3DX Strong Genetic Variation [207]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 DTP(s)
This Disease Is Related to 26 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
ABO DESIA7R Limited Genetic Variation [479]
CRMP1 DE0EUXB Limited Biomarker [183]
CYP2R1 DEBIHM3 Limited Genetic Variation [480]
CYP4A11 DE2XQGW Limited Genetic Variation [481]
DDAH1 DEY0TQC Limited Genetic Variation [408]
PCYT1A DEQYXD4 Limited Biomarker [482]
ACSS2 DEE76VW Strong Biomarker [483]
ADH5 DEIOH6A Strong Genetic Variation [484]
AKR1A1 DED2FW3 Strong Genetic Variation [485]
AKR1D1 DEVON3M Strong Genetic Variation [486]
BAAT DERA3OF Strong Biomarker [487]
CPA4 DEXKD7J Strong Biomarker [87]
CYP4F2 DE3GT9C Strong Genetic Variation [488]
CYP4F3 DEFCMPI Strong Genetic Variation [489]
CYP7A1 DEDZRQ1 Strong Genetic Variation [490]
DIO3 DET89OV Strong Biomarker [272]
EGLN3 DEMQTKH Strong Biomarker [491]
GCLC DESYL1F Strong Biomarker [305]
GFPT2 DERQCJM Strong Altered Expression [492]
GPT DER5HFI Strong Biomarker [493]
MSRA DEU2ZBY Strong Altered Expression [494]
PMM2 DEBRX3L Strong Genetic Variation [495]
MAT2B DEKF1OH Definitive Biomarker [496]
PON2 DEHJU7E Definitive Biomarker [497]
WARS1 DEPVE0M Definitive Biomarker [498]
WARS2 DEPTKBQ Definitive Genetic Variation [498]
------------------------------------------------------------------------------------
⏷ Show the Full List of 26 DME(s)
This Disease Is Related to 556 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ABRAXAS2 OTAW1I4C Limited Altered Expression [499]
ACSL5 OT3L9XO3 Limited Genetic Variation [500]
ACSL6 OT0TT8P8 Limited Genetic Variation [500]
AGGF1 OTA7U2T8 Limited Biomarker [501]
AIMP1 OTTA5C3U Limited Biomarker [502]
AIRE OTA7G1Y1 Limited Biomarker [503]
AK1 OT614AR3 Limited Therapeutic [504]
ANP32B OT3SQMLU Limited Biomarker [505]
APOD OTT77XW8 Limited Biomarker [506]
APOM OTI3FQQC Limited Altered Expression [507]
ATG5 OT4T5SMS Limited Biomarker [251]
ATP5F1D OTXTAG2V Limited Biomarker [508]
ATXN1 OTQF0HNR Limited Biomarker [509]
AZIN2 OT8OB7CG Limited Biomarker [510]
BAG3 OTVXYUDQ Limited Biomarker [511]
BEST1 OTWHE1ZC Limited Biomarker [512]
BHLHE40 OTITX14U Limited Altered Expression [513]
BRINP3 OT4VFHWN Limited Genetic Variation [514]
BTBD8 OT3A3RD7 Limited Biomarker [515]
BTN2A1 OTUYPMZJ Limited Genetic Variation [516]
C7 OTZ27VJN Limited Biomarker [517]
C8A OTIJ65J4 Limited Biomarker [518]
C8B OTGDJJOK Limited Biomarker [518]
CACYBP OTJMZD2T Limited Biomarker [519]
CAST OTBXZZGF Limited Biomarker [520]
CD93 OT6HZT6H Limited Genetic Variation [521]
CFL1 OTT6D5MH Limited Therapeutic [522]
CGAS OTJYIXNB Limited Biomarker [523]
CHP1 OTHTXN1A Limited Biomarker [524]
CLOCK OTNEOJY7 Limited Genetic Variation [525]
COL1A1 OTI31178 Limited Therapeutic [526]
COL4A3 OT6SB8X5 Limited Biomarker [527]
CREG1 OTRHJ8HK Limited Biomarker [528]
CREM OTJIJ5AL Limited Biomarker [84]
CSNK2B OT2WW7R1 Limited Biomarker [85]
CXCL16 OTD49T9R Limited Biomarker [529]
DAB2 OTRMQTMZ Limited Biomarker [530]
DAB2IP OTF456VC Limited Biomarker [531]
DAPK2 OTWODUQG Limited Biomarker [183]
DDAH2 OT8Q40G2 Limited Genetic Variation [532]
DENR OTXP9HOY Limited Biomarker [183]
DUOX1 OTQ2AEW0 Limited Altered Expression [344]
DUOX2 OTU14HCN Limited Altered Expression [344]
DVL1 OTD67RF1 Limited Biomarker [533]
ETV2 OTP5URZ8 Limited Biomarker [534]
FCN2 OTTHJBKZ Limited Genetic Variation [535]
FIS1 OT2HL10J Limited Biomarker [74]
FOXO4 OT90X9LN Limited Altered Expression [536]
FZD2 OT952ML1 Limited Biomarker [537]
GDF11 OTOSNMND Limited Biomarker [538]
GHRH OT94U6MO Limited Therapeutic [539]
GOLGA6A OTHU9MRX Limited Genetic Variation [279]
GPR42 OTEB0ROY Limited Altered Expression [79]
GRK4 OTUU8V2S Limited Genetic Variation [540]
GSTM2 OTG4WT05 Limited Genetic Variation [541]
HADH OTJDOL20 Limited Biomarker [542]
HAVCR1 OT184CRZ Limited Altered Expression [344]
INSRR OT3F75WA Limited Genetic Variation [543]
ITGA3 OTBCH21D Limited Biomarker [544]
KCNE2 OTUO214Y Limited Genetic Variation [180]
KLF13 OTMIKHZ4 Limited Biomarker [77]
LRG1 OTLD0KWA Limited Genetic Variation [227]
MFF OTEVIXOM Limited Biomarker [545]
MFN2 OTPYN8A3 Limited Therapeutic [546]
MIA3 OTBVIZQD Limited Genetic Variation [192]
MOK OTQK7M9V Limited Genetic Variation [547]
MPI OTBH6ZK1 Limited Biomarker [548]
MRAS OTNCVCQW Limited Genetic Variation [549]
MST1 OTOC4UNG Limited Biomarker [550]
MTHFD1L OTV01EFP Limited Genetic Variation [551]
MYDGF OT9HRPL6 Limited Biomarker [552]
NANOS3 OTGX9IQU Limited Genetic Variation [553]
NEIL3 OTBCI2NS Limited Posttranslational Modification [554]
NUCB2 OTHO6JWN Limited Biomarker [555]
PDCD4 OTZ6NXUX Limited Altered Expression [556]
PER2 OTU2B1DJ Limited Biomarker [557]
PFN2 OT5SSSA7 Limited Biomarker [558]
PKD1 OT5ALRZ5 Limited Genetic Variation [559]
PLB1 OTZ6TTYV Limited Altered Expression [387]
PLCB3 OT0OMDEM Limited Biomarker [158]
PROCR OTRHED17 Limited Genetic Variation [560]
PRORP OTWIS44P Limited Genetic Variation [561]
RAD50 OTYMU9G1 Limited Therapeutic [562]
RANBP1 OTQE226K Limited Biomarker [563]
RAPGEF5 OT53VS75 Limited Biomarker [564]
RCBTB1 OTAYELI8 Limited Genetic Variation [279]
RHOV OTW4N3QN Limited Biomarker [524]
RYR2 OT0PF19E Limited Biomarker [565]
SDC4 OTKUVUGZ Limited Biomarker [407]
SEMA3F OTQFMS8S Limited Genetic Variation [566]
SEMA6A OTDQ7QAW Limited Biomarker [567]
SERPINA3 OT9BP2S0 Limited Altered Expression [568]
SH2B1 OTJZO2CI Limited Genetic Variation [569]
SLPI OTUNFUU8 Limited Therapeutic [570]
SMN2 OT54RLO1 Limited Altered Expression [95]
SOD3 OTIOZQAB Limited Genetic Variation [571]
SPESP1 OTWXKKTJ Limited Genetic Variation [246]
TAS2R50 OTPRMVZW Limited Biomarker [572]
TBX3 OTM64N7K Limited Biomarker [573]
TCP1 OT1MGUX9 Limited Biomarker [482]
TGFBR3 OTQOOUC4 Limited Biomarker [574]
THBS2 OTXET551 Limited Genetic Variation [288]
THY1 OTVONVTB Limited Altered Expression [575]
TRIB1 OTPEO17G Limited Genetic Variation [576]
TTN OT0LZ058 Limited Biomarker [577]
C1QTNF9 OTLI3VA3 Disputed Biomarker [578]
ADAMTS7 OTVKZ1DV moderate Biomarker [579]
ANKUB1 OT8QXDL8 moderate Genetic Variation [180]
CD151 OTF3UZS7 moderate Biomarker [580]
CD180 OTITK5E6 moderate Biomarker [581]
CELSR2 OTON6JSZ moderate Genetic Variation [192]
DDX39A OT0Z6E1K moderate Genetic Variation [469]
DDX39B OTEVCFVU moderate Genetic Variation [469]
EPRS1 OTXK0FLB moderate Genetic Variation [582]
MORF4L1 OTEA6FYJ moderate Genetic Variation [192]
NFKBIL1 OTYFTPS0 moderate Genetic Variation [469]
PDZD2 OTPPVRGY moderate Genetic Variation [180]
PLPP3 OTSSF7BK moderate Genetic Variation [192]
REG1A OTMHUH1D moderate Biomarker [583]
RETN OTW5Z1NH moderate Altered Expression [584]
SCG2 OTXWUQQL moderate Biomarker [585]
SMAD2 OTC6VB4K moderate Altered Expression [96]
TFAM OTXXV5V7 moderate Altered Expression [586]
TIMP4 OT8A68SW moderate Genetic Variation [587]
A1CF OTJBKFA1 Strong Biomarker [194]
AATF OT1QOKLD Strong Biomarker [231]
ACCS OTHIHI9D Strong Biomarker [483]
ACD OTC54EPO Strong Biomarker [588]
ACOT7 OT7C68YV Strong Genetic Variation [589]
ACSS1 OT6C1WQD Strong Genetic Variation [207]
ACTA2 OTEDLG8E Strong Genetic Variation [590]
ACTBL2 OTD6B81U Strong Genetic Variation [589]
ACTG2 OTRDWUO0 Strong Genetic Variation [589]
ADIPOR2 OT2HDTL8 Strong Genetic Variation [591]
ADTRP OTFI2BQX Strong Altered Expression [592]
AGBL2 OTCX9987 Strong Biomarker [593]
AHSA1 OTC7AFHT Strong Altered Expression [135]
AIDA OTMRLWGT Strong Biomarker [594]
AKAP12 OTCVRDDX Strong Biomarker [595]
AKT1S1 OT4JHN4Y Strong Biomarker [596]
ALMS1 OTW66JKS Strong Genetic Variation [597]
ANGPTL2 OTB6JG41 Strong Altered Expression [598]
ANK2 OTWB4R1Y Strong Biomarker [599]
ANXA7 OTLMD0TK Strong Biomarker [600]
AP3D1 OTJLI0IM Strong Genetic Variation [274]
APELA OTYY0P69 Strong Biomarker [98]
APIP OT8ZABOU Strong Biomarker [215]
APOA5 OTEVKLVA Strong Genetic Variation [601]
APOC4 OTE8ZUXY Strong Biomarker [602]
ARC OTN2QQPG Strong Biomarker [603]
ARPP21 OTWXZN5I Strong Biomarker [604]
ARTN OTWIWGL6 Strong Biomarker [217]
ARVCF OT78DKOU Strong Genetic Variation [207]
ASCC1 OTH4VAP9 Strong Altered Expression [605]
ASPM OTKXQMNA Strong Biomarker [194]
ATF6 OTAFHAVI Strong Biomarker [606]
ATL1 OTR2788Y Strong Biomarker [607]
ATP10D OT3JPE4H Strong Genetic Variation [608]
ATP6AP2 OT0IABVV Strong Altered Expression [609]
AZU1 OTHXU264 Strong Biomarker [610]
BCAP31 OTKSACR4 Strong Altered Expression [320]
BFAR OTTBG0V7 Strong Biomarker [611]
BID OTOSHSHU Strong Altered Expression [612]
BIN1 OTK8O0X8 Strong Genetic Variation [207]
BNIP3 OT4SO7J4 Strong Biomarker [613]
BNIP3L OTJKOMXE Strong Altered Expression [614]
BTNL2 OTTTEMZA Strong Biomarker [615]
C1QTNF5 OTLKU5I2 Strong Biomarker [616]
C9 OT7I5FDX Strong Biomarker [196]
CACUL1 OT6P1ZVP Strong Genetic Variation [617]
CANX OTYP1F6J Strong Biomarker [618]
CARD8 OTXXZYWU Strong Altered Expression [619]
CASZ1 OTWJ2OR8 Strong Altered Expression [474]
CAV3 OTWSFDB4 Strong Altered Expression [620]
CCDC63 OTKDRXAE Strong Genetic Variation [213]
CCDC93 OTTEMYL1 Strong Genetic Variation [621]
CCL19 OTQ2UJMH Strong Genetic Variation [622]
CCT2 OTW1VV4E Strong Genetic Variation [207]
CD5L OTPY4WQR Strong Biomarker [623]
CDC73 OT6JASZ1 Strong Genetic Variation [624]
CDCA7L OT1FFWKC Strong Genetic Variation [223]
CDCP1 OTD7RRWK Strong Genetic Variation [624]
CEACAM7 OTKFDTZY Strong Genetic Variation [253]
CEBPD OTNBIPMY Strong Altered Expression [625]
CELF1 OT6JQ5RS Strong Altered Expression [626]
CELF4 OT4FS4F5 Strong Biomarker [627]
CENPC OTVJ6VE9 Strong Altered Expression [628]
CFAP97 OT0RSQO4 Strong Altered Expression [629]
CIITA OTRJNZFO Strong Genetic Variation [630]
CITED4 OTR6NHI2 Strong Biomarker [301]
CKB OTUCKOTT Strong Biomarker [631]
CKM OTME0KO7 Strong Biomarker [632]
CLEC16A OTLGV5SV Strong Genetic Variation [207]
CLEC4E OT7P8ICY Strong Altered Expression [633]
CNNM2 OTZHO8WU Strong Genetic Variation [634]
CNPY2 OTGY8ESX Strong Altered Expression [635]
COL13A1 OTM9IM6J Strong Genetic Variation [207]
COL3A1 OTT1EMLM Strong Biomarker [636]
COL4A1 OTL6D1YE Strong Biomarker [527]
COL4A2 OTJK1LKN Strong Altered Expression [637]
COL5A2 OT5VOSQE Strong Biomarker [638]
COL6A5 OTJT8O80 Strong Genetic Variation [213]
COMMD7 OTWWJ97D Strong Genetic Variation [639]
COMP OTS2FPMI Strong Altered Expression [640]
COQ5 OTRLXGS6 Strong Biomarker [641]
CPA3 OTOK8M0V Strong Biomarker [87]
CPLX2 OTU5QWFH Strong Genetic Variation [207]
CPT1A OTI862QH Strong Biomarker [642]
CPT2 OTIN6G20 Strong Biomarker [642]
CREBZF OTO3TOEU Strong Genetic Variation [643]
CRX OTH435SV Strong Biomarker [400]
CSH1 OT33HTRR Strong Biomarker [644]
CSH2 OTW8JVAN Strong Biomarker [644]
CST2 OTRKRW50 Strong Genetic Variation [207]
CTSZ OTSCX2LL Strong Biomarker [645]
CUL9 OTPUCLZT Strong Genetic Variation [207]
CXCL6 OTFTCQ4O Strong Biomarker [646]
DBP OTE0W7LN Strong Genetic Variation [647]
DCP1B OTX7PHCI Strong Genetic Variation [648]
DDIT3 OTI8YKKE Strong Altered Expression [520]
DDT OTF5HTYL Strong Altered Expression [628]
DECR1 OTCDIR6X Strong Biomarker [649]
DEGS1 OT4WXPKW Strong Biomarker [650]
DERL3 OTRZRT6Q Strong Biomarker [651]
DIDO1 OT9PB547 Strong Genetic Variation [207]
DIPK2A OTL1DBIM Strong Biomarker [652]
DISC1 OT43AW4H Strong Genetic Variation [624]
DNAI1 OTF6C65Q Strong Biomarker [653]
DNAJA3 OT61924T Strong Biomarker [654]
DNAJC6 OT1P6ZIE Strong Genetic Variation [207]
DNALI1 OTTB3L8N Strong Altered Expression [320]
DNM1L OTXK1Q1G Strong Biomarker [655]
DSPP OT1TYNDN Strong Biomarker [656]
ECM1 OT1K65VW Strong Biomarker [657]
EFNA3 OTJGOUMZ Strong Genetic Variation [658]
EIF4A3 OTYYFE7K Strong Biomarker [106]
ELN OTFSO7PG Strong Biomarker [659]
ELOVL6 OTB26UJJ Strong Biomarker [660]
EMC10 OTQ6S50X Strong Biomarker [661]
EMC8 OTIUTHS1 Strong Genetic Variation [207]
ERAL1 OTSH78HD Strong Biomarker [662]
ERCC8 OT0T4WKI Strong Biomarker [644]
ERFE OTSES1HA Strong Biomarker [616]
ERGIC1 OT351FKB Strong Genetic Variation [207]
FAIM2 OT6QINVO Strong Genetic Variation [663]
FANCD2 OTVEB5LF Strong Biomarker [664]
FBP1 OTQBANEP Strong Genetic Variation [295]
FBXO32 OTUE978R Strong Biomarker [665]
FEM1A OT0BGJQS Strong Altered Expression [666]
FERMT3 OTFQOT3C Strong Biomarker [667]
FGA OTMIHY80 Strong Genetic Variation [668]
FGB OT6RKLI9 Strong Genetic Variation [133]
FGF16 OT6BHWZP Strong Biomarker [669]
FHL5 OT6C00Z1 Strong Genetic Variation [589]
FSD1 OT8P6PT3 Strong Biomarker [232]
FSD1L OTBQ48RF Strong Biomarker [232]
FSTL1 OT6KEZUD Strong Biomarker [670]
FUBP1 OT77SC9N Strong Genetic Variation [295]
FUT7 OTJF6BSN Strong Genetic Variation [207]
FZD1 OTZATHVS Strong Altered Expression [671]
GABPA OT9YB2SA Strong Altered Expression [672]
GAL3ST1 OTSFFZRD Strong Altered Expression [474]
GCA OTAJ7ZHG Strong Biomarker [673]
GCKR OTSIWXGG Strong Genetic Variation [674]
GDF1 OTZ1VRBH Strong Genetic Variation [675]
GDF10 OTEVXGJ7 Strong Biomarker [520]
GLRA2 OTDQ0KW7 Strong Biomarker [595]
GNLY OTZJKA8C Strong Biomarker [676]
GOLGA4 OTCMEHNJ Strong Biomarker [646]
GOSR1 OTX8TMVU Strong Altered Expression [320]
GOSR2 OTYHIYN2 Strong Genetic Variation [677]
GPLD1 OTUUQOVY Strong Biomarker [385]
GPR135 OTXOY5NW Strong Genetic Variation [207]
GPR151 OT7EACU6 Strong Altered Expression [79]
GPR160 OTMXJT73 Strong Genetic Variation [207]
GPR65 OTCF5O4G Strong Biomarker [678]
GPX4 OTRAFFX2 Strong Altered Expression [679]
GRAP2 OTS5NIZ3 Strong Altered Expression [135]
GREM2 OTE91EWT Strong Biomarker [680]
GUCY1A1 OTPTCBUN Strong Genetic Variation [681]
HHEX OTLIUVYX Strong Genetic Variation [682]
HHIPL1 OT3GMU2X Strong Genetic Variation [683]
HLA-DMB OT17HGXJ Strong Biomarker [684]
HMCN1 OTLZAS0P Strong Altered Expression [685]
HSPA14 OTZCA5LK Strong Biomarker [686]
HSPA1L OTC2V1K6 Strong Biomarker [687]
HSPB2 OTS01646 Strong Genetic Variation [330]
HSPB6 OTFPLGZI Strong Biomarker [688]
HSPB7 OTLATAOV Strong Biomarker [689]
ICAM3 OTTZ5A5D Strong Biomarker [430]
IER3 OTZJI5FZ Strong Altered Expression [690]
IGFBP4 OT2HZRBD Strong Biomarker [691]
IKZF5 OTJN51OC Strong Genetic Variation [692]
IL1F10 OTJAASGC Strong Biomarker [693]
IL34 OTZ15VVK Strong Altered Expression [694]
IL6R OTCQL07Z Strong Genetic Variation [695]
IL6ST OT1N9C70 Strong Biomarker [696]
ILF3 OTKMZ5K5 Strong Genetic Variation [697]
IPP OTCGBS3H Strong Biomarker [698]
IRF5 OT8SIIAP Strong Genetic Variation [207]
ISL1 OTVNVKAX Strong Biomarker [699]
ITIH3 OT4SLMLY Strong Genetic Variation [700]
ITPK1 OTP4PGL6 Strong Genetic Variation [207]
IVD OT8JFXUQ Strong Genetic Variation [207]
JCAD OT7G1WJW Strong Biomarker [114]
JDP2 OTW35WKX Strong Biomarker [701]
JPH2 OTL9YH7V Strong Biomarker [702]
JPH3 OTHTJO2I Strong Genetic Variation [207]
KBTBD7 OT1NIRLK Strong Biomarker [703]
KCNIP2 OTY4BLOJ Strong Altered Expression [704]
KIF2C OTJ8G3NP Strong Genetic Variation [705]
KIF3A OTMUBSSK Strong Biomarker [401]
KIF6 OTDH3MR4 Strong Genetic Variation [706]
KLF9 OTBFEJRQ Strong Biomarker [707]
KRT1 OTIOJWA4 Strong Biomarker [708]
LAD1 OT6YGTVX Strong Biomarker [709]
LAMA3 OTFME7HT Strong Genetic Variation [207]
LARGE2 OT5BZS3J Strong Genetic Variation [207]
LCP1 OTK61F2A Strong Genetic Variation [710]
LDLRAP1 OT6QTX7R Strong Genetic Variation [711]
LIPC OTZY5SC9 Strong Genetic Variation [712]
LRP8 OTZ71YV2 Strong Genetic Variation [713]
LRPAP1 OT6DVD2Q Strong Genetic Variation [207]
LRPPRC OTXSK5LP Strong Biomarker [696]
LRRFIP1 OTN7XAUD Strong Genetic Variation [639]
LTBP2 OTS88GSD Strong Genetic Variation [207]
LZTR1 OTIDM6XO Strong Genetic Variation [207]
MAP1LC3A OTPMGIU4 Strong Altered Expression [714]
MARCHF10 OTAYGHDM Strong Genetic Variation [207]
MBNL1 OTOV7J85 Strong Biomarker [715]
MCCC2 OTQDHSMI Strong Genetic Variation [207]
MDH2 OT7364GY Strong Biomarker [381]
MED23 OTKZQT0R Strong Biomarker [716]
MEF2C OTZGF1Y5 Strong Altered Expression [717]
MEFV OTRJ6S6K Strong Biomarker [372]
MEIS2 OTG4ADLM Strong Biomarker [718]
MLC1 OTCNZLSP Strong Biomarker [719]
MLKL OTDSLC81 Strong Biomarker [613]
MOB3C OT2OFNGF Strong Genetic Variation [213]
MPRIP OT5FV5NS Strong Biomarker [613]
MRE11 OTGU8TZM Strong Genetic Variation [720]
MRGPRX3 OTRKCCDS Strong Altered Expression [79]
MRGPRX4 OTOBHZVA Strong Altered Expression [79]
MRPS6 OTKFY73U Strong Genetic Variation [476]
MRTFA OTCVXASM Strong Biomarker [721]
MSC OTBRPZL5 Strong Biomarker [722]
MTHFD1 OTMKHVWC Strong Genetic Variation [723]
MYBL2 OTZ3JX8Q Strong Biomarker [724]
MYH6 OT3YNCH1 Strong Biomarker [725]
MYOCD OTSJNHTH Strong Biomarker [726]
NAB1 OTEWHIZR Strong Biomarker [727]
NBEAL1 OTLJ11N3 Strong Biomarker [728]
NCAPG2 OTZYENKO Strong Biomarker [729]
NCOR2 OTY917X0 Strong Genetic Variation [207]
NCR3 OT20M764 Strong Biomarker [213]
NDNF OTCDL9PG Strong Biomarker [730]
NDST1 OT9E10W2 Strong Genetic Variation [207]
NENF OTGL7MHB Strong Biomarker [730]
NFAT5 OTKIE59S Strong Biomarker [731]
NGB OTW0SIUY Strong Biomarker [732]
NKX2-5 OTS1SAWM Strong Biomarker [733]
NOX5 OTHTH59G Strong Biomarker [734]
NPPA OTMQNTNX Strong Altered Expression [735]
NR2E3 OTO3GBHQ Strong Biomarker [315]
NRG3 OTIFZ5CT Strong Biomarker [627]
NRIP1 OTIZOJQV Strong Biomarker [736]
NUCKS1 OTL4VJC5 Strong Biomarker [737]
NUP210 OT3BLQ9M Strong Genetic Variation [207]
OGA OT7ZBWT1 Strong Altered Expression [492]
OGN OTKP5S4L Strong Altered Expression [738]
OMA1 OT0JRVY7 Strong Biomarker [739]
OSGIN1 OT9KIVZW Strong Genetic Variation [207]
OSTN OTL4A57N Strong Biomarker [740]
PADI2 OTT40K94 Strong Biomarker [709]
PAGR1 OTXR5PQ8 Strong Genetic Variation [741]
PALLD OTZ2MUJZ Strong Genetic Variation [742]
PAPPA OTTTG9PG Strong Genetic Variation [743]
PCDH18 OTTLQWRN Strong Biomarker [744]
PDE8B OT4217NK Strong Genetic Variation [745]
PDHB OT2NHE5E Strong Biomarker [286]
PDK4 OTCMHMBZ Strong Biomarker [286]
PEAR1 OT2XLTB2 Strong Genetic Variation [746]
PELI1 OTMLBCLC Strong Biomarker [747]
PER3 OTVKYVJA Strong Biomarker [748]
PFN1 OTHTGA1H Strong Altered Expression [749]
PHLPP2 OTXB1OUI Strong Biomarker [750]
PIEZO1 OTBG1FU4 Strong Altered Expression [751]
PIGQ OTOD93DQ Strong Genetic Variation [207]
PIK3C2G OTW3LY1C Strong Genetic Variation [624]
PITRM1 OTDEAZ8K Strong Genetic Variation [207]
PITX3 OTE2KT8P Strong Biomarker [535]
PLA2G15 OT6VJTPA Strong Biomarker [483]
PLA2G3 OT3K7TMY Strong Genetic Variation [207]
PLCB2 OTPAHDGO Strong Genetic Variation [213]
PLCL2 OTK5FDF6 Strong Genetic Variation [274]
PLEKHO1 OTMVUQ9W Strong Biomarker [752]
POFUT1 OTOBJZIT Strong Altered Expression [753]
POLDIP2 OT8SZSJ6 Strong Altered Expression [135]
POTEM OT7L2HGH Strong Genetic Variation [589]
PPARGC1A OTHCDQ22 Strong Biomarker [754]
PPIG OTZ8BTTM Strong Genetic Variation [481]
PPM1L OTGGNG6M Strong Biomarker [755]
PPP1R1A OTGTAGCV Strong Biomarker [756]
PPP1R42 OTN1HRBN Strong Biomarker [322]
PPP6R2 OTERHESI Strong Biomarker [757]
PPP6R3 OTIXD60Q Strong Biomarker [758]
PRF1 OTFVXD7H Strong Biomarker [759]
PRH1 OTQZ6HX0 Strong Biomarker [760]
PRKAB1 OT1OG4QZ Strong Altered Expression [761]
PROX1 OT68R6IO Strong Biomarker [762]
PSG2 OT2EIXAI Strong Genetic Variation [253]
PSMA4 OTAD2XXI Strong Genetic Variation [207]
PSMA6 OTJ6RPX5 Strong Genetic Variation [763]
PSMB4 OTOJ9OHA Strong Genetic Variation [207]
PSRC1 OT7MDJMN Strong Genetic Variation [634]
PTBP2 OTF4S7NE Strong Genetic Variation [764]
PTPRN2 OTL6SH28 Strong Genetic Variation [207]
PTX3 OTPXHRKU Strong Biomarker [765]
PXDN OTFGGM9R Strong Biomarker [766]
QKI OTTAUGLB Strong Genetic Variation [767]
RAB14 OTF1J0TB Strong Genetic Variation [295]
RABGEF1 OTWC3Z3R Strong Biomarker [768]
RAE1 OT54OKC3 Strong Altered Expression [769]
RAP1A OT5RH6TI Strong Biomarker [768]
RECQL5 OTVZMP1Q Strong Biomarker [770]
REM1 OTUXL0HC Strong Biomarker [771]
RFC1 OT3L5PK3 Strong Genetic Variation [772]
RGS5 OTUY0Q2I Strong Biomarker [773]
RIPK3 OTL1D484 Strong Biomarker [613]
RLN2 OTY3OG71 Strong Biomarker [774]
RMDN1 OTE1NB6U Strong Biomarker [714]
RMDN2 OTK5WSFI Strong Biomarker [714]
RMDN3 OTKO7AUM Strong Biomarker [714]
RNASE1 OTKZ7CO9 Strong Biomarker [775]
RNASE2 OT8Z4FNE Strong Biomarker [776]
RNASE7 OTIXO0Z4 Strong Altered Expression [769]
RNF13 OT7HNYF4 Strong Genetic Variation [180]
RNF19A OTKWCV80 Strong Altered Expression [135]
ROPN1L OTRWZJ68 Strong Biomarker [194]
RTCA OTSJRVTD Strong Biomarker [777]
RYR3 OT4EHIP4 Strong Genetic Variation [778]
SAFB OTGRV2LW Strong Biomarker [779]
SBF1 OTW6I9RV Strong Genetic Variation [207]
SEC24D OTXR3KC9 Strong Genetic Variation [780]
SELENOP OT02B8IR Strong Biomarker [781]
SEPTIN1 OT4GVSU3 Strong Biomarker [782]
SEPTIN9 OT1VMRFQ Strong Genetic Variation [207]
SERPINF2 OTZGAF8B Strong Genetic Variation [783]
SF3A2 OTJ68IB1 Strong Genetic Variation [274]
SFRP2 OT8GZ0CA Strong Biomarker [784]
SIAH2 OTKED2XN Strong Biomarker [785]
SIRT4 OT5S0J23 Strong Altered Expression [786]
SLC22A18 OT9C3KR4 Strong Biomarker [779]
SLN OTERIU75 Strong Biomarker [787]
SMAD4 OTWQWCKG Strong Altered Expression [96]
SMTN OT4R2TYK Strong Biomarker [788]
SNX17 OT2I652M Strong Genetic Variation [789]
SOAT1 OTB4Y5RJ Strong Biomarker [790]
SORCS2 OTBF3DYK Strong Genetic Variation [207]
SOSTDC1 OTAKDNSM Strong Genetic Variation [791]
SPAAR OTWXG2R8 Strong Biomarker [792]
SPRR2A OT62ZU6B Strong Biomarker [235]
SPTBN5 OT8MUQDU Strong Genetic Variation [207]
SPTLC2 OTBTMH1Z Strong Genetic Variation [793]
SRSF3 OTOFT707 Strong Altered Expression [794]
ST3GAL4 OTNENJZQ Strong Biomarker [795]
ST6GALNAC1 OT3JQD99 Strong Biomarker [796]
STARD7 OTDUZ296 Strong Genetic Variation [216]
STAT4 OTAK3VFR Strong Biomarker [336]
STING1 OTDAP4G0 Strong Altered Expression [332]
STRA6 OT2IDF27 Strong Biomarker [797]
STX6 OTC5F5M6 Strong Biomarker [798]
STXBP1 OTRYA8C3 Strong Biomarker [351]
STXBP2 OTX8GUC4 Strong Genetic Variation [799]
SUMO1 OTJFD4P5 Strong Altered Expression [800]
SYBU OT3FQV7N Strong Biomarker [714]
TAF4 OTPIRFEF Strong Genetic Variation [207]
TBPL1 OT4I143E Strong Biomarker [801]
TBX20 OTMPU2XQ Strong Biomarker [802]
TBX5 OT70PISV Strong Biomarker [717]
TCF25 OTTFHHU9 Strong Genetic Variation [207]
TCFL5 OTJL4348 Strong Biomarker [803]
TCHP OTVDMHSY Strong Biomarker [804]
TENM2 OTPLUYEF Strong Biomarker [805]
TENM3 OTWY13GR Strong Genetic Variation [767]
TERF2IP OT3M5P3G Strong Biomarker [768]
THAP5 OT6ZMFYF Strong Altered Expression [806]
TIMP1 OTOXC51H Strong Biomarker [807]
TIMP2 OT8S1RRP Strong Biomarker [807]
TIMP3 OTDGQAD1 Strong Biomarker [808]
TINAGL1 OTZZO56M Strong Genetic Variation [809]
TM7SF2 OTILU5S7 Strong Biomarker [68]
TMED5 OT70W1J8 Strong Altered Expression [320]
TMEM11 OTL9HDEY Strong Genetic Variation [495]
TMEM54 OTPQEFR0 Strong Genetic Variation [617]
TMOD4 OTXLGJ4R Strong Genetic Variation [213]
TMTC3 OTMTTDYG Strong Genetic Variation [643]
TNFAIP6 OT1SLUZH Strong Altered Expression [810]
TNNI2 OTGGZFSC Strong Biomarker [811]
TNRC6A OT493IOM Strong Altered Expression [812]
TNXB OTVBWAV5 Strong Biomarker [813]
TOMM70 OT8QBYZ0 Strong Biomarker [814]
TP73 OT0LUO47 Strong Genetic Variation [207]
TRAF3IP2 OTLLZERL Strong Genetic Variation [815]
TRAPPC9 OTF0CVMC Strong Genetic Variation [207]
TRDMT1 OTAYQ8ZF Strong Genetic Variation [207]
TSC22D3 OT03UM03 Strong Biomarker [816]
TSPAN9 OT3DI3NH Strong Genetic Variation [207]
TTC3 OTTR9WUC Strong Biomarker [817]
A2M OTFTX90K Definitive Genetic Variation [818]
AKAP10 OTPNFTOU Definitive Genetic Variation [448]
AMPD1 OTU17BCI Definitive Genetic Variation [819]
APOC2 OTLINYIQ Definitive Genetic Variation [820]
ATAD1 OTJ02XFL Definitive Genetic Variation [821]
ATOH1 OTBZYG2R Definitive Genetic Variation [822]
ATP5PF OTDAE8FP Definitive Biomarker [823]
B3GNT2 OTE69HV8 Definitive Biomarker [824]
B3GNTL1 OTYWGHF1 Definitive Biomarker [824]
BMS1 OTEGQ8ZO Definitive Genetic Variation [825]
CKMT2 OT1KNPI1 Definitive Genetic Variation [826]
CLDN5 OTUX60YO Definitive Biomarker [827]
CPSF4 OT53UK5L Definitive Biomarker [828]
DGCR2 OTEGL17Z Definitive Genetic Variation [829]
E2F4 OTB3JFH4 Definitive Genetic Variation [830]
EAF2 OTSOET5L Definitive Genetic Variation [831]
EARS2 OTNCJKY7 Definitive Biomarker [832]
GARS1 OT5B6R9Y Definitive Biomarker [833]
GYS1 OTJZJRWK Definitive Genetic Variation [834]
HFM1 OTHV3EFE Definitive Genetic Variation [835]
HNRNPUL1 OTJP4U7K Definitive Genetic Variation [836]
HRG OTPLUFOG Definitive Genetic Variation [837]
IRF6 OTKJ44EV Definitive Genetic Variation [838]
ISYNA1 OT49ONSE Definitive Altered Expression [839]
ITIH4 OT460OO1 Definitive Biomarker [840]
JTB OT314JB6 Definitive Genetic Variation [828]
KCNE1 OTZNQUW9 Definitive Genetic Variation [841]
KRT16 OTGA0EQN Definitive Genetic Variation [842]
LRRC3B OT9VDGPR Definitive Genetic Variation [826]
MAP2K6 OTK13JKC Definitive Altered Expression [843]
MPZL2 OTKFNDUI Definitive Genetic Variation [464]
ND2 OTG9OHOX Definitive Genetic Variation [844]
PC OT6O0V51 Definitive Altered Expression [845]
PI3 OT47MTC3 Definitive Biomarker [846]
PLA1A OT2IXYNX Definitive Genetic Variation [847]
PPP1R11 OTSHYPPW Definitive Genetic Variation [700]
PTPRA OTZA82J1 Definitive Genetic Variation [848]
RAMP1 OT7UT2XB Definitive Altered Expression [849]
RASGRF2 OT67DAGF Definitive Genetic Variation [826]
RCAN1 OT1MVXC7 Definitive Altered Expression [850]
SARS2 OTU4T99W Definitive Biomarker [851]
SERPINA4 OTBK0GG7 Definitive Biomarker [852]
SNRNP70 OTP52YZ3 Definitive Genetic Variation [853]
SP3 OTYDQZ1T Definitive Genetic Variation [854]
TPD52 OTPKSK43 Definitive Genetic Variation [842]
TRIB3 OTG5OS7X Definitive Genetic Variation [855]
TSPAN10 OTL4LIHB Definitive Biomarker [856]
------------------------------------------------------------------------------------
⏷ Show the Full List of 556 DOT(s)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 Emerging drugs in peripheral arterial disease. Expert Opin Emerg Drugs. 2006 Mar;11(1):75-90.
3 Atenolol FDA Label
4 ClinicalTrials.gov (NCT01732822) A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease. U.S. National Institutes of Health.
5 Clopidogrel FDA Label
6 Dicumarol FDA Label
7 Fondaparinux sodium FDA Label
8 Lisinopril FDA Label
9 Metoprolol FDA Label
10 Phenprocoumon FDA Label
11 Fully biodegradable coronary stents : progress to date. Am J Cardiovasc Drugs. 2008;8(5):305-14.
12 Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study. J Neurosurg. 2013 Sep;119(3):634-41.
13 Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics. J Med Chem. 2005 Jan 13;48(1):171-9.
14 Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70.
15 Ticlopidine FDA Label
16 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4047).
17 Amediplase: CGP 42935, K2tu-PA, MEN 9036. BioDrugs. 2002;16(5):378-9.
18 ClinicalTrials.gov (NCT00112281) A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart Attack. U.S. National Institutes of Health.
19 Clinical pipeline report, company report or official report of Fina Biotech Slu.
20 ClinicalTrials.gov (NCT02976467) A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction (CHIARA MIA 2). U.S. National Institutes of Health.
21 ClinicalTrials.gov (NCT02485938) HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne).
22 Efegatran. Institute for drug research/IVAX. IDrugs. 2001 Jun;4(6):691-4.
23 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
24 Frontiers in Anti-Infective Drug Discovery, Atta-ur-Rahman, . Iqbal Choudhary. Page(57).
25 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007709)
26 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023304)
27 ClinicalTrials.gov (NCT01311518) A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction. U.S. National Institutes of Health.
28 Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic Res Commun. 1991;12-13 Pt 2:563-9.
29 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021706)
30 ClinicalTrials.gov (NCT00144014) Safety and Efficacy Study in Acute Ischaemic Stroke. U.S. National Institutes of Health.
31 Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention. J Cardiol. 2014 Jan;63(1):82-7.
32 Clinical pipeline report, company report or official report of 22nd Century Group.
33 ClinicalTrials.gov (NCT00557531) Safety and Feasibility of the Injectable BL-1040 Implant. U.S. National Institutes of Health.
34 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5715).
35 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025803)
36 Clinical pipeline report, company report or official report of Cytori Therapeutics.
37 ClinicalTrials.gov (NCT00886353) Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2). U.S. National Institutes of Health.
38 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027040)
39 Clinical pipeline report, company report or official report of Capricor.
40 ClinicalTrials.gov (NCT00984113) Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment. U.S. National Institutes of Health.
41 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019945)
42 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001565)
43 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6548).
44 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005012)
45 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004026)
46 Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart fail... Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2522-7.
47 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015478)
48 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007938)
49 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004614)
50 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004736)
51 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010067)
52 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010403)
53 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004615)
54 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025735)
55 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004786)
56 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
57 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 948).
58 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2771).
59 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2393).
60 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800042366)
61 Myocardial infarction in a 36-year-old man with combined ABCA1 and APOA-1 deficiency.J Clin Lipidol. 2015 May-Jun;9(3):396-9. doi: 10.1016/j.jacl.2015.01.006. Epub 2015 Jan 28.
62 The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.Biomed Pharmacother. 2018 Nov;107:212-218. doi: 10.1016/j.biopha.2018.07.170. Epub 2018 Aug 6.
63 Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function.J Mol Cell Cardiol. 2017 Apr;105:1-11. doi: 10.1016/j.yjmcc.2017.02.002. Epub 2017 Feb 16.
64 Intermedin 1-53 Inhibits Myocardial Fibrosis in Rats by Down-Regulating Transforming Growth Factor-.Med Sci Monit. 2017 Jan 9;23:121-128. doi: 10.12659/msm.898522.
65 Role of adenosine in delayed preconditioning of myocardium.Cardiovasc Res. 2002 Aug 15;55(3):483-94. doi: 10.1016/s0008-6363(02)00280-8.
66 A(3) adenosine receptor activation during reperfusion reduces infarct size through actions on bone marrow-derived cells.J Mol Cell Cardiol. 2010 Aug;49(2):280-6. doi: 10.1016/j.yjmcc.2010.01.018. Epub 2010 Feb 2.
67 Protease-activated receptor 2 protects against myocardial ischemia-reperfusion injury through the lipoxygenase pathway and TRPV1 channels.Exp Ther Med. 2019 Nov;18(5):3636-3642. doi: 10.3892/etm.2019.7987. Epub 2019 Sep 9.
68 Angiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4.J Proteomics. 2019 Sep 30;208:103486. doi: 10.1016/j.jprot.2019.103486. Epub 2019 Aug 19.
69 ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction.Lipids Health Dis. 2018 Aug 7;17(1):184. doi: 10.1186/s12944-018-0835-0.
70 Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype.Cardiovasc Diabetol. 2019 Mar 22;18(1):39. doi: 10.1186/s12933-019-0829-x.
71 APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.
72 Regulation mechanism of aquaporin 9 gene on inflammatory response and cardiac function in rats with myocardial infarction through extracellular signal-regulated kinase1/2 pathway.Heart Vessels. 2019 Dec;34(12):2041-2051. doi: 10.1007/s00380-019-01452-8. Epub 2019 Jun 19.
73 Revised Cardiac Risk Index as a Predictor for Myocardial Infarction and Cardiac Arrest Following Posterior Lumbar Decompression.Spine (Phila Pa 1976). 2019 Feb 1;44(3):E187-E193. doi: 10.1097/BRS.0000000000002783.
74 Autophagy signaling in skeletal muscle of infarcted rats.PLoS One. 2014 Jan 10;9(1):e85820. doi: 10.1371/journal.pone.0085820. eCollection 2014.
75 DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na(+)-K(+)-ATPase, inhibiting Na(+)-K(+)-ATPase/ROS pathway and activating PI3K/Akt and ERK1/2.Toxicol Appl Pharmacol. 2018 Jun 15;349:62-71. doi: 10.1016/j.taap.2018.04.030. Epub 2018 Apr 25.
76 Enhanced involvement of brain vasopressin V1 receptors in cardiovascular responses to stress in rats with myocardial infarction.Stress. 2005 Dec;8(4):273-84. doi: 10.1080/10253890500456287.
77 A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.J Mol Cell Cardiol. 2018 Jan;114:72-82. doi: 10.1016/j.yjmcc.2017.11.003. Epub 2017 Nov 7.
78 Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction.J Mol Cell Cardiol. 2004 Apr;36(4):547-59. doi: 10.1016/j.yjmcc.2004.02.002.
79 Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors.Cell Signal. 2017 Aug;36:240-254. doi: 10.1016/j.cellsig.2017.04.010. Epub 2017 Apr 13.
80 CD177-mediated nanoparticle targeting of human and mouse neutrophils.PLoS One. 2018 Jul 10;13(7):e0200444. doi: 10.1371/journal.pone.0200444. eCollection 2018.
81 Involvement of lncR-30245 in Myocardial Infarction-Induced Cardiac Fibrosis Through Peroxisome Proliferator-Activated Receptor--Mediated Connective Tissue Growth Factor Signalling Pathway.Can J Cardiol. 2019 Apr;35(4):480-489. doi: 10.1016/j.cjca.2019.02.005. Epub 2019 Feb 16.
82 Acute myocardial infarction induced functional cardiomyocytes to re-enter the cell cycle.Am J Transl Res. 2013 Apr 19;5(3):327-35. Print 2013.
83 CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.J Thorac Cardiovasc Surg. 2008 Oct;136(4):1044-53. doi: 10.1016/j.jtcvs.2007.12.067. Epub 2008 Jul 7.
84 Interventional effect of valsartan on expression of inducible cAMP early repressor and phosphodiesterase 3A in rats after myocardial infarction.Eur J Pharmacol. 2009 Jan 14;602(2-3):348-54. doi: 10.1016/j.ejphar.2008.11.002. Epub 2008 Nov 9.
85 Differential gene expression in infarct scar and viable myocardium from rat heart following coronary ligation.J Cell Mol Med. 2004 Jan-Mar;8(1):85-92. doi: 10.1111/j.1582-4934.2004.tb00262.x.
86 Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction.Ups J Med Sci. 2019 Aug;124(3):187-192. doi: 10.1080/03009734.2019.1650141. Epub 2019 Aug 20.
87 Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease.Cardiol J. 2019;26(6):680-686. doi: 10.5603/CJ.a2018.0018. Epub 2018 Mar 7.
88 Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction.J Mol Cell Cardiol. 2019 Feb;127:44-56. doi: 10.1016/j.yjmcc.2018.11.010. Epub 2018 Nov 19.
89 Modification of Cardiac Progenitor Cell-Derived Exosomes by miR-322 Provides Protection against Myocardial Infarction through Nox2-Dependent Angiogenesis.Antioxidants (Basel). 2019 Jan 10;8(1):18. doi: 10.3390/antiox8010018.
90 Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.Cardiovasc Res. 2009 Feb 15;81(3):574-81. doi: 10.1093/cvr/cvn222. Epub 2008 Aug 8.
91 Long-term coffee consumption, caffeine metabolism genetics, and risk of cardiovascular disease: a prospective analysis of up to 347,077 individuals and 8368 cases.Am J Clin Nutr. 2019 Mar 1;109(3):509-516. doi: 10.1093/ajcn/nqy297.
92 Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty.Circulation. 2002 May 28;105(21):2556-61. doi: 10.1161/01.cir.0000016722.37138.f2.
93 Versican is induced in infiltrating monocytes in myocardial infarction.Mol Cell Biochem. 2005 Dec;280(1-2):47-56. doi: 10.1007/s11010-005-8051-4.
94 Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1105-12. doi: 10.1152/ajpheart.00927.2006. Epub 2006 Oct 27.
95 Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing After Myocardial Infarction in Mice.Circ Res. 2019 Apr 26;124(9):1323-1336. doi: 10.1161/CIRCRESAHA.118.314569.
96 Downregulated microRNA-224 aggravates vulnerable atherosclerotic plaques and vascular remodeling in acute coronary syndrome through activation of the TGF-/Smad pathway.J Cell Physiol. 2019 Mar;234(3):2537-2551. doi: 10.1002/jcp.26945. Epub 2018 Oct 14.
97 Myocardial expression of endothelin-2 is altered reciprocally to that of endothelin-1 during ischemia of cardiomyocytes in vitro and during heart failure in vivo.Life Sci. 1999;65(16):1671-83. doi: 10.1016/s0024-3205(99)00416-6.
98 Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction.Br J Pharmacol. 2017 May;174(10):1104-1115. doi: 10.1111/bph.13755. Epub 2017 Apr 5.
99 A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.Eur Heart J. 2018 Jan 7;39(2):111-116. doi: 10.1093/eurheartj/ehx218.
100 Regional expression of the hypoxia-inducible factor (HIF) system and association with cardiomyocyte cell cycle re-entry after myocardial infarction in rats.Heart Vessels. 2008 May;23(3):193-200. doi: 10.1007/s00380-007-1029-2. Epub 2008 May 17.
101 Protective effects of erythropoietin on myocardial infarction in rats: the role of AMP-activated protein kinase signaling pathway.Am J Med Sci. 2011 Aug;342(2):153-9. doi: 10.1097/MAJ.0b013e318210041d.
102 Genetic determinants of activity and antigen levels of contact system factors.J Thromb Haemost. 2019 Jan;17(1):157-168. doi: 10.1111/jth.14307. Epub 2018 Nov 2.
103 Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.Mol Med. 2007 Jan-Feb;13(1-2):112-20. doi: 10.2119/2006-00049.Gemmati.
104 Cytokine-loaded PLGA and PEG-PLGA microparticles showed similar heart regeneration in a rat myocardial infarction model.Int J Pharm. 2017 May 25;523(2):531-533. doi: 10.1016/j.ijpharm.2016.11.022. Epub 2016 Nov 9.
105 Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.Pharmacol Res. 2019 Aug;146:104295. doi: 10.1016/j.phrs.2019.104295. Epub 2019 Jun 16.
106 Screening for the Biomarkers Associated with Myocardial Infarction by Bioinformatics Analysis.J Comput Biol. 2020 May;27(5):779-785. doi: 10.1089/cmb.2019.0180. Epub 2019 Sep 9.
107 Cardioprotective effects of aqueous extract of Oxalis corniculata in experimental myocardial infarction.Exp Toxicol Pathol. 2011 Sep;63(6):535-40. doi: 10.1016/j.etp.2010.04.004. Epub 2010 May 11.
108 Sympathetic nervous remodeling is induced in the intermediolateral nucleus after myocardial infarction - Role of BDNF-TrkB axis.Neurosci Lett. 2018 Oct 15;685:114-123. doi: 10.1016/j.neulet.2018.08.004. Epub 2018 Aug 16.
109 Role of gamma-glutamyl transpeptidase in redox regulation of K+ channel remodeling in postmyocardial infarction rat hearts.Am J Physiol Cell Physiol. 2009 Aug;297(2):C253-62. doi: 10.1152/ajpcell.00634.2008. Epub 2009 May 6.
110 Shengmai San-derived herbal prevents the development of a vulnerable substrate for atrial fibrillation in a rat model of ischemic heart failure.Biomed Pharmacother. 2018 Apr;100:156-167. doi: 10.1016/j.biopha.2018.02.013. Epub 2018 Feb 8.
111 GPR 30 reduces myocardial infarct area and fibrosis in female ovariectomized mice by activating the PI3K/AKT pathway.Life Sci. 2019 Jun 1;226:22-32. doi: 10.1016/j.lfs.2019.03.049. Epub 2019 Mar 21.
112 Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion.EBioMedicine. 2019 Oct;48:605-618. doi: 10.1016/j.ebiom.2019.09.019. Epub 2019 Oct 5.
113 Oleuropein offers cardioprotection in rats with acute myocardial infarction.Cardiovasc Toxicol. 2015 Jan;15(1):61-8. doi: 10.1007/s12012-014-9271-1.
114 The association of functional polymorphisms in genes expressed in endothelial cells and smooth muscle cells with the myocardial infarction.Hum Genomics. 2019 Jan 24;13(1):5. doi: 10.1186/s40246-018-0189-8.
115 Heme oxygenase-1 prevents heart against myocardial infarction by attenuating ischemic injury-induced cardiomyocytes senescence.EBioMedicine. 2019 Jan;39:59-68. doi: 10.1016/j.ebiom.2018.11.056. Epub 2018 Dec 5.
116 The value of endoplasmic reticulum stress markers (GRP78 and CHOP) in the diagnosis of acute mesenteric ischemia.Am J Emerg Med. 2019 Apr;37(4):596-602. doi: 10.1016/j.ajem.2018.06.033. Epub 2018 Jun 19.
117 Interferon alfa-2b/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.Invest New Drugs. 1987;5 Suppl:S41-6. doi: 10.1007/BF00207262.
118 Sustained release of bioactive IGF-1 from a silk fibroin microsphere-based injectable alginate hydrogel for the treatment of myocardial infarction.J Mater Chem B. 2020 Jan 14;8(2):308-315. doi: 10.1039/c9tb01971e. Epub 2019 Dec 6.
119 The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium.Clin Cancer Res. 1998 Apr;4(4):1071-4.
120 Identification of regulated genes in rat heart after myocardial infarction by means of differential mRNA display.Jpn Heart J. 2000 Jan;41(1):59-66. doi: 10.1536/jhj.41.59.
121 Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment.Circ Res. 2020 Jan 31;126(3):315-329. doi: 10.1161/CIRCRESAHA.119.315829. Epub 2019 Dec 9.
122 Expression of adhesion molecules on granulocytes and monocytes following myocardial infarction in rats drinking white wine.PLoS One. 2018 May 10;13(5):e0196842. doi: 10.1371/journal.pone.0196842. eCollection 2018.
123 Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.Cancer. 2019 Jul 1;125(13):2233-2241. doi: 10.1002/cncr.32056. Epub 2019 Mar 12.
124 Mesenchymal stem cell transplantation mitigates electrophysiological remodeling in a rat model of myocardial infarction.J Cardiovasc Electrophysiol. 2013 Jul;24(7):813-21. doi: 10.1111/jce.12162. Epub 2013 May 3.
125 Methylation-dependent transcriptional repression of RUNX3 by KCNQ1OT1 regulates mouse cardiac microvascular endothelial cell viability and inflammatory response following myocardial infarction.FASEB J. 2019 Dec;33(12):13145-13160. doi: 10.1096/fj.201900310R. Epub 2019 Oct 18.
126 LncRNA H19 ameliorates myocardial infarction-induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A.J Cell Mol Med. 2020 Jan;24(1):1099-1115. doi: 10.1111/jcmm.14846. Epub 2019 Nov 21.
127 miR-10a rejuvenates aged human mesenchymal stem cells and improves heart function after myocardial infarction through KLF4.Stem Cell Res Ther. 2018 May 30;9(1):151. doi: 10.1186/s13287-018-0895-0.
128 Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus.Clin Infect Dis. 2020 Apr 10;70(8):1764-1767. doi: 10.1093/cid/ciz765.
129 Preventive effect of S-allyl cysteine sulfoxide (alliin) on cardiac marker enzymes and lipids in isoproterenol-induced myocardial injury.J Pharm Pharmacol. 2006 May;58(5):617-23. doi: 10.1211/jpp.58.5.0006.
130 Effect of very early intravenous streptokinase infusion in patients with evolving myocardial infarction.Acta Med Scand. 1988;223(1):15-8. doi: 10.1111/j.0954-6820.1988.tb15759.x.
131 Interval exercise training increases LIF expression and prevents myocardial infarction-induced skeletal muscle atrophy in rats.Life Sci. 2018 Jan 15;193:77-86. doi: 10.1016/j.lfs.2017.12.009. Epub 2017 Dec 7.
132 Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.Lancet. 2012 Aug 11;380(9841):572-80. doi: 10.1016/S0140-6736(12)60312-2. Epub 2012 May 17.
133 Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset.Mol Biol Rep. 2017 Aug;44(4):315-321. doi: 10.1007/s11033-017-4112-5. Epub 2017 Jul 6.
134 An apoptosis signal-regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia-reperfusion model.J Cardiovasc Pharmacol. 2012 Sep;60(3):276-82. doi: 10.1097/FJC.0b013e31825ea0fa.
135 Effect of ulinastatin on myocardial ischemia-reperfusion injury through JNK and P38 MAPK signaling pathways.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8658-8664. doi: 10.26355/eurrev_201910_19183.
136 Mesenchymal stem cells rejuvenate cardiac muscle after ischemic injury.Aging (Albany NY). 2019 Jan 6;11(1):63-72. doi: 10.18632/aging.101718.
137 Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction.Thromb Haemost. 2011 Apr;105(4):670-5. doi: 10.1160/TH10-10-0641. Epub 2011 Jan 25.
138 Angiotensin Receptor Neprilysin Inhibitor Attenuates Myocardial Remodeling and Improves Infarct Perfusion in Experimental Heart Failure.Sci Rep. 2019 Apr 8;9(1):5791. doi: 10.1038/s41598-019-42113-0.
139 Association between rs10118757(A/G) in methylthioadenosine phosphorylase gene and coronary artery disease in Chinese Hans.Gene. 2013 Sep 10;526(2):344-6. doi: 10.1016/j.gene.2013.02.013. Epub 2013 Feb 24.
140 Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat.J Cell Physiol. 2015 Jan;230(1):170-9. doi: 10.1002/jcp.24696.
141 Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.Cardiovasc Res. 2019 Jan 1;115(1):243-254. doi: 10.1093/cvr/cvy143.
142 Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.J Cell Mol Med. 2017 Dec;21(12):3277-3287. doi: 10.1111/jcmm.13231. Epub 2017 Jun 13.
143 Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction.Cardiovasc Toxicol. 2019 Feb;19(1):72-81. doi: 10.1007/s12012-018-9478-7.
144 Polymorphisms of renin-angiotensin system and natriuretic peptide receptor A genes in patients of Greek origin with a history of myocardial infarction.Angiology. 2010 Nov;61(8):737-43. doi: 10.1177/0003319710373091. Epub 2010 Jun 7.
145 C-type natriuretic peptide co-ordinates cardiac structure and function.Eur Heart J. 2020 Mar 1;41(9):1006-1020. doi: 10.1093/eurheartj/ehz093.
146 Deficiency of liver-X-receptor- reduces glucose uptake and worsens post-myocardial infarction remodeling.Biochem Biophys Res Commun. 2017 Jul 1;488(3):489-495. doi: 10.1016/j.bbrc.2017.05.072. Epub 2017 May 13.
147 Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway.Front Physiol. 2019 Mar 27;10:189. doi: 10.3389/fphys.2019.00189. eCollection 2019.
148 Role of oxidative stress-related biomarkers in heart failure: galectin 3, 1-antitrypsin and LOX-1: new therapeutic perspective?.Mol Cell Biochem. 2020 Jan;464(1-2):143-152. doi: 10.1007/s11010-019-03656-y. Epub 2019 Nov 29.
149 Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction.J Cardiovasc Pharmacol. 2004 Mar;43(3):410-5. doi: 10.1097/00005344-200403000-00012.
150 Inhibition of peptidyl arginine deiminase-4 protects against myocardial infarction induced cardiac dysfunction.Int Immunopharmacol. 2020 Jan;78:106055. doi: 10.1016/j.intimp.2019.106055. Epub 2019 Dec 6.
151 Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function.Cardiovasc Res. 2013 Jul 1;99(1):83-91. doi: 10.1093/cvr/cvt078. Epub 2013 Apr 3.
152 A haplotype of the phosphodiesterase 4D (PDE4D) gene is associated with myocardial infarction and with cardiometabolic parameters: the GEA study.EXCLI J. 2018 Dec 19;17:1182-1190. doi: 10.17179/excli2018-1608. eCollection 2018.
153 Platelet-derived growth factor involvement in myocardial remodeling following infarction.J Mol Cell Cardiol. 2011 Nov;51(5):830-8. doi: 10.1016/j.yjmcc.2011.06.023. Epub 2011 Jul 13.
154 Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome.Atherosclerosis. 2009 Oct;206(2):486-93. doi: 10.1016/j.atherosclerosis.2009.02.037. Epub 2009 Mar 19.
155 Region-specific alterations of global protein expression in the remodelled rat myocardium.Int J Mol Med. 2006 Dec;18(6):1207-15.
156 Exogenous CXCL4 infusion inhibits macrophage phagocytosis by limiting CD36 signalling to enhance post-myocardial infarction cardiac dilation and mortality.Cardiovasc Res. 2019 Feb 1;115(2):395-408. doi: 10.1093/cvr/cvy211.
157 PIM1-minicircle as a therapeutic treatment for myocardial infarction.PLoS One. 2017 Mar 21;12(3):e0173963. doi: 10.1371/journal.pone.0173963. eCollection 2017.
158 Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction.Circulation. 1998 Mar 10;97(9):892-9. doi: 10.1161/01.cir.97.9.892.
159 The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity.J Biol Chem. 2007 Nov 30;282(48):34984-93. doi: 10.1074/jbc.M703513200. Epub 2007 Oct 9.
160 Disparate regulation of signaling proteins after exercise and myocardial infarction.Med Sci Sports Exerc. 2006 Mar;38(3):455-62. doi: 10.1249/01.mss.0000205138.02440.79.
161 S100A8/A9 in Myocardial Infarction.Methods Mol Biol. 2019;1929:739-754. doi: 10.1007/978-1-4939-9030-6_46.
162 Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.J Atheroscler Thromb. 2019 Oct 1;26(10):915-930. doi: 10.5551/jat.48405. Epub 2019 Mar 14.
163 Long non-coding RNA GAS5 reduces cardiomyocyte apoptosis induced by MI through sema3a.Int J Biol Macromol. 2018 Dec;120(Pt A):371-377. doi: 10.1016/j.ijbiomac.2018.08.039. Epub 2018 Aug 9.
164 Correlations of acute myocardial infarction complicated by cerebral infarction with insulin resistance, adiponectin and HMGB1.Eur Rev Med Pharmacol Sci. 2019 May;23(10):4425-4431. doi: 10.26355/eurrev_201905_17951.
165 A "Hibernating-Like" Viable State Induced by Lentiviral Vector-Mediated Pigment Epithelium-Derived Factor Overexpression in Rat Acute Ischemic Myocardium.Hum Gene Ther. 2019 Jun;30(6):762-776. doi: 10.1089/hum.2018.186. Epub 2019 Mar 29.
166 Sonic Hedgehog gene delivery to the rodent heart promotes angiogenesis via iNOS/netrin-1/PKC pathway.PLoS One. 2010 Jan 5;5(1):e8576. doi: 10.1371/journal.pone.0008576.
167 MiR-34a promotes myocardial infarction in rats by inhibiting the activity of SIRT1.Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):7059-7065. doi: 10.26355/eurrev_201908_18750.
168 The novel relationship between Sirt3 and autophagy in myocardial ischemia-reperfusion.J Cell Physiol. 2019 May;234(5):5488-5495. doi: 10.1002/jcp.27329. Epub 2018 Nov 28.
169 Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study.PLoS One. 2008 Apr 9;3(4):e1948. doi: 10.1371/journal.pone.0001948.
170 Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro.Biochem Biophys Res Commun. 2010 Feb 12;392(3):283-8. doi: 10.1016/j.bbrc.2009.12.170. Epub 2010 Jan 10.
171 Effects of heme oxygenase-1 upregulation on isoproterenol-induced myocardial infarction.Korean J Physiol Pharmacol. 2019 May;23(3):203-217. doi: 10.4196/kjpp.2019.23.3.203. Epub 2019 Apr 24.
172 Sterol regulatory element-binding transcription factor (SREBF)-2, SREBF cleavage-activating protein (SCAP), and premature coronary artery disease in a Chinese population.Mol Biol Rep. 2011 Jun;38(5):2895-901. doi: 10.1007/s11033-010-9951-2. Epub 2010 Jan 29.
173 Compensatory growth of coronary arterioles in postinfarcted heart: regional differences in DNA synthesis and growth factor/receptor expression patterns.Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1686-93. doi: 10.1152/ajpheart.00307.2006. Epub 2006 May 19.
174 Effect of propranolol on cardiac cytokine expression after myocardial infarction in rats.Mol Cell Biochem. 2003 Sep;251(1-2):127-37.
175 Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing.J Mol Cell Cardiol. 1999 Mar;31(3):667-78. doi: 10.1006/jmcc.1998.0902.
176 A dimeric thymosin beta 4 with novel bio-activity protects post-ischemic cardiac function by accelerating vascular endothelial cell proliferation.Int J Cardiol. 2018 Jun 15;261:146-154. doi: 10.1016/j.ijcard.2018.03.052. Epub 2018 Mar 14.
177 Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.Acta Physiol (Oxf). 2010 May;199(1):11-22. doi: 10.1111/j.1748-1716.2010.02080.x. Epub 2010 Jan 16.
178 Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure.Eur J Heart Fail. 2008 Apr;10(4):352-9. doi: 10.1016/j.ejheart.2008.02.010. Epub 2008 Mar 18.
179 TREM-1 multimerization is essential for its activation on monocytes and neutrophils.Cell Mol Immunol. 2019 May;16(5):460-472. doi: 10.1038/s41423-018-0003-5. Epub 2018 Mar 22.
180 A genome-wide association study reveals susceptibility loci for myocardial infarction/coronary artery disease in Saudi Arabs.Atherosclerosis. 2016 Feb;245:62-70. doi: 10.1016/j.atherosclerosis.2015.11.019. Epub 2015 Nov 22.
181 Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system.Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H416-24. doi: 10.1152/ajpheart.91446.2007. Epub 2008 May 30.
182 Association of thioredoxin reductase 2 (TXNRD2) gene polymorphisms with myocardial infarction in Slovene patients with type 2 diabetes mellitus.Diabetes Res Clin Pract. 2015 May;108(2):323-8. doi: 10.1016/j.diabres.2015.01.038. Epub 2015 Feb 7.
183 A cytoskeletal anchor connects ischemic mitochondrial fission to myocardial senescence.Sci Signal. 2018 Nov 13;11(556):eaav3267. doi: 10.1126/scisignal.aav3267.
184 Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.Naunyn Schmiedebergs Arch Pharmacol. 2004 Oct;370(4):238-50. doi: 10.1007/s00210-004-0980-z. Epub 2004 Sep 30.
185 Long-term oral resveratrol intake provides nutritional preconditioning against myocardial ischemia/reperfusion injury: involvement of VDAC1 downregulation.Mol Nutr Food Res. 2015 Mar;59(3):454-64. doi: 10.1002/mnfr.201400730. Epub 2015 Jan 19.
186 Proteomic analysis reveals late exercise effects on cardiac remodeling following myocardial infarction.J Proteomics. 2010 Sep 10;73(10):2041-9. doi: 10.1016/j.jprot.2010.06.009. Epub 2010 Jul 1.
187 XPO1 Gene Therapy Attenuates Cardiac Dysfunction in Rats with Chronic Induced Myocardial Infarction.J Cardiovasc Transl Res. 2020 Aug;13(4):593-600. doi: 10.1007/s12265-019-09932-y. Epub 2019 Nov 25.
188 Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.Eur J Pharmacol. 2020 Jan 5;866:172810. doi: 10.1016/j.ejphar.2019.172810. Epub 2019 Nov 15.
189 Let-7a regulates expression of 1-adrenoceptors and forms a negative feedback circuit with the 1-adrenoceptor signaling pathway in chronic ischemic heart failure.Oncotarget. 2017 Jan 31;8(5):8752-8764. doi: 10.18632/oncotarget.14436.
190 Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro.EXCLI J. 2019 Sep 26;18:876-892. doi: 10.17179/excli2019-1792. eCollection 2019.
191 FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.Circ Res. 2015 Nov 6;117(11):967-77. doi: 10.1161/CIRCRESAHA.115.306919. Epub 2015 Oct 5.
192 A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.Nat Genet. 2015 Oct;47(10):1121-1130. doi: 10.1038/ng.3396. Epub 2015 Sep 7.
193 Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypes.Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):871-80. doi: 10.1161/ATVBAHA.112.301073. Epub 2013 Feb 7.
194 Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway.Life Sci. 2019 Aug 15;231:116554. doi: 10.1016/j.lfs.2019.116554. Epub 2019 Jun 10.
195 Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis.J Thromb Haemost. 2006 Feb;4(2):341-8. doi: 10.1111/j.1538-7836.2006.01754.x.
196 Glycoproteomic Profiling Provides Candidate Myocardial Infarction Predictors of Later Progression to Heart Failure.ACS Omega. 2019 Jan 31;4(1):1272-1280. doi: 10.1021/acsomega.8b02207. Epub 2019 Jan 15.
197 Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction.Am J Hypertens. 2000 Feb;13(2):134-9. doi: 10.1016/s0895-7061(99)00176-4.
198 Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.Int J Cardiol. 2017 Apr 1;232:155-159. doi: 10.1016/j.ijcard.2017.01.037. Epub 2017 Jan 5.
199 Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.Physiol Res. 2001;50(1):1-8.
200 Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death.Int J Legal Med. 2018 Jan;132(1):197-203. doi: 10.1007/s00414-017-1605-7. Epub 2017 May 11.
201 Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?.Heart. 2018 Aug;104(15):1244-1250. doi: 10.1136/heartjnl-2017-312865. Epub 2018 Mar 8.
202 Polymorphisms in the genes encoding platelet-derived growth factor A and alpha receptor.J Mol Med (Berl). 2000;78(5):287-92. doi: 10.1007/s001090000111.
203 Olmesartan attenuates pressure-overload- or post-infarction-induced cardiac remodeling in mice.Oncotarget. 2017 Dec 23;9(37):24601-24618. doi: 10.18632/oncotarget.23628. eCollection 2018 May 15.
204 MicroRNA-29b upregulation improves myocardial fibrosis and cardiac function in myocardial infarction rats through targeting SH2B3.Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):10115-10122. doi: 10.26355/eurrev_201911_19581.
205 Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.Cardiovasc Res. 2019 Mar 1;115(3):614-624. doi: 10.1093/cvr/cvy244.
206 Association of OX40 and OX40L gene polymorphisms with acute coronary syndrome in a Han Chinese population.DNA Cell Biol. 2011 Aug;30(8):597-602. doi: 10.1089/dna.2010.1201. Epub 2011 Apr 10.
207 Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations.Atherosclerosis. 2011 Mar;215(1):145-52. doi: 10.1016/j.atherosclerosis.2010.12.005. Epub 2010 Dec 15.
208 DNA methylation of lipid-related genes affects blood lipid levels. Circ Cardiovasc Genet. 2015 Apr;8(2):334-42.
209 The ABCG5/8 cholesterol transporter and myocardial infarction versus gallstone disease.J Am Coll Cardiol. 2014 May 27;63(20):2121-2128. doi: 10.1016/j.jacc.2013.12.055. Epub 2014 Mar 19.
210 -Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study.Int J Cardiol. 2018 Jun 1;260:7-10. doi: 10.1016/j.ijcard.2018.02.013.
211 Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction.Pharmacogenet Genomics. 2010 Dec;20(12):766-74. doi: 10.1097/FPC.0b013e328340aded.
212 Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission.Thromb Res. 2019 Jan;173:42-47. doi: 10.1016/j.thromres.2018.11.005. Epub 2018 Nov 12.
213 Identification of 13 novel susceptibility loci for early-onset myocardial infarction, hypertension, or chronic kidney disease.Int J Mol Med. 2018 Nov;42(5):2415-2436. doi: 10.3892/ijmm.2018.3852. Epub 2018 Sep 4.
214 Transcriptomic Analysis of the Association Between Diabetes Mellitus and Myocardial Infarction.Exp Clin Endocrinol Diabetes. 2019 Oct;127(9):603-614. doi: 10.1055/a-0619-4412. Epub 2018 Jun 11.
215 Cardioprotective role of APIP in myocardial infarction through ADORA2B.Cell Death Dis. 2019 Jul 1;10(7):511. doi: 10.1038/s41419-019-1746-3.
216 High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction.J Am Coll Cardiol. 2018 Oct 16;72(16):1926-1935. doi: 10.1016/j.jacc.2018.07.075.
217 Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials.Open Forum Infect Dis. 2018 Apr 20;5(5):ofy086. doi: 10.1093/ofid/ofy086. eCollection 2018 May.
218 Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.Acta Diabetol. 2019 Jan;56(1):97-104. doi: 10.1007/s00592-018-1220-1. Epub 2018 Sep 5.
219 Human Fetuin-A Rs4918 Polymorphism and its Association with Obesity in Healthy Persons and in Patients with Myocardial Infarction in Two Hungarian Cohorts.Med Sci Monit. 2016 Aug 4;22:2742-50. doi: 10.12659/msm.896232.
220 Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.Stem Cell Res Ther. 2015 Apr 11;6(1):53. doi: 10.1186/s13287-015-0028-y.
221 Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac(2-26), Against Myocardial Infarction.Front Pharmacol. 2019 Apr 3;10:269. doi: 10.3389/fphar.2019.00269. eCollection 2019.
222 The bifunctional SDF-1-AnxA5 fusion protein protects cardiac function after myocardial infarction.J Cell Mol Med. 2019 Nov;23(11):7673-7684. doi: 10.1111/jcmm.14640. Epub 2019 Aug 30.
223 Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats.Biomaterials. 2016 Aug;97:164-75. doi: 10.1016/j.biomaterials.2016.04.025. Epub 2016 Apr 26.
224 Angiotensin-converting enzyme insertion/deletion (rs106180) and angiotensin type 1 receptor A(1166) C (rs106165) genotypes and psoriasis: Correlation with cellular immunity, lipid profile, and oxidative stress markers.J Cell Biochem. 2019 Feb;120(2):2627-2633. doi: 10.1002/jcb.27569. Epub 2018 Oct 10.
225 Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart.Mol Ther. 2018 Mar 7;26(3):902-916. doi: 10.1016/j.ymthe.2017.11.007. Epub 2017 Nov 16.
226 Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction.JCI Insight. 2017 Jun 15;2(12):e93887. doi: 10.1172/jci.insight.93887. eCollection 2017 Jun 15.
227 Screening and Identification of Pregnancy Zone Protein and Leucine-Rich Alpha-2-Glycoprotein as Potential Serum Biomarkers for Early-Onset Myocardial Infarction using Protein Profile Analysis.Proteomics Clin Appl. 2019 May;13(3):e1800079. doi: 10.1002/prca.201800079. Epub 2018 Nov 28.
228 Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.Lancet Neurol. 2009 Nov;8(11):998-1005. doi: 10.1016/S1474-4422(09)70239-X. Epub 2009 Sep 25.
229 Activation of DNA Damage Response and Cellular Senescence in Cardiac Fibroblasts Limit Cardiac Fibrosis After Myocardial Infarction.Int Heart J. 2019 Jul 27;60(4):944-957. doi: 10.1536/ihj.18-701. Epub 2019 Jun 28.
230 Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1.J Biol Chem. 2020 Jan 3;295(1):69-82. doi: 10.1074/jbc.RA119.009548. Epub 2019 Nov 18.
231 Che-1 attenuates hypoxia/reoxygenation-induced cardiomyocyte apoptosis by upregulation of Nrf2 signaling.Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):1084-1093. doi: 10.26355/eurrev_201802_14395.
232 MicroRNA? downregulation induced by carvedilol protects cardiomyocytes against apoptosis by targeting heat shock protein 60.Mol Med Rep. 2019 May;19(5):3527-3536. doi: 10.3892/mmr.2019.10034. Epub 2019 Mar 14.
233 Myocardial autophagy variation during acute myocardial infarction in rats: the effects of carvedilol.Chin Med J (Engl). 2009 Oct 5;122(19):2372-9.
234 Expression of genes encoding kinin receptors in peripheral blood mononuclear cells from patients with acute coronary syndromes.Intern Med J. 2008 Dec;38(12):892-6. doi: 10.1111/j.1445-5994.2008.01718.x.
235 Progressive Reduction in Myocyte Autophagy After Myocardial Infarction in Rabbits: Association with Oxidative Stress and Left Ventricular Remodeling.Cell Physiol Biochem. 2017;44(6):2439-2454. doi: 10.1159/000486167. Epub 2017 Dec 18.
236 MiRNA and TF co-regulatory network analysis for the pathology and recurrence of myocardial infarction.Sci Rep. 2015 Apr 13;5:9653. doi: 10.1038/srep09653.
237 Adiponectin exerts cardioprotection against ischemia/reperfusion injury partially via calreticulin mediated anti-apoptotic and anti-oxidative actions.Apoptosis. 2017 Jan;22(1):108-117. doi: 10.1007/s10495-016-1304-8.
238 PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis.Biochem Biophys Res Commun. 2019 Dec 10;520(3):645-650. doi: 10.1016/j.bbrc.2019.10.085. Epub 2019 Oct 16.
239 Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y(12) receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function.Basic Res Cardiol. 2018 Jul 10;113(5):32. doi: 10.1007/s00395-018-0692-z.
240 MiR-34a regulates cell apoptosis after myocardial infarction in rats through the Wnt/-catenin signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2555-2562. doi: 10.26355/eurrev_201903_17404.
241 MicroRNA-23a is involved in tumor necrosis factor- induced apoptosis in mesenchymal stem cells and myocardial infarction.Exp Mol Pathol. 2014 Aug;97(1):23-30. doi: 10.1016/j.yexmp.2013.11.005. Epub 2013 Nov 19.
242 Calciumsensing receptor promotes high glucoseinduced myocardial fibrosis via upregulation of the TGF?/Smads pathway in cardiac fibroblasts.Mol Med Rep. 2019 Aug;20(2):1093-1102. doi: 10.3892/mmr.2019.10330. Epub 2019 Jun 4.
243 Estrogen Therapy Worsens Cardiac Function and Remodeling and Reverses the Effects of Exercise Training After Myocardial Infarction in Ovariectomized Female Rats.Front Physiol. 2018 Sep 5;9:1242. doi: 10.3389/fphys.2018.01242. eCollection 2018.
244 Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction.Atherosclerosis. 2016 Mar;246:148-156. doi: 10.1016/j.atherosclerosis.2016.01.008. Epub 2016 Jan 8.
245 Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans.Thromb Res. 2001 Jul 15;103(2):109-15. doi: 10.1016/s0049-3848(01)00278-x.
246 Common and Rare Genetic Variation in CCR2, CCR5, or CX3CR1 and Risk of Atherosclerotic Coronary Heart Disease and Glucometabolic Traits.Circ Cardiovasc Genet. 2016 Jun;9(3):250-8. doi: 10.1161/CIRCGENETICS.115.001374. Epub 2016 Mar 24.
247 The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling.Int J Cardiol. 2019 Mar 1;278:210-216. doi: 10.1016/j.ijcard.2018.11.132. Epub 2018 Dec 3.
248 Sitagliptin protects diabetic rats with acute myocardial infarction through induction of angiogenesis: role of IGF-1 and VEGF.Can J Physiol Pharmacol. 2019 Nov;97(11):1053-1063. doi: 10.1139/cjpp-2018-0670. Epub 2019 May 22.
249 Dysregulation of CD69 by overexpression of microRNA?67?p associated with postmyocardial infarction cardiac fibrosis.Mol Med Rep. 2018 Sep;18(3):3085-3092. doi: 10.3892/mmr.2018.9234. Epub 2018 Jun 29.
250 Cadherin-11 blockade reduces inflammation-driven fibrotic remodeling and improves outcomes after myocardial infarction.JCI Insight. 2019 Sep 19;4(18):e131545. doi: 10.1172/jci.insight.131545.
251 p27kip1 haploinsufficiency preserves myocardial function in the early stages of myocardial infarction via Atg5mediated autophagy flux restoration.Mol Med Rep. 2019 Oct;20(4):3840-3848. doi: 10.3892/mmr.2019.10632. Epub 2019 Sep 2.
252 Loss of CEACAM1, a Tumor-Associated Factor, Attenuates Post-infarction Cardiac Remodeling by Inhibiting Apoptosis.Sci Rep. 2016 Feb 25;6:21972. doi: 10.1038/srep21972.
253 Clinical and surrogate endpoints in future studies on outcome of carotid revascularization.J Cardiovasc Surg (Torino). 2019 Jun;60(3):325-331. doi: 10.23736/S0021-9509.19.10910-X. Epub 2019 Mar 1.
254 Complement factor B mutation-associated aHUS and myocardial infarction.BMJ Case Rep. 2017 Jul 14;2017:bcr2017219716. doi: 10.1136/bcr-2017-219716.
255 Roles of volume-regulatory anion channels, VSOR and Maxi-Cl, in apoptosis, cisplatin resistance, necrosis, ischemic cell death, stroke and myocardial infarction.Curr Top Membr. 2019;83:205-283. doi: 10.1016/bs.ctm.2019.03.001. Epub 2019 Apr 19.
256 Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1-related defense mechanisms.J Am Heart Assoc. 2013 Jan 18;2(1):e004887. doi: 10.1161/JAHA.112.004887.
257 Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.J Mol Cell Cardiol. 2019 Dec;137:25-33. doi: 10.1016/j.yjmcc.2019.09.011. Epub 2019 Oct 17.
258 CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.Nicotine Tob Res. 2014 Sep;16(9):1224-31. doi: 10.1093/ntr/ntu059. Epub 2014 Apr 11.
259 Macrophage-Specific IB Kinase Contributes to Ventricular Remodelling and Dysfunction After Myocardial Infarction.Can J Cardiol. 2019 Apr;35(4):490-500. doi: 10.1016/j.cjca.2019.01.002. Epub 2019 Jan 19.
260 Dectin-2 Deficiency Modulates Th1 Differentiation and Improves Wound Healing After Myocardial Infarction.Circ Res. 2017 Mar 31;120(7):1116-1129. doi: 10.1161/CIRCRESAHA.116.310260. Epub 2017 Feb 13.
261 A New Chimeric Natriuretic Peptide, C(N)AA(C), for the Treatment of Left Ventricular Dysfunction after Myocardial Infarction.Sci Rep. 2017 Aug 30;7(1):10099. doi: 10.1038/s41598-017-10748-6.
262 Cannabinoid receptor 2 deletion deteriorates myocardial infarction through the down-regulation of AMPK-mTOR-p70S6K signaling-mediated autophagy.Biosci Rep. 2019 Apr 26;39(4):BSR20180650. doi: 10.1042/BSR20180650. Print 2019 Apr 30.
263 Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men.Haematologica. 2009 Jun;94(6):811-8. doi: 10.3324/haematol.2008.002386. Epub 2009 Apr 18.
264 Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.Atherosclerosis. 2017 Feb;257:16-21. doi: 10.1016/j.atherosclerosis.2016.12.017. Epub 2016 Dec 20.
265 Genetic variations in circadian rhythm genes and susceptibility for myocardial infarction.Genet Mol Biol. 2018 Apr./Jun;41(2):403-409. doi: 10.1590/1678-4685-GMB-2017-0147. Epub 2018 May 14.
266 [Retracted] Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway.Mol Med Rep. 2017 Nov;16(5):7873. doi: 10.3892/mmr.2017.7551. Epub 2017 Sep 20.
267 Exosomes derived from SDF1-overexpressing mesenchymal stem cells inhibit ischemic myocardial cell apoptosis and promote cardiac endothelial microvascular regeneration in mice with myocardial infarction.J Cell Physiol. 2019 Aug;234(8):13878-13893. doi: 10.1002/jcp.28070. Epub 2019 Feb 5.
268 Association of interleukin 8 with myocardial infarction: results from the Stockholm Heart Epidemiology Program.Int J Cardiol. 2014 Mar 1;172(1):173-8. doi: 10.1016/j.ijcard.2013.12.170. Epub 2014 Jan 9.
269 C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.Circulation. 2019 Apr 9;139(15):1798-1812. doi: 10.1161/CIRCULATIONAHA.118.036053.
270 Genetic variant in the CYP17 gene and risk of premature coronary artery disease.Hellenic J Cardiol. 2014 Mar-Apr;55(2):126-31.
271 Redd1 protects against postinfarction cardiac dysfunction by targeting apoptosis and autophagy.Int J Mol Med. 2019 Dec;44(6):2065-2076. doi: 10.3892/ijmm.2019.4366. Epub 2019 Oct 4.
272 Cardiac expression of deiodinase type 3 (Dio3) following myocardial infarction is associated with the induction of a pluripotency microRNA signature from the Dlk1-Dio3 genomic region.Endocrinology. 2013 Jun;154(6):1973-8. doi: 10.1210/en.2012-2017. Epub 2013 Apr 3.
273 Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.Circ Res. 2009 Apr 10;104(7):896-904. doi: 10.1161/CIRCRESAHA.108.172882. Epub 2009 Feb 26.
274 A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese.Eur J Hum Genet. 2015 Mar;23(3):374-80. doi: 10.1038/ejhg.2014.110. Epub 2014 Jun 11.
275 TRPA1 Promotes Cardiac Myofibroblast Transdifferentiation after Myocardial Infarction Injury via the Calcineurin-NFAT-DYRK1A Signaling Pathway.Oxid Med Cell Longev. 2019 May 14;2019:6408352. doi: 10.1155/2019/6408352. eCollection 2019.
276 Endothelin converting-enzyme-1 mRNA expression in human cardiovascular disease. Clin Exp Hypertens. 1998 May;20(4):417-37. doi: 10.3109/10641969809053222.
277 Endothelin-1 receptor subtypes expression and binding in a perfused rat model of myocardial infarction.Comp Biochem Physiol C Toxicol Pharmacol. 2003 Jan;134(1):35-43. doi: 10.1016/s1532-0456(02)00209-0.
278 Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium.Circ Res. 2013 Jul 19;113(3):288-300. doi: 10.1161/CIRCRESAHA.113.300929. Epub 2013 May 21.
279 Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits.Diabetes Obes Metab. 2019 Aug;21(8):1780-1789. doi: 10.1111/dom.13740. Epub 2019 Apr 29.
280 Effects of GCN2/eIF2 on myocardial ischemia/hypoxia reperfusion and myocardial cells injury.Am J Transl Res. 2019 Sep 15;11(9):5586-5598. eCollection 2019.
281 Inhibiting DPP4 in a mouse model of HHT1 results in a shift towards regenerative macrophages and reduces fibrosis after myocardial infarction.PLoS One. 2017 Dec 18;12(12):e0189805. doi: 10.1371/journal.pone.0189805. eCollection 2017.
282 Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction.J Cardiovasc Pharmacol. 2019 Feb;73(2):82-91. doi: 10.1097/FJC.0000000000000638.
283 Association of genetic variants of MTHFR, ENPP1, and ADIPOQ with myocardial infarction in Egyptian patients.Cell Biochem Biophys. 2014 Jun;69(2):265-74. doi: 10.1007/s12013-013-9794-2.
284 Functions and Regeneration of Mature Cardiac Lymphatic Vessels in Atherosclerosis, Myocardial Infarction, and Heart Failure.Lymphat Res Biol. 2018 Dec;16(6):507-515. doi: 10.1089/lrb.2018.0023. Epub 2018 Oct 19.
285 Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.J Biol Chem. 2018 Mar 2;293(9):3281-3292. doi: 10.1074/jbc.RA117.000298. Epub 2018 Jan 3.
286 Modulation of NFKB1/p50 by ROS leads to impaired ATP production during MI compared to cardiac hypertrophy.J Cell Biochem. 2018 Feb;119(2):1575-1590. doi: 10.1002/jcb.26318. Epub 2017 Sep 12.
287 Non-vitamin K oral anticoagulants (NOAC) and the risk of myocardial infarction: Differences between factor IIa and factor Xa inhibition?.Pharmacol Ther. 2019 Mar;195:1-4. doi: 10.1016/j.pharmthera.2018.10.005. Epub 2018 Oct 12.
288 Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.J Thromb Thrombolysis. 2019 Oct;48(3):519-527. doi: 10.1007/s11239-019-01856-3.
289 Long-Term Risk Stratification of Patients Undergoing Coronary Angiography According to the Thrombolysis in Myocardial InfarctionRisk Score for Secondary Prevention.J Am Heart Assoc. 2019 Jul 16;8(14):e012433. doi: 10.1161/JAHA.119.012433. Epub 2019 Jul 4.
290 Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events.Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2800-6. doi: 10.1161/01.ATV.0000247249.82030.94. Epub 2006 Sep 28.
291 Fatty acid-binding protein 3 contributes to ischemic heart injury by regulating cardiac myocyte apoptosis and MAPK pathways.Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H971-H984. doi: 10.1152/ajpheart.00360.2018. Epub 2019 Feb 8.
292 Epigenome-wide association study of adiposity and future risk of obesity-related diseases.Int J Obes (Lond). 2018 Dec;42(12):2022-2035. doi: 10.1038/s41366-018-0064-7. Epub 2018 May 1.
293 Cardiac FGF23: new insights into the role and function of FGF23 after acute myocardial infarction.Cardiovasc Pathol. 2019 May-Jun;40:47-54. doi: 10.1016/j.carpath.2019.02.001. Epub 2019 Feb 10.
294 Distinct expression patterns of Flk1 and Flt1 in the coronary vascular system during development and after myocardial infarction.Biochem Biophys Res Commun. 2018 Jan 1;495(1):884-891. doi: 10.1016/j.bbrc.2017.11.094. Epub 2017 Nov 20.
295 Lipid-associated genetic polymorphisms are associated with FBP and LDL-c levels among myocardial infarction patients in Chinese population.Gene. 2018 Nov 15;676:22-28. doi: 10.1016/j.gene.2018.07.016. Epub 2018 Jul 10.
296 Acute myocardial infarction activates magnocellular vasopressin and oxytocin neurones.J Neuroendocrinol. 2019 Dec;31(12):e12808. doi: 10.1111/jne.12808.
297 Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice.Nat Commun. 2017 Feb 7;8:14232. doi: 10.1038/ncomms14232.
298 FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.Circulation. 2019 Jan 22;139(4):518-532. doi: 10.1161/CIRCULATIONAHA.118.033794.
299 Bioinformatics analysis of key genes and signaling pathways associated with myocardial infarction following telomerase activation.Mol Med Rep. 2017 Sep;16(3):2915-2924. doi: 10.3892/mmr.2017.6938. Epub 2017 Jul 6.
300 Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heart.Dis Model Mech. 2018 Jun 22;11(6):dmm033282. doi: 10.1242/dmm.033282.
301 High-intensity interval training increase GATA4, CITED4 and c-Kit and decreases C/EBP in rats after myocardial infarction.Life Sci. 2019 Mar 15;221:319-326. doi: 10.1016/j.lfs.2019.02.045. Epub 2019 Feb 22.
302 Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction.Eur Heart J. 2020 Feb 14;41(7):882-889. doi: 10.1093/eurheartj/ehz728.
303 Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.Cardiovasc Diabetol. 2019 Jan 9;18(1):1. doi: 10.1186/s12933-019-0806-4.
304 Transgenic overexpression of GTP cyclohydrolase 1 in cardiomyocytes ameliorates post-infarction cardiac remodeling.Sci Rep. 2017 Jun 8;7(1):3093. doi: 10.1038/s41598-017-03234-6.
305 Evaluation of the impact of genetic polymorphisms in glutathione-related genes on the association between methylmercury or n-3 polyunsaturated long chain fatty acids and risk of myocardial infarction: a case-control study.Environ Health. 2011 Apr 19;10:33. doi: 10.1186/1476-069X-10-33.
306 ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.Atherosclerosis. 2020 Jan;293:35-41. doi: 10.1016/j.atherosclerosis.2019.11.031. Epub 2019 Nov 29.
307 Cardiovascular biology of the GIP receptor.Peptides. 2020 Mar;125:170228. doi: 10.1016/j.peptides.2019.170228. Epub 2019 Dec 5.
308 Association of Connexin37 C1019T with myocardial infarction and coronary artery disease: a meta-analysis.Exp Gerontol. 2014 Oct;58:203-7. doi: 10.1016/j.exger.2014.06.011. Epub 2014 Jun 14.
309 Transplantation of mesenchymal stem cells modulated Cx43 and Cx45 expression in rats with myocardial infarction.Cytotechnology. 2018 Feb;70(1):225-234. doi: 10.1007/s10616-017-0136-x. Epub 2017 Sep 19.
310 Alpha-galactosidase A in vascular disease.Trends Cardiovasc Med. 2007 May;17(4):129-33. doi: 10.1016/j.tcm.2007.02.006.
311 Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction.Basic Res Cardiol. 2017 Sep 1;112(5):57. doi: 10.1007/s00395-017-0646-x.
312 DPP-4 inhibition enhanced renal tubular and myocardial GLP-1 receptor expression decreased in CKD with myocardial infarction.BMC Nephrol. 2019 Mar 1;20(1):75. doi: 10.1186/s12882-019-1243-z.
313 Myocardial infarction before and after the age of 45: Possible role of platelet receptor polymorphisms.Rev Port Cardiol (Engl Ed). 2018 Sep;37(9):727-735. doi: 10.1016/j.repc.2018.03.015. Epub 2018 Aug 22.
314 Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction.FASEB J. 2017 Feb;31(2):556-568. doi: 10.1096/fj.201600613R. Epub 2016 Oct 25.
315 Ribonucleotide reductase-mediated increase in dATP improves cardiac performance via myosin activation in a large animal model of heart failure.Eur J Heart Fail. 2015 Aug;17(8):772-81. doi: 10.1002/ejhf.270. Epub 2015 Apr 15.
316 LncRNA PCFL promotes cardiac fibrosis via miR-378/GRB2 pathway following myocardial infarction.J Mol Cell Cardiol. 2019 Aug;133:188-198. doi: 10.1016/j.yjmcc.2019.06.011. Epub 2019 Jun 17.
317 Knockdown of MicroRNA-1 in the Hippocampus Ameliorates Myocardial Infarction Induced Impairment of Long-Term Potentiation.Cell Physiol Biochem. 2018;50(4):1601-1616. doi: 10.1159/000494657. Epub 2018 Oct 25.
318 Stilbenoid pterostilbene complexed with cyclodextrin preserves left ventricular function after myocardial infarction in rats: possible involvement of thiol proteins and modulation of phosphorylated GSK-3.Free Radic Res. 2018 Sep;52(9):988-999. doi: 10.1080/10715762.2018.1506115. Epub 2018 Sep 11.
319 Protective effects of gelsolin in acute pulmonary thromboembolism and thrombosis in the carotid artery of mice.PLoS One. 2019 Apr 19;14(4):e0215717. doi: 10.1371/journal.pone.0215717. eCollection 2019.
320 Profiling analysis of long non-coding RNAs in early postnatal mouse hearts.Sci Rep. 2017 Mar 7;7:43485. doi: 10.1038/srep43485.
321 The subunit of soluble guanylyl cyclase GUCY1B3 exerts cardioprotective effects against ischemic injury via the PKC/Akt pathway.J Cell Biochem. 2019 Mar;120(3):3071-3081. doi: 10.1002/jcb.27479. Epub 2018 Nov 28.
322 Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction.Circ Res. 2014 Jul 7;115(2):284-95. doi: 10.1161/CIRCRESAHA.115.303567. Epub 2014 May 1.
323 A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent model.Acta Biomater. 2019 Mar 1;86:223-234. doi: 10.1016/j.actbio.2019.01.022. Epub 2019 Jan 16.
324 Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.Nat Genet. 2002 Dec;32(4):650-4. doi: 10.1038/ng1047. Epub 2002 Nov 11.
325 Association of serum HMGB2 level with MACE at 1 mo of myocardial infarction: Aggravation of myocardial ischemic injury in rats by HMGB2 via ROS.Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H422-H436. doi: 10.1152/ajpheart.00249.2016. Epub 2016 Dec 23.
326 Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction.Aging Dis. 2018 Apr 1;9(2):317-321. doi: 10.14336/AD.2017.0630. eCollection 2018 Apr.
327 Getting to the heart of intracellular glucocorticoid regeneration: 11-HSD1 in the myocardium.J Mol Endocrinol. 2017 Jan;58(1):R1-R13. doi: 10.1530/JME-16-0128. Epub 2016 Aug 23.
328 Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.Hypertens Res. 2007 May;30(5):427-37. doi: 10.1291/hypres.30.427.
329 Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats.J Cardiovasc Transl Res. 2017 Apr;10(2):209-220. doi: 10.1007/s12265-017-9734-4. Epub 2017 Mar 9.
330 Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-inflammatory therapy.FASEB J. 2019 Feb;33(2):1617-1630. doi: 10.1096/fj.201800987R. Epub 2018 Sep 6.
331 Angiotensin-converting enzyme insertion/deletion polymorphism and risk of myocardial infarction in an updated meta-analysis based on 34993 participants.Gene. 2013 Jun 15;522(2):196-205. doi: 10.1016/j.gene.2013.03.076. Epub 2013 Apr 6.
332 IRF3 and type I interferons fuel a fatal response to myocardial infarction.Nat Med. 2017 Dec;23(12):1481-1487. doi: 10.1038/nm.4428. Epub 2017 Nov 6.
333 Insulin-Like Growth Factor 1 Receptor-Dependent Pathway Drives Epicardial Adipose Tissue Formation After Myocardial Injury.Circulation. 2017 Jan 3;135(1):59-72. doi: 10.1161/CIRCULATIONAHA.116.022064. Epub 2016 Nov 1.
334 Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction.Br J Pharmacol. 2019 Mar;176(5):699-710. doi: 10.1111/bph.14549. Epub 2019 Jan 8.
335 Relationship between activin A level and infarct size in patients with acute myocardial infarction undergoing successful primary coronary intervention.Clin Chim Acta. 2009 Mar;401(1-2):3-7. doi: 10.1016/j.cca.2008.10.027. Epub 2008 Nov 8.
336 Systemic lupus erythematosus: still a challenge for physicians.J Intern Med. 2017 Jan;281(1):52-64. doi: 10.1111/joim.12529. Epub 2016 Jun 16.
337 The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.Blood. 2009 Jan 22;113(4):816-26. doi: 10.1182/blood-2007-12-128702. Epub 2008 Sep 25.
338 Integrin 1 Increases Stem Cell Survival and Cardiac Function after Myocardial Infarction.Front Pharmacol. 2017 Mar 17;8:135. doi: 10.3389/fphar.2017.00135. eCollection 2017.
339 Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23.Eur Heart J. 2011 Jan;32(2):158-68. doi: 10.1093/eurheartj/ehq405. Epub 2010 Nov 18.
340 Relationship between haplotypes of KCNN4 gene and susceptibility to human vascular diseases in Japanese.Med Sci Monit. 2009 Aug;15(8):CR389-97.
341 Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction.Circ J. 2013;77(8):2134-44. doi: 10.1253/circj.cj-12-1585. Epub 2013 May 21.
342 Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension. 2002 Nov;40(5):653-9. doi: 10.1161/01.hyp.0000036035.41122.99.
343 Leukocyte-Associated Immunoglobulin-like Receptor-1 is regulated in human myocardial infarction but its absence does not affect infarct size in mice.Sci Rep. 2017 Dec 21;7(1):18039. doi: 10.1038/s41598-017-13678-5.
344 Canagliflozin, a sodium-glucose cotransporter2 inhibitor, normalizes renal susceptibility to type1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.J Diabetes Investig. 2019 Jul;10(4):933-946. doi: 10.1111/jdi.13009. Epub 2019 Feb 25.
345 Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.Int J Epidemiol. 2015 Apr;44(2):587-603. doi: 10.1093/ije/dyv109.
346 Galectin-3 in Acute Myocardial Infarction Patients with Atrial Fibrillation.Med Princ Pract. 2019;28(3):284-290. doi: 10.1159/000497611. Epub 2019 Feb 6.
347 Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction.Cell Metab. 2018 Feb 6;27(2):450-460.e6. doi: 10.1016/j.cmet.2017.11.003. Epub 2017 Dec 21.
348 The LRP6 rs2302685 polymorphism is associated with increased risk of myocardial infarction.Lipids Health Dis. 2014 Jun 7;13:94. doi: 10.1186/1476-511X-13-94.
349 Genetic variation in the leukotriene pathway is associated with myocardial infarction in the Chinese population.Lipids Health Dis. 2019 Jan 24;18(1):25. doi: 10.1186/s12944-019-0968-9.
350 Common Polymorphisms in the 5-Lipoxygenase Pathway and Risk of Incident Myocardial Infarction: A Danish Case-Cohort Study.PLoS One. 2016 Nov 28;11(11):e0167217. doi: 10.1371/journal.pone.0167217. eCollection 2016.
351 Bioinformatic Analysis of the Possible Regulative Network of miR-30a/e in Cardiomyocytes 2 Days Post Myocardial Infarction.Acta Cardiol Sin. 2018 Mar;34(2):175-188. doi: 10.6515/ACS.201803_34(2).20170926A.
352 The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction.J Clin Invest. 2018 Aug 1;128(8):3402-3412. doi: 10.1172/JCI97192. Epub 2018 Jul 9.
353 Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.Circulation. 2018 Nov 6;138(19):2081-2090. doi: 10.1161/CIRCULATIONAHA.118.034464.
354 Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice.Blood Adv. 2018 Jun 26;2(12):1439-1448. doi: 10.1182/bloodadvances.2017015149.
355 Microtubule associated protein 4 phosphorylation leads to pathological cardiac remodeling in mice.EBioMedicine. 2018 Nov;37:221-235. doi: 10.1016/j.ebiom.2018.10.017. Epub 2018 Oct 13.
356 Reprogramming-derived gene cocktail increases cardiomyocyte proliferation for heart regeneration.EMBO Mol Med. 2017 Feb;9(2):251-264. doi: 10.15252/emmm.201606558.
357 Sin1 (Stress-Activated Protein Kinase-Interacting Protein) Regulates Ischemia-Induced Microthrombosis Through Integrin IIb3-Mediated Outside-In Signaling and Hypoxia Responses in Platelets.Arterioscler Thromb Vasc Biol. 2018 Dec;38(12):2793-2805. doi: 10.1161/ATVBAHA.118.311822.
358 p38-Regulated/activated protein kinase plays a pivotal role in protecting heart against ischemia-reperfusion injury and preserving cardiac performance.Am J Physiol Cell Physiol. 2019 Sep 1;317(3):C525-C533. doi: 10.1152/ajpcell.00122.2019. Epub 2019 Jul 10.
359 Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):23-37. doi: 10.1177/1074248417708617. Epub 2017 May 31.
360 The ACE2-Ang(1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction.Mol Med Rep. 2017 Aug;16(2):1973-1981. doi: 10.3892/mmr.2017.6848. Epub 2017 Jun 23.
361 Biological role of mannose binding lectin: From newborns to centenarians.Clin Chim Acta. 2015 Dec 7;451(Pt A):78-81. doi: 10.1016/j.cca.2015.03.007. Epub 2015 Mar 14.
362 Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.Am J Physiol Heart Circ Physiol. 2009 Feb;296(2):H462-9. doi: 10.1152/ajpheart.00733.2008. Epub 2008 Dec 5.
363 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction.Cardiovasc Res. 2019 Mar 1;115(3):602-613. doi: 10.1093/cvr/cvy242.
364 Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings.Clin Sci (Lond). 2014 Aug;127(3):149-61. doi: 10.1042/CS20130828.
365 Matrix metalloproteinase-12 produced by Ly6C(low) macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx.J Mol Cell Cardiol. 2019 Jun;131:41-52. doi: 10.1016/j.yjmcc.2019.04.007. Epub 2019 Apr 19.
366 Relationship of long-term prognosis to MMP and TIMP polymorphisms in patients after ST elevation myocardial infarction.J Appl Genet. 2017 Aug;58(3):331-341. doi: 10.1007/s13353-016-0388-8. Epub 2017 Jan 18.
367 Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction.J Thromb Thrombolysis. 2020 Feb;49(2):235-244. doi: 10.1007/s11239-019-02004-7.
368 Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction.Heart Lung Circ. 2018 Jun;27(6):693-701. doi: 10.1016/j.hlc.2017.05.138. Epub 2017 Jun 15.
369 Ataxia telangiectasia mutated kinase deficiency impairs the autophagic response early during myocardial infarction.Am J Physiol Heart Circ Physiol. 2018 Jul 1;315(1):H48-H57. doi: 10.1152/ajpheart.00042.2018. Epub 2018 Apr 13.
370 Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies.DNA Cell Biol. 2012 Feb;31(2):238-49. doi: 10.1089/dna.2011.1281. Epub 2011 Jul 22.
371 -94 ins/del ATTG NFKB1 gene variant is associated with lower susceptibility to myocardial infarction.Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):679-84. doi: 10.1016/j.numecd.2009.12.012. Epub 2010 Mar 20.
372 Kanglexin, a novel anthraquinone compound, protects against myocardial ischemic injury in mice by suppressing NLRP3 and pyroptosis.Acta Pharmacol Sin. 2020 Mar;41(3):319-326. doi: 10.1038/s41401-019-0307-8. Epub 2019 Oct 23.
373 Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1079-C1092. doi: 10.1152/ajpcell.00285.2019. Epub 2019 Aug 28.
374 Netrin-1 plays a role in the effect of moderate exercise on myocardial fibrosis in rats.PLoS One. 2019 Feb 21;14(2):e0199802. doi: 10.1371/journal.pone.0199802. eCollection 2019.
375 Hypertriglyceridaemia predicts subsequent long-term risk of cardiovascular events in Chinese adults: 23-year follow-up of the Daqing Diabetes Study.Diabetes Metab Res Rev. 2019 Sep;35(6):e3163. doi: 10.1002/dmrr.3163. Epub 2019 Apr 25.
376 OSM mitigates post-infarction cardiac remodeling and dysfunction by up-regulating autophagy through Mst1 suppression.Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):1951-1961. doi: 10.1016/j.bbadis.2016.11.004. Epub 2016 Nov 4.
377 Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population.Mol Biol Rep. 2012 Feb;39(2):1917-25. doi: 10.1007/s11033-011-0938-4. Epub 2011 Jun 4.
378 Association of the purinergic receptor P2Y, G-protein coupled, 2 (P2RY2) gene with myocardial infarction in Japanese men.Circ J. 2009 Dec;73(12):2322-9. doi: 10.1253/circj.cj-08-1198. Epub 2009 Oct 2.
379 Association of genetic variants in SEMA3F, CLEC16A, LAMA3, and PCSK2 with myocardial infarction in Japanese individuals.Atherosclerosis. 2010 Jun;210(2):468-73. doi: 10.1016/j.atherosclerosis.2009.11.050. Epub 2009 Dec 5.
380 Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor.J Thorac Cardiovasc Surg. 2011 May;141(5):1238-45. doi: 10.1016/j.jtcvs.2010.10.054. Epub 2011 Feb 16.
381 Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis.J Biomed Sci. 2017 Jun 15;24(1):38. doi: 10.1186/s12929-017-0345-9.
382 Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.Cardiovasc Res. 2018 Jan 1;114(1):138-157. doi: 10.1093/cvr/cvx206.
383 Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.PLoS One. 2019 Apr 1;14(4):e0214784. doi: 10.1371/journal.pone.0214784. eCollection 2019.
384 uPA, uPAR and TGF?expression during early and late post myocardial infarction period in rat myocardium.In Vivo. 2010 Sep-Oct;24(5):647-52.
385 Enzymatic Activity Is Not Required for Phospholipase D Mediated TNF- Regulation and Myocardial Healing.Front Physiol. 2018 Nov 29;9:1698. doi: 10.3389/fphys.2018.01698. eCollection 2018.
386 The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.Clin Chem Lab Med. 2014 Jul;52(7):937-50. doi: 10.1515/cclm-2013-1124.
387 Human myoblast transplantation in mice infarcted heart alters the expression profile of cardiac genes associated with left ventricle remodeling.Int J Cardiol. 2016 Jan 1;202:710-21. doi: 10.1016/j.ijcard.2015.09.115. Epub 2015 Oct 22.
388 Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.J Biol Chem. 2010 May 21;285(21):16378-86. doi: 10.1074/jbc.M109.077859. Epub 2010 Mar 29.
389 Platelet surface expression of cyclophilin A is associated with increased mortality in patients with symptomatic coronary artery disease.J Thromb Haemost. 2020 Jan;18(1):234-242. doi: 10.1111/jth.14635. Epub 2019 Oct 20.
390 Protein kinase C expression in platelets from patients with acute myocardial infarction.PLoS One. 2012;7(10):e46409. doi: 10.1371/journal.pone.0046409. Epub 2012 Oct 5.
391 Platelets-released insulin-like growth factor 1 is correlated with anxiety in myocardial infarction.Biochem Biophys Res Commun. 2019 Dec 3;520(2):441-448. doi: 10.1016/j.bbrc.2019.10.042. Epub 2019 Oct 10.
392 Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.Eur Heart J Acute Cardiovasc Care. 2017 Jun;6(4):348-358. doi: 10.1177/2048872616637036. Epub 2016 Mar 2.
393 Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach.J Thromb Haemost. 2006 Aug;4(8):1718-22. doi: 10.1111/j.1538-7836.2006.02054.x.
394 Prostaglandin E(2) and an EP4 receptor agonist inhibit LPS-Induced monocyte chemotactic protein 5 production and secretion in mouse cardiac fibroblasts via Akt and NF-B signaling.Prostaglandins Other Lipid Mediat. 2019 Oct;144:106349. doi: 10.1016/j.prostaglandins.2019.106349. Epub 2019 Jun 20.
395 Structure-activity relationships for the synthesis of selective cyclooxygenase 2 inhibitors: an overview (2009-2016).Medchemcomm. 2016 Dec 12;8(3):492-500. doi: 10.1039/c6md00569a. eCollection 2017 Mar 1.
396 microRNA-212-induced protection of the heart against myocardial infarction occurs via the interplay between AQP9 and PI3K/Akt signaling pathway.Exp Cell Res. 2018 Sep 15;370(2):531-541. doi: 10.1016/j.yexcr.2018.07.018. Epub 2018 Jul 12.
397 Reg proteins direct accumulation of functionally distinct macrophage subsets after myocardial infarction.Cardiovasc Res. 2018 Oct 1;114(12):1667-1679. doi: 10.1093/cvr/cvy126.
398 iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction.JCI Insight. 2018 Feb 8;3(3):e98268. doi: 10.1172/jci.insight.98268. eCollection 2018 Feb 8.
399 Molecular understanding of Epigallocatechin gallate (EGCG) in cardiovascular and metabolic diseases.J Ethnopharmacol. 2018 Jan 10;210:296-310. doi: 10.1016/j.jep.2017.08.035. Epub 2017 Aug 31.
400 Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays.Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):619-640. doi: 10.1080/14737167.2018.1512857. Epub 2018 Sep 6.
401 Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.Circulation. 2019 May 14;139(20):2342-2357. doi: 10.1161/CIRCULATIONAHA.117.028752.
402 Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction.Eur Heart J. 2019 Aug 21;40(32):2713-2723. doi: 10.1093/eurheartj/ehz461.
403 S100B: a multifunctional role in cardiovascular pathophysiology.Amino Acids. 2011 Oct;41(4):843-7. doi: 10.1007/s00726-010-0527-1. Epub 2010 Mar 4.
404 Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization.Int J Biochem Cell Biol. 2019 Sep;114:105564. doi: 10.1016/j.biocel.2019.105564. Epub 2019 Jul 2.
405 High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation.Angiogenesis. 2018 May;21(2):381-394. doi: 10.1007/s10456-018-9603-z. Epub 2018 Feb 15.
406 Association of genetic polymorphisms of SAA1 (rs12218) with myocardial infarction in a Chinese population.Genet Mol Res. 2014 May 9;13(2):3693-6. doi: 10.4238/2014.May.9.13.
407 Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Troms Study.Atherosclerosis. 2018 Nov;278:166-173. doi: 10.1016/j.atherosclerosis.2018.08.005. Epub 2018 Sep 15.
408 Genotype/allelic combinations as potential predictors of myocardial infarction.Mol Biol Rep. 2016 Jan;43(1):11-6. doi: 10.1007/s11033-015-3933-3. Epub 2015 Dec 12.
409 Application of speCtraL computed tomogrAphy to impRove specIficity of cardiac compuTed tomographY (CLARITY study): rationale and design.BMJ Open. 2019 Mar 1;9(3):e025793. doi: 10.1136/bmjopen-2018-025793.
410 Aerobic training prior to myocardial infarction increases cardiac GLUT4 and partially preserves heart function in spontaneously hypertensive rats.Appl Physiol Nutr Metab. 2017 Mar;42(3):334-337. doi: 10.1139/apnm-2016-0439. Epub 2016 Dec 19.
411 AT(2) receptor and tissue injury: therapeutic implications.Curr Hypertens Rep. 2014 Feb;16(2):416. doi: 10.1007/s11906-013-0416-6.
412 Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.Cardiovasc Diabetol. 2018 Jul 7;17(1):99. doi: 10.1186/s12933-018-0741-9.
413 The Serotonin Transporter Gene Polymorphisms and Risk of Ischemic Stroke.Cerebrovasc Dis. 2018;45(3-4):187-192. doi: 10.1159/000488364. Epub 2018 Apr 3.
414 Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction.Pharmacogenomics. 2010 Aug;11(8):1065-76. doi: 10.2217/pgs.10.81.
415 BRG1-SWI/SNF-dependent regulation of the Wt1 transcriptional landscape mediates epicardial activity during heart development and disease.Nat Commun. 2017 Jul 24;8:16034. doi: 10.1038/ncomms16034.
416 Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.Am J Physiol Lung Cell Mol Physiol. 2019 Apr 1;316(4):L679-L690. doi: 10.1152/ajplung.00516.2018. Epub 2019 Jan 31.
417 MicroRNA-155 inhibition attenuates endoplasmic reticulum stress-induced cardiomyocyte apoptosis following myocardial infarction via reducing macrophage inflammation.Eur J Pharmacol. 2019 Aug 15;857:172449. doi: 10.1016/j.ejphar.2019.172449. Epub 2019 Jun 14.
418 Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats.J Pharmacol Exp Ther. 2019 Mar;368(3):524-534. doi: 10.1124/jpet.118.253666. Epub 2018 Dec 14.
419 Sortilin and the risk of cardiovascular disease.Rev Port Cardiol. 2013 Oct;32(10):793-9. doi: 10.1016/j.repc.2013.02.006. Epub 2013 Jul 31.
420 Extracellular SPARC increases cardiomyocyte contraction during health and disease.PLoS One. 2019 Apr 1;14(4):e0209534. doi: 10.1371/journal.pone.0209534. eCollection 2019.
421 The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.Theranostics. 2018 Apr 14;8(10):2799-2813. doi: 10.7150/thno.22980. eCollection 2018.
422 Cardiac CD68+ and stabilin-1+ macrophages in wound healing following myocardial infarction: From experiment to clinic.Immunobiology. 2018 Apr-May;223(4-5):413-421. doi: 10.1016/j.imbio.2017.11.006. Epub 2017 Nov 22.
423 The histone H3K9 methyltransferase SUV39H links SIRT1 repression to myocardial infarction.Nat Commun. 2017 Mar 31;8:14941. doi: 10.1038/ncomms14941.
424 Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.Atherosclerosis. 2009 Jun;204(2):e58-63. doi: 10.1016/j.atherosclerosis.2008.10.011. Epub 2008 Nov 1.
425 Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.Heart Vessels. 2011 Nov;26(6):646-53. doi: 10.1007/s00380-010-0106-0. Epub 2011 Jan 13.
426 Differential Expression of Transforming Growth Factor-1 Is Associated With Fetal Regeneration After Myocardial Infarction.Ann Thorac Surg. 2019 Jul;108(1):59-66. doi: 10.1016/j.athoracsur.2018.12.042. Epub 2019 Jan 25.
427 The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis.J Cell Mol Med. 2019 Jun;23(6):4229-4243. doi: 10.1111/jcmm.14313. Epub 2019 Apr 14.
428 MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.J Mol Cell Cardiol. 2018 Aug;121:266-276. doi: 10.1016/j.yjmcc.2018.07.251. Epub 2018 Jul 24.
429 Association of Thrombomodulin Gene Polymorphisms with Susceptibility to Atherosclerotic Diseases: A Meta-Analysis.Ann Hum Genet. 2016 May;80(3):172-81. doi: 10.1111/ahg.12148. Epub 2016 Feb 17.
430 Biomarkers of vascular injury in relation to myocardial infarction risk: A population-based study.Sci Rep. 2019 Feb 28;9(1):3004. doi: 10.1038/s41598-018-38259-y.
431 Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis.Hum Mol Genet. 2017 Jul 15;26(14):2719-2731. doi: 10.1093/hmg/ddx159.
432 Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.J Am Heart Assoc. 2018 Jan 12;7(2):e007009. doi: 10.1161/JAHA.117.007009.
433 Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.Atherosclerosis. 2018 May;272:41-46. doi: 10.1016/j.atherosclerosis.2018.03.020. Epub 2018 Mar 9.
434 The rs3850641 polymorphism of the TNFSF4 gene increases the risk of myocardial infarction in a Chinese Han population.Biosci Rep. 2018 Jul 12;38(4):BSR20180526. doi: 10.1042/BSR20180526. Print 2018 Aug 31.
435 Long-Range Surface Plasmon-Polariton Waveguide Biosensors for Human Cardiac Troponin I Detection.Sensors (Basel). 2019 Feb 2;19(3):631. doi: 10.3390/s19030631.
436 A novel troponin T peptide in humans: Assay, biochemistry and preliminary findings in acute coronary syndromes.Int J Cardiol. 2015;190:68-74. doi: 10.1016/j.ijcard.2015.04.145. Epub 2015 Apr 17.
437 Brain-derived neurotrophic factor regulates TRPC3/6 channels and protects against myocardial infarction in rodents.Int J Biol Sci. 2015 Mar 25;11(5):536-45. doi: 10.7150/ijbs.10754. eCollection 2015.
438 A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction.Cardiovasc Res. 2011 Aug 1;91(3):465-71. doi: 10.1093/cvr/cvr083. Epub 2011 Mar 22.
439 Role of the TRPM4 Channel in Cardiovascular Physiology and Pathophysiology.Cells. 2018 Jun 15;7(6):62. doi: 10.3390/cells7060062.
440 Overexpression of microRNA-202-3p protects against myocardial ischemia-reperfusion injury through activation of TGF-1/Smads signaling pathway by targeting TRPM6.Cell Cycle. 2019 Mar;18(5):621-637. doi: 10.1080/15384101.2019.1580494. Epub 2019 Feb 27.
441 Dietary Menthol Attenuates Inflammation and Cardiac Remodeling After Myocardial Infarction via the Transient Receptor Potential Melastatin 8.Am J Hypertens. 2020 Mar 13;33(3):223-233. doi: 10.1093/ajh/hpz162.
442 Cardiac TRPV1 afferent signaling promotes arrhythmogenic ventricular remodeling after myocardial infarction.JCI Insight. 2020 Feb 13;5(3):e124477. doi: 10.1172/jci.insight.124477.
443 TRPV2 knockout mice demonstrate an improved cardiac performance following myocardial infarction due to attenuated activity of peri-infarct macrophages.PLoS One. 2017 May 8;12(5):e0177132. doi: 10.1371/journal.pone.0177132. eCollection 2017.
444 Salvianolic acid A attenuated myocardial infarction-induced apoptosis and inflammation by activating Trx.Naunyn Schmiedebergs Arch Pharmacol. 2020 Jun;393(6):991-1002. doi: 10.1007/s00210-019-01766-4. Epub 2019 Dec 7.
445 Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction.FASEB J. 2010 May;24(5):1467-78. doi: 10.1096/fj.09-143180. Epub 2009 Dec 17.
446 WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling.Nat Commun. 2019 Aug 9;10(1):3616. doi: 10.1038/s41467-019-11551-9.
447 A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction.Clin Chim Acta. 2006 Aug;370(1-2):124-8. doi: 10.1016/j.cca.2006.02.007. Epub 2006 Mar 6.
448 Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.Int J Mol Med. 2007 Oct;20(4):581-90.
449 DNA polymorphisms in linkage disequilibrium at the 3' end of the human APO AII gene: relationships with lipids, apolipoproteins and coronary heart disease.Clin Genet. 1996 Oct;50(4):191-8. doi: 10.1111/j.1399-0004.1996.tb02624.x.
450 Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction.Clin Chem Lab Med. 2002 Nov;40(11):1097-100. doi: 10.1515/CCLM.2002.191.
451 Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.Circulation. 2018 Oct 16;138(16):1720-1735. doi: 10.1161/CIRCULATIONAHA.118.034600.
452 Serum myoglobin/carbonic anhydrase III ratio in the diagnosis of perioperative myocardial infarction during coronary bypass surgery.Scand Cardiovasc J. 2003;37(1):23-9. doi: 10.1080/14017430310006992.
453 Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.Int J Mol Med. 2004 Jun;13(6):889-93.
454 Segregation and linkage analyses of dopamine-beta-hydroxylase activity in a six-generation pedigree.Am J Med Genet. 1987 Jul;27(3):613-21. doi: 10.1002/ajmg.1320270314.
455 Asp92Asn polymorphism in the myeloid IgA Fc receptor is associated with myocardial infarction in two disparate populations: CARE and WOSCOPS.Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2763-8. doi: 10.1161/01.ATV.0000247248.76409.8b. Epub 2006 Sep 28.
456 Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis.J Mol Cell Cardiol. 2008 Feb;44(2):252-60. doi: 10.1016/j.yjmcc.2007.08.021. Epub 2007 Sep 14.
457 Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development.Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3666-9. doi: 10.1073/pnas.91.9.3666.
458 KCNJ11 polymorphisms and sudden cardiac death in patients with acute myocardial infarction.J Mol Cell Cardiol. 2004 Feb;36(2):287-93. doi: 10.1016/j.yjmcc.2003.11.009.
459 The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility.Allergy. 2008 Aug;63(8):1046-53. doi: 10.1111/j.1398-9995.2008.01667.x. Epub 2008 Jun 10.
460 Identification of two polymorphisms in the promoter of the microsomal triglyceride transfer protein (MTP) gene: lack of association with lipoprotein profiles.J Lipid Res. 1998 Dec;39(12):2432-5.
461 SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction.Atherosclerosis. 2008 Feb;196(2):896-904. doi: 10.1016/j.atherosclerosis.2007.02.006. Epub 2007 Mar 26.
462 Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction.Am Heart J. 2004 Oct;148(4):602-5. doi: 10.1016/j.ahj.2004.04.020.
463 Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.Coron Artery Dis. 2008 Dec;19(8):597-602. doi: 10.1097/MCA.0b013e3283155579.
464 Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC Studies.Eur J Hum Genet. 2004 Mar;12(3):213-9. doi: 10.1038/sj.ejhg.5201143.
465 Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma.Clin Exp Allergy. 2005 May;35(5):585-90. doi: 10.1111/j.1365-2222.2005.02220.x.
466 Zinc Finger Protein 202: a new candidate gene for ischemic heart disease: The Copenhagen City Heart Study.Atherosclerosis. 2006 Sep;188(1):43-50. doi: 10.1016/j.atherosclerosis.2005.10.014. Epub 2005 Nov 14.
467 C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction.Cell Death Dis. 2019 Jul 11;10(7):530. doi: 10.1038/s41419-019-1760-5.
468 Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart.Cardiovasc Res. 2006 Dec 1;72(3):430-7. doi: 10.1016/j.cardiores.2006.08.020. Epub 2006 Sep 1.
469 Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans.Hum Mol Genet. 2007 Aug 1;16(15):1821-7. doi: 10.1093/hmg/ddm130. Epub 2007 May 21.
470 Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.JCI Insight. 2016 Dec 8;1(20):e89384. doi: 10.1172/jci.insight.89384.
471 TREK-1 protects the heart against ischemia-reperfusion-induced injury and from adverse remodeling after myocardial infarction.Pflugers Arch. 2019 Oct;471(10):1263-1272. doi: 10.1007/s00424-019-02306-y. Epub 2019 Sep 12.
472 Canceled coronary computed tomography angiography: Downstream testing and outcomes.Int J Cardiol. 2017 Jan 15;227:457-461. doi: 10.1016/j.ijcard.2016.11.011. Epub 2016 Nov 8.
473 The level of the zinc homeostasis regulating proteins in the brain of rats subjected to olfactory bulbectomy model of depression.Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jan 4;72:36-48. doi: 10.1016/j.pnpbp.2016.08.009. Epub 2016 Aug 24.
474 Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study.J Clin Med. 2019 Jul 30;8(8):1132. doi: 10.3390/jcm8081132.
475 Overexpression of Na(+)-HCO(3)(-) cotransporter contributes to the exacerbation of cardiac remodeling in mice with myocardial infarction by increasing intracellular calcium overload.Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165623. doi: 10.1016/j.bbadis.2019.165623. Epub 2019 Nov 26.
476 The rs9982601 polymorphism of the region between the SLC5A3/MRPS6 and KCNE2 genes associated with a prevalence of myocardial infarction and subsequent long-term mortality.Pol Arch Med Wewn. 2015;125(4):240-8. doi: 10.20452/pamw.2780. Epub 2015 Feb 20.
477 Association study: SLC6A18 gene and myocardial infarction.Clin Biochem. 2011 Jul;44(10-11):789-94. doi: 10.1016/j.clinbiochem.2011.03.031. Epub 2011 Mar 21.
478 Low-dose taurine upregulates taurine transporter expression in acute myocardial ischemia.Int J Mol Med. 2013 Apr;31(4):817-24. doi: 10.3892/ijmm.2013.1264. Epub 2013 Feb 1.
479 The ABO locus is associated with increased platelet aggregation in patients with stable coronary artery disease.Int J Cardiol. 2019 Jul 1;286:152-158. doi: 10.1016/j.ijcard.2019.01.090. Epub 2019 Feb 11.
480 Genetic Variants of CYP2R1 Are Key Regulators of Serum Vitamin D Levels and Incidence of Myocardial Infarction in Middle-Aged Egyptians.Curr Pharm Biotechnol. 2018;19(3):265-273. doi: 10.2174/1389201019666180528082737.
481 Haplotype-based case-control study of CYP4A11 gene and myocardial infarction.Hereditas. 2012 Jun;149(3):91-8. doi: 10.1111/j.1601-5223.2012.02247.x. Epub 2012 Jul 4.
482 Regional differences of fat depot attenuation using non-contrast, contrast-enhanced, and delayed-enhanced cardiac CT.Acta Radiol. 2019 Apr;60(4):459-467. doi: 10.1177/0284185118787356. Epub 2018 Jul 31.
483 Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery Disease.Can J Cardiol. 2019 Nov;35(11):1505-1512. doi: 10.1016/j.cjca.2019.08.022. Epub 2019 Aug 22.
484 Endogenous S-nitrosothiols protect against myocardial injury.Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6297-302. doi: 10.1073/pnas.0901043106. Epub 2009 Mar 26.
485 Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the Second Northwick Park Heart Study.Atherosclerosis. 2005 Jun;180(2):225-32. doi: 10.1016/j.atherosclerosis.2004.12.010. Epub 2005 Jan 15.
486 The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome.Pharmgenomics Pers Med. 2019 Oct 21;12:287-295. doi: 10.2147/PGPM.S222212. eCollection 2019.
487 Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.Lancet Oncol. 2018 Jan;19(1):76-86. doi: 10.1016/S1470-2045(17)30906-3. Epub 2017 Dec 14.
488 A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men.Mol Genet Metab. 2009 Mar;96(3):145-7. doi: 10.1016/j.ymgme.2008.11.161. Epub 2008 Dec 18.
489 Genetics of caffeine consumption and responses to caffeine.Psychopharmacology (Berl). 2010 Aug;211(3):245-57. doi: 10.1007/s00213-010-1900-1. Epub 2010 Jun 9.
490 Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.Eur Heart J. 2018 Jun 7;39(22):2106-2116. doi: 10.1093/eurheartj/ehy068.
491 Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.Curr Pharm Des. 2014;20(9):1305-10. doi: 10.2174/13816128113199990549.
492 Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.Physiol Genomics. 2012 Feb 1;44(2):162-72. doi: 10.1152/physiolgenomics.00016.2011. Epub 2011 Nov 29.
493 Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.Sci Rep. 2018 Feb 28;8(1):3764. doi: 10.1038/s41598-018-19700-8.
494 Oxidation of CaMKII determines the cardiotoxic effects of aldosterone.Nat Med. 2011 Nov 13;17(12):1610-8. doi: 10.1038/nm.2506.
495 Albumin, a marker for post-operative myocardial damage in cardiac surgery.J Crit Care. 2018 Oct;47:55-60. doi: 10.1016/j.jcrc.2018.06.009. Epub 2018 Jun 6.
496 Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.Eur J Pharmacol. 2006 Nov 21;550(1-3):143-8. doi: 10.1016/j.ejphar.2006.08.054. Epub 2006 Sep 7.
497 Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction.Eur J Clin Invest. 2004 Jan;34(1):14-20. doi: 10.1111/j.1365-2362.2004.01292.x.
498 Tryptophanyl-tRNA synthetase gene polymorphisms and risk of incident myocardial infarction.Atherosclerosis. 2005 Jul;181(1):137-41. doi: 10.1016/j.atherosclerosis.2005.01.016. Epub 2005 Feb 17.
499 Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination.J Mol Cell Cardiol. 2011 Apr;50(4):652-61. doi: 10.1016/j.yjmcc.2010.12.015. Epub 2010 Dec 30.
500 Rivaroxaban: A New Treatment Paradigm in the Setting of Vascular Protection?.Thromb Haemost. 2018 May;118(S 01):S12-S22. doi: 10.1055/s-0038-1636530. Epub 2018 Mar 22.
501 Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease.PLoS Biol. 2016 Aug 11;14(8):e1002529. doi: 10.1371/journal.pbio.1002529. eCollection 2016 Aug.
502 Potential role for antiangiogenic proteins in the myocardial infarction repair process.J Surg Res. 2004 Jan;116(1):156-64. doi: 10.1016/j.jss.2003.06.001.
503 Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.FASEB J. 2002 Jul;16(9):1027-40. doi: 10.1096/fj.01-0793com.
504 Resveratrol protects left ventricle by increasing adenylate kinase and isocitrate dehydrogenase activities in rats with myocardial infarction.Chin J Physiol. 2011 Dec 31;54(6):406-12. doi: 10.4077/CJP.2011.AMM097.
505 The tumour necrosis factor superfamily ligand APRIL (TNFSF13) is released upon platelet activation and expressed in atherosclerosis.Thromb Haemost. 2009 Oct;102(4):704-10. doi: 10.1160/TH08-10-0665.
506 Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17023-8. doi: 10.1073/pnas.1315986110. Epub 2013 Sep 30.
507 A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.Lipids Health Dis. 2016 Aug 30;15(1):142. doi: 10.1186/s12944-016-0307-3.
508 iTRAQ-Based Proteomic Analysis Reveals Recovery of Impaired Mitochondrial Function in Ischemic Myocardium by Shenmai Formula.J Proteome Res. 2018 Feb 2;17(2):794-803. doi: 10.1021/acs.jproteome.7b00450. Epub 2018 Jan 23.
509 Transplantation of cardiac Sca-1-positive cells rather than c-Kit-positive cells preserves mitochondrial oxygen consumption of the viable myocardium following myocardial infarction in rats.J Pharmacol Sci. 2019 Jul;140(3):236-241. doi: 10.1016/j.jphs.2019.07.005. Epub 2019 Jul 20.
510 Inhibition of AZIN2-sv induces neovascularization and improves prognosis after myocardial infarction by blocking ubiquitin-dependent talin1 degradation and activating the Akt pathway.EBioMedicine. 2019 Jan;39:69-82. doi: 10.1016/j.ebiom.2018.12.001. Epub 2018 Dec 10.
511 The PXXP domain is critical for the protective effect of BAG3 in cardiomyocytes.Clin Exp Pharmacol Physiol. 2019 May;46(5):435-443. doi: 10.1111/1440-1681.13031. Epub 2019 Mar 7.
512 Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease.Platelets. 2019;30(5):615-623. doi: 10.1080/09537104.2018.1499885. Epub 2018 Jul 26.
513 Dec1 Deficiency Suppresses Cardiac Perivascular Fibrosis Induced by Transverse Aortic Constriction.Int J Mol Sci. 2019 Oct 8;20(19):4967. doi: 10.3390/ijms20194967.
514 The relationships between FAM5C SNP (rs10920501) variability and metabolic syndrome and inflammation in women with coronary heart disease.Biol Res Nurs. 2013 Apr;15(2):160-6. doi: 10.1177/1099800411424487. Epub 2011 Oct 18.
515 Long-term effects of brief hypoxia due to cardiac arrest: Hippocampal reductions and memory deficits.Resuscitation. 2018 May;126:65-71. doi: 10.1016/j.resuscitation.2018.02.016. Epub 2018 Feb 21.
516 Association of a polymorphism of BTN2A1 with dyslipidemia in community-dwelling individuals.Mol Med Rep. 2014 Mar;9(3):808-12. doi: 10.3892/mmr.2014.1902. Epub 2014 Jan 16.
517 Time course studies on the initiation of complement activation in acute myocardial infarction induced by coronary artery ligation in rats.Mol Cell Biochem. 2005 Jan;268(1-2):149-58. doi: 10.1007/s11010-005-3856-8.
518 Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium.Am J Pathol. 1994 Jun;144(6):1357-68.
519 Calcyclin binding protein promotes DNA synthesis and differentiation in rat neonatal cardiomyocytes.J Cell Biochem. 2006 Jun 1;98(3):555-66. doi: 10.1002/jcb.20710.
520 Over-expression of calpastatin attenuates myocardial injury following myocardial infarction by inhibiting endoplasmic reticulum stress.J Thorac Dis. 2018 Sep;10(9):5283-5297. doi: 10.21037/jtd.2018.08.133.
521 Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.J Intern Med. 2011 Sep;270(3):229-36. doi: 10.1111/j.1365-2796.2011.02364.x. Epub 2011 Mar 21.
522 Membrane ER attenuates myocardial fibrosis via RhoA/ROCK-mediated actin remodeling in ovariectomized female infarcted rats.J Mol Med (Berl). 2014 Jan;92(1):43-51. doi: 10.1007/s00109-013-1103-4. Epub 2013 Nov 29.
523 Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury.Circulation. 2018 Jun 12;137(24):2613-2634. doi: 10.1161/CIRCULATIONAHA.117.031046. Epub 2018 Feb 1.
524 In Situ Imaging of Tissue Remodeling with Collagen Hybridizing Peptides.ACS Nano. 2017 Oct 24;11(10):9825-9835. doi: 10.1021/acsnano.7b03150. Epub 2017 Sep 18.
525 Circadian clock genes and circadian phenotypes in patients with myocardial infarction.Adv Med Sci. 2019 Sep;64(2):224-229. doi: 10.1016/j.advms.2018.12.003. Epub 2019 Feb 26.
526 microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling.J Cardiovasc Pharmacol. 2015 May;65(5):456-64. doi: 10.1097/FJC.0000000000000214.
527 New Insights into the Role of Basement Membrane-Derived Matricryptins in the Heart.Biol Pharm Bull. 2017;40(12):2050-2060. doi: 10.1248/bpb.b17-00308.
528 Transplantation of CREG modified embryonic stem cells improves cardiac function after myocardial infarction in mice.Biochem Biophys Res Commun. 2018 Sep 5;503(2):482-489. doi: 10.1016/j.bbrc.2018.04.160. Epub 2018 Jun 30.
529 C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes.Arterioscler Thromb Vasc Biol. 2019 Nov;39(11):2402-2410. doi: 10.1161/ATVBAHA.119.312633. Epub 2019 Sep 26.
530 miR-145 is differentially regulated by TGF-1 and ischaemia and targets Disabled-2 expression and wnt/-catenin activity.J Cell Mol Med. 2012 May;16(5):1106-13. doi: 10.1111/j.1582-4934.2011.01385.x.
531 Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.Nat Genet. 2010 Aug;42(8):692-7. doi: 10.1038/ng.622. Epub 2010 Jul 11.
532 A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.Cardiovasc Diabetol. 2019 Aug 13;18(1):102. doi: 10.1186/s12933-019-0906-1.
533 Expression of Dishevelled-1 in wound healing after acute myocardial infarction: possible involvement in myofibroblast proliferation and migration.J Cell Mol Med. 2004 Apr-Jun;8(2):257-64. doi: 10.1111/j.1582-4934.2004.tb00281.x.
534 In vivo transduction of ETV2 improves cardiac function and induces vascular regeneration following myocardial infarction.Exp Mol Med. 2019 Feb 12;51(2):1-14. doi: 10.1038/s12276-019-0206-6.
535 Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study.Sci Rep. 2017 Feb 20;7:43045. doi: 10.1038/srep43045.
536 Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction.Front Pharmacol. 2019 Oct 24;10:1268. doi: 10.3389/fphar.2019.01268. eCollection 2019.
537 A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart.Nat Med. 1997 May;3(5):541-4. doi: 10.1038/nm0597-541.
538 Exogenous GDF11 attenuates non-canonical TGF- signaling to protect the heart from acute myocardial ischemia-reperfusion injury.Basic Res Cardiol. 2019 Mar 21;114(3):20. doi: 10.1007/s00395-019-0728-z.
539 Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.Peptides. 2014 Feb;52:104-12. doi: 10.1016/j.peptides.2013.12.010. Epub 2013 Dec 25.
540 G protein receptor kinase 4 polymorphisms: -blocker pharmacogenetics and treatment-related outcomes in hypertension.Hypertension. 2012 Oct;60(4):957-64. doi: 10.1161/HYPERTENSIONAHA.112.198721. Epub 2012 Sep 4.
541 Glutathione S-transferase M1 and T1 genotypes and myocardial infarction.Mol Biol Rep. 2013 Apr;40(4):3263-7. doi: 10.1007/s11033-012-2401-6. Epub 2012 Dec 30.
542 Serial evaluation of fatty acid metabolism in rats with myocardial infarction by pinhole SPECT.J Nucl Cardiol. 2001 Jul-Aug;8(4):472-81. doi: 10.1067/mnc.2001.114519.
543 Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.Heart. 2019 Sep;105(17):1358-1363. doi: 10.1136/heartjnl-2018-314471. Epub 2019 Apr 1.
544 Cardiac myofibroblast differentiation is attenuated by alpha(3) integrin blockade: potential role in post-MI remodeling.J Mol Cell Cardiol. 2009 Feb;46(2):186-92. doi: 10.1016/j.yjmcc.2008.10.022. Epub 2008 Nov 7.
545 miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor.Free Radic Biol Med. 2013 Dec;65:371-379. doi: 10.1016/j.freeradbiomed.2013.07.009. Epub 2013 Jul 15.
546 Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition.Basic Res Cardiol. 2011 Jan;106(1):99-109. doi: 10.1007/s00395-010-0122-3. Epub 2010 Oct 1.
547 Predictive Nomogram of RAGE Genetic Polymorphisms and Metabolic Risk Factors for Myocardial Infarction Risk in a Han Chinese Population.Angiology. 2017 Nov;68(10):877-883. doi: 10.1177/0003319717696622. Epub 2017 Mar 10.
548 Survival benefit of coronary revascularization after myocardial perfusion SPECT: The role of ischemia.J Nucl Cardiol. 2021 Aug;28(4):1676-1687. doi: 10.1007/s12350-019-01932-4. Epub 2019 Nov 11.
549 MRAS gene marker rs9818870 is not associated with acute coronary syndrome in the Czech population and does not predict mortality in males after acute coronary syndrome.Adv Clin Exp Med. 2017 Nov;26(8):1213-1217. doi: 10.17219/acem/67460.
550 Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1.Biochem Biophys Res Commun. 2018 Jan 1;495(1):292-299. doi: 10.1016/j.bbrc.2017.11.041. Epub 2017 Nov 7.
551 Association of SNP rs17465637 on chromosome 1q41 and rs599839 on 1p13.3 with myocardial infarction in an American caucasian population.Ann Hum Genet. 2011 Jul;75(4):475-82. doi: 10.1111/j.1469-1809.2011.00646.x. Epub 2011 Apr 4.
552 Crystal structure and receptor-interacting residues of MYDGF - a protein mediating ischemic tissue repair.Nat Commun. 2019 Nov 26;10(1):5379. doi: 10.1038/s41467-019-13343-7.
553 Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes.Pathol Oncol Res. 2009 Dec;15(4):631-7. doi: 10.1007/s12253-009-9163-z. Epub 2009 Mar 29.
554 NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture.Cell Rep. 2017 Jan 3;18(1):82-92. doi: 10.1016/j.celrep.2016.12.009.
555 Protective effects of Nesfatin-1 peptide on cerebral ischemia reperfusion injury via inhibition of neuronal cell death and enhancement of antioxidant defenses.Metab Brain Dis. 2019 Feb;34(1):79-85. doi: 10.1007/s11011-018-0323-2. Epub 2018 Sep 30.
556 Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.Biomed Pharmacother. 2019 Mar;111:1036-1045. doi: 10.1016/j.biopha.2018.12.122. Epub 2019 Jan 11.
557 Period 2-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction.Hum Gene Ther. 2020 Jan;31(1-2):119-128. doi: 10.1089/hum.2019.146.
558 Knocking down PFL can improve myocardial ischemia/reperfusion injury in rats by up-regulating heat shock protein-20.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7619-7627. doi: 10.26355/eurrev_201909_18885.
559 Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.Stem Cell Res. 2017 Dec;25:83-87. doi: 10.1016/j.scr.2017.10.026. Epub 2017 Oct 28.
560 Endothelial protein C receptor polymorphisms and risk of myocardial infarction.Haematologica. 2008 Sep;93(9):1358-63. doi: 10.3324/haematol.13066.
561 Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease.Ann Hum Genet. 2009 Sep;73(Pt 5):475-83. doi: 10.1111/j.1469-1809.2009.00534.x. Epub 2009 Jun 16.
562 Antibody-array technique reveals overexpression of important DNA-repair proteins during cardiac ischemic preconditioning.J Mol Cell Cardiol. 2005 Jan;38(1):99-102. doi: 10.1016/j.yjmcc.2004.11.032.
563 Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.Cardiovasc Res. 2015 Jan 1;105(1):31-43. doi: 10.1093/cvr/cvu218. Epub 2014 Oct 23.
564 Cigarette smoking and cardio-renal events in patients with atherosclerotic renal artery stenosis.PLoS One. 2017 Mar 17;12(3):e0173562. doi: 10.1371/journal.pone.0173562. eCollection 2017.
565 Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.Sci Transl Med. 2018 Sep 12;10(458):eaan0724. doi: 10.1126/scitranslmed.aan0724.
566 Association of genetic variants with myocardial infarction in Japanese individuals with different lipid profiles.Int J Mol Med. 2010 Apr;25(4):607-16. doi: 10.3892/ijmm_00000383.
567 Endogenous reduction of miR-185 accelerates cardiac function recovery in mice following myocardial infarction via targeting of cathepsin K.J Cell Mol Med. 2019 Feb;23(2):1164-1173. doi: 10.1111/jcmm.14016. Epub 2018 Nov 18.
568 Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction.Int J Cardiol. 2020 Feb 1;300:34-38. doi: 10.1016/j.ijcard.2019.08.034. Epub 2019 Aug 15.
569 The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells.Atherosclerosis. 2011 Dec;219(2):667-72. doi: 10.1016/j.atherosclerosis.2011.08.019. Epub 2011 Aug 19.
570 Attenuation of increased secretory leukocyte protease inhibitor, matricellular proteins and angiotensin II and left ventricular remodeling by candesartan and omapatrilat during healing after reperfused myocardial infarction.Mol Cell Biochem. 2013 Apr;376(1-2):175-88. doi: 10.1007/s11010-013-1565-2. Epub 2013 Jan 30.
571 Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.Cardiovasc Diabetol. 2015 Jan 15;14:845. doi: 10.1186/s12933-014-0163-2.
572 KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly.Atherosclerosis. 2012 Feb;220(2):456-62. doi: 10.1016/j.atherosclerosis.2011.11.037. Epub 2011 Dec 7.
573 Estrogen receptor alpha supports cardiomyocytes indirectly through post-infarct cardiac c-kit+ cells.J Mol Cell Cardiol. 2009 Jul;47(1):66-75. doi: 10.1016/j.yjmcc.2009.03.014. Epub 2009 Mar 31.
574 MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction.EBioMedicine. 2019 Aug;46:236-247. doi: 10.1016/j.ebiom.2019.08.001. Epub 2019 Aug 7.
575 Enhanced cardiac repair by telomerase reverse transcriptase over-expression in human cardiac mesenchymal stromal cells.Sci Rep. 2019 Jul 22;9(1):10579. doi: 10.1038/s41598-019-47022-w.
576 Novel tricyclic glycal-based TRIB1 inducers that reprogram LDL metabolism in hepatic cells.Medchemcomm. 2018 Sep 14;9(11):1831-1842. doi: 10.1039/c8md00297e. eCollection 2018 Nov 1.
577 Titin isoform switch in ischemic human heart disease.Circulation. 2002 Sep 10;106(11):1333-41. doi: 10.1161/01.cir.0000029803.93022.93.
578 miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders.Circ Res. 2020 Jan 17;126(2):212-228. doi: 10.1161/CIRCRESAHA.119.315067. Epub 2019 Nov 7.
579 Proteinases and plaque rupture: unblocking the road to translation.Curr Opin Lipidol. 2014 Oct;25(5):358-66. doi: 10.1097/MOL.0000000000000111.
580 Adeno associated viral vector-delivered and hypoxia response element-regulated CD151 expression in ischemic rat heart.Acta Pharmacol Sin. 2011 Feb;32(2):201-8. doi: 10.1038/aps.2010.205. Epub 2011 Jan 17.
581 The Role of RP105 in Cardiovascular Disease through Regulating TLR4 and PI3K Signaling Pathways.Curr Med Sci. 2019 Apr;39(2):185-189. doi: 10.1007/s11596-019-2017-3. Epub 2019 Apr 23.
582 Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies.Circulation. 1997 Aug 5;96(3):733-40. doi: 10.1161/01.cir.96.3.733.
583 The SGLT2 Inhibitor Empagliflozin Might Be a New Approach for the Prevention of Acute Kidney Injury.Kidney Blood Press Res. 2019;44(2):149-157. doi: 10.1159/000498963. Epub 2019 Apr 2.
584 Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry.Coron Artery Dis. 2009 Jan;20(1):33-9. doi: 10.1097/MCA.0b013e328318ecb0.
585 Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E??mice without influencing systemic atherosclerosis.Cardiovasc Res. 2015 Jan 1;105(1):96-106. doi: 10.1093/cvr/cvu237. Epub 2014 Nov 5.
586 Recombinant mitochondrial transcription factor A protein inhibits nuclear factor of activated T cells signaling and attenuates pathological hypertrophy of cardiac myocytes.Mitochondrion. 2012 Jul;12(4):449-58. doi: 10.1016/j.mito.2012.06.002. Epub 2012 Jun 16.
587 Usefulness of Plasma Tissue Inhibitor of Matrix Metalloproteinase-4 to Predict Death and Myocardial Infarction in Patients With Diabetes Mellitus Referred for Coronary Angiography.Am J Cardiol. 2017 Jul 1;120(1):1-7. doi: 10.1016/j.amjcard.2017.03.267. Epub 2017 Apr 12.
588 Long-term prognostic implications of myocardial perfusion imaging in octogenarians: an all-comer, cohort study.Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1547-1558. doi: 10.1007/s00259-017-3739-8. Epub 2017 Jun 8.
589 Effects of l-arginine supplementation associated with continuous or interval aerobic training on chronic heart failure rats.Metabolism. 2017 Nov;76:1-10. doi: 10.1016/j.metabol.2017.06.009. Epub 2017 Jul 5.
590 Acute aortic dissections with pregnancy in women with ACTA2 mutations.Am J Med Genet A. 2014 Jan;164A(1):106-12. doi: 10.1002/ajmg.a.36208. Epub 2013 Nov 15.
591 Susceptibility of multiple polymorphisms in ADIPOQ, ADIPOR1 and ADIPOR2 genes to myocardial infarction in Han Chinese.Gene. 2018 Jun 5;658:10-17. doi: 10.1016/j.gene.2018.03.022. Epub 2018 Mar 7.
592 Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.Biochim Biophys Acta Mol Basis Dis. 2017 Sep;1863(9):2319-2332. doi: 10.1016/j.bbadis.2017.06.015. Epub 2017 Jun 20.
593 Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis.Arthritis Care Res (Hoboken). 2017 Feb;69(2):166-174. doi: 10.1002/acr.22930.
594 Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction.JACC Cardiovasc Imaging. 2018 Oct;11(10):1433-1444. doi: 10.1016/j.jcmg.2017.11.034. Epub 2018 Feb 14.
595 Identification of risk genes associated with myocardial infarction based on the recursive feature elimination algorithm and support vector machine classifier.Mol Med Rep. 2018 Jan;17(1):1555-1560. doi: 10.3892/mmr.2017.8044. Epub 2017 Nov 14.
596 Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.Circulation. 2013 Nov 5;128(19):2132-44. doi: 10.1161/CIRCULATIONAHA.113.003638. Epub 2013 Sep 5.
597 Identification of a glutamic acid repeat polymorphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction by genome-wide linkage analysis.Circ Cardiovasc Genet. 2013 Dec;6(6):569-78. doi: 10.1161/CIRCGENETICS.111.000027. Epub 2013 Oct 11.
598 Correlation between angiopoietin-like proteins in inflammatory mediators in peripheral blood and severity of coronary arterial lesion in patients with acute myocardial infarction.Exp Ther Med. 2019 May;17(5):3495-3500. doi: 10.3892/etm.2019.7386. Epub 2019 Mar 13.
599 Cardiac ankyrins in health and disease.J Mol Cell Cardiol. 2009 Aug;47(2):203-9. doi: 10.1016/j.yjmcc.2009.04.010. Epub 2009 Apr 24.
600 Copeptin level in the early prediction of cardiorenal syndrome in rats.Exp Ther Med. 2018 Aug;16(2):937-944. doi: 10.3892/etm.2018.6239. Epub 2018 May 30.
601 Frameshift mutation in the APOA5 gene causing hypertriglyceridemia in a Pakistani family: Management and considerations for cardiovascular risk.J Clin Lipidol. 2016 Sep-Oct;10(5):1272-7. doi: 10.1016/j.jacl.2016.07.009. Epub 2016 Aug 9.
602 Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death.J Am Coll Cardiol. 2019 May 7;73(17):2135-2145. doi: 10.1016/j.jacc.2019.01.073.
603 Autophagic program is regulated by miR-325.Cell Death Differ. 2014 Jun;21(6):967-77. doi: 10.1038/cdd.2014.18. Epub 2014 Feb 14.
604 Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support.EuroIntervention. 2018 Apr 6;13(18):e2160-e2168. doi: 10.4244/EIJ-D-17-01014.
605 Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.Circ Res. 2009 Mar 13;104(5):699-706. doi: 10.1161/CIRCRESAHA.108.189746. Epub 2009 Jan 24.
606 Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis.Nat Commun. 2019 Jan 14;10(1):187. doi: 10.1038/s41467-018-08129-2.
607 Identification of a pro-angiogenic functional role for FSP1-positive fibroblast subtype in wound healing.Nat Commun. 2019 Jul 9;10(1):3027. doi: 10.1038/s41467-019-10965-9.
608 A gene variant in the Atp10d gene associates with atherosclerotic indices in Japanese elderly population.Atherosclerosis. 2013 Nov;231(1):158-62. doi: 10.1016/j.atherosclerosis.2013.08.034. Epub 2013 Sep 5.
609 (Pro)renin receptor expression in myocardial infarction in transgenic mice expressing rat tonin.Int J Biol Macromol. 2018 Mar;108:817-825. doi: 10.1016/j.ijbiomac.2017.10.179. Epub 2017 Nov 2.
610 A Novel Marker of Inflammation: Azurocidin in Patients with ST Segment Elevation Myocardial Infarction.Int J Mol Sci. 2018 Nov 29;19(12):3797. doi: 10.3390/ijms19123797.
611 Outcome after new generation single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation.Catheter Cardiovasc Interv. 2019 Apr 1;93(5):912-920. doi: 10.1002/ccd.27979. Epub 2018 Nov 23.
612 Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.Elife. 2018 Oct 3;7:e40907. doi: 10.7554/eLife.40907.
613 Simultaneous Suppression of Multiple Programmed Cell Death Pathways by miRNA-105 in Cardiac Ischemic Injury.Mol Ther Nucleic Acids. 2019 Mar 1;14:438-449. doi: 10.1016/j.omtn.2018.12.015. Epub 2019 Jan 10.
614 Incidence and Expression of Circulating Cell Free p53-Related Genes in Acute Myocardial Infarction Patients.J Atheroscler Thromb. 2015;22(9):981-98. doi: 10.5551/jat.29223. Epub 2015 May 11.
615 Comparison of the Predictive Roles of Risk Scores of In-Hospital Major Adverse Cardiovascular Events in Patients with Non-ST Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.Med Princ Pract. 2018;27(5):459-465. doi: 10.1159/000489399. Epub 2018 Apr 19.
616 Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury.Circ Res. 2018 Dec 7;123(12):1326-1338. doi: 10.1161/CIRCRESAHA.118.313777.
617 Coronary Artery Calcium and Long-TermRisk of Death, MyocardialInfarction, and Stroke: The Walter Reed Cohort Study.JACC Cardiovasc Imaging. 2018 Dec;11(12):1799-1806. doi: 10.1016/j.jcmg.2017.09.003. Epub 2017 Nov 15.
618 Enhanced MiR-711 transcription by PPAR induces endoplasmic reticulum stress-mediated apoptosis targeting calnexin in rat cardiomyocytes after myocardial infarction.J Mol Cell Cardiol. 2018 May;118:36-45. doi: 10.1016/j.yjmcc.2018.03.006. Epub 2018 Mar 6.
619 CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation.Clin Sci (Lond). 2013 Oct;125(8):401-7. doi: 10.1042/CS20120572.
620 Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction.Cell Physiol Biochem. 2018;45(4):1641-1653. doi: 10.1159/000487732. Epub 2018 Feb 21.
621 A common variant in CCDC93 protects against myocardial infarction and cardiovascular mortality by regulating endosomal trafficking of low-density lipoprotein receptor.Eur Heart J. 2020 Mar 1;41(9):1040-1053. doi: 10.1093/eurheartj/ehz727.
622 Sequence variation in promoter regions of genes for CC chemokine ligands (CCL)19 and 21 in Czech patients with myocardial infarction.Mol Biol Rep. 2014 May;41(5):3163-8. doi: 10.1007/s11033-014-3175-9. Epub 2014 Feb 4.
623 Apoptosis inhibitor of macrophage depletion decreased M1 macrophage accumulation and the incidence of cardiac rupture after myocardial infarction in mice.PLoS One. 2017 Nov 9;12(11):e0187894. doi: 10.1371/journal.pone.0187894. eCollection 2017.
624 Genetic copy number variants in myocardial infarction patients with hyperlipidemia.BMC Genomics. 2011 Nov 30;12 Suppl 3(Suppl 3):S23. doi: 10.1186/1471-2164-12-S3-S23. Epub 2011 Nov 30.
625 Reconstitution of HuR-Inhibited CUGBP1 Expression Protects Cardiomyocytes from Acute Myocardial Infarction-Induced Injury.Antioxid Redox Signal. 2017 Nov 10;27(14):1013-1026. doi: 10.1089/ars.2016.6880. Epub 2017 Mar 28.
626 CELF1 Mediates Connexin 43 mRNA Degradation in Dilated Cardiomyopathy.Circ Res. 2017 Oct 27;121(10):1140-1152. doi: 10.1161/CIRCRESAHA.117.311281. Epub 2017 Sep 5.
627 Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.Mol Psychiatry. 2009 Nov;14(11):1024-31. doi: 10.1038/mp.2008.52. Epub 2008 Jun 3.
628 Macrophage Migration Inhibitory Factor (MIF) Expression Increases during Myocardial Infarction and Supports Pro-Inflammatory Signaling in Cardiac Fibroblasts.Biomolecules. 2019 Jan 23;9(2):38. doi: 10.3390/biom9020038.
629 Adiponectin gene variants and decreased adiponectin plasma levels are associated with the risk of myocardial infarction in young age.Gene. 2018 Feb 5;642:498-504. doi: 10.1016/j.gene.2017.11.064. Epub 2017 Nov 28.
630 Age-dependent variation of genotypes in MHC II transactivator gene (CIITA) in controls and association to type 1 diabetes.Genes Immun. 2012 Dec;13(8):632-40. doi: 10.1038/gene.2012.44. Epub 2012 Oct 11.
631 Utility of troponin I in patients with cocaine-associated chest pain. Acad Emerg Med. 2002 Oct;9(10):1007-13. doi: 10.1111/j.1553-2712.2002.tb02134.x.
632 Role of JNK signalling pathway and plateletlymphocyte aggregates in myocardial ischemiareperfusion injury and the cardioprotective effect of ischemic postconditioning in rats.Mol Med Rep. 2018 Dec;18(6):5237-5242. doi: 10.3892/mmr.2018.9545. Epub 2018 Oct 10.
633 Microglial Mincle receptor in the PVN contributes to sympathetic hyperactivity in acute myocardial infarction rat.J Cell Mol Med. 2019 Jan;23(1):112-125. doi: 10.1111/jcmm.13890. Epub 2018 Oct 24.
634 Association of six genetic variants with myocardial infarction.Int J Mol Med. 2015 May;35(5):1451-9. doi: 10.3892/ijmm.2015.2115. Epub 2015 Feb 27.
635 Knockout of Canopy 2 activates p16(INK4a) pathway to impair cardiac repair.J Mol Cell Cardiol. 2019 Jul;132:36-48. doi: 10.1016/j.yjmcc.2019.04.018. Epub 2019 Apr 29.
636 Effects of miR-29a and miR-101a Expression on Myocardial Interstitial Collagen Generation After Aerobic Exercise in Myocardial-infarcted Rats.Arch Med Res. 2017 Jan;48(1):27-34. doi: 10.1016/j.arcmed.2017.01.006.
637 A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain.J Pharmacol Sci. 2019 Feb;139(2):59-64. doi: 10.1016/j.jphs.2018.12.001. Epub 2018 Dec 10.
638 Analysis of a gene co-expression network establishes robust association between Col5a2 and ischemic heart disease.BMC Med Genomics. 2013 Apr 10;6:13. doi: 10.1186/1755-8794-6-13.
639 Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function.Blood. 2010 Nov 25;116(22):4646-56. doi: 10.1182/blood-2010-04-280925. Epub 2010 Sep 10.
640 Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway.Eur J Prev Cardiol. 2017 Jul;24(11):1161-1167. doi: 10.1177/2047487317703826. Epub 2017 Apr 21.
641 A metabolomics-driven approach reveals metabolic responses and mechanisms in the rat heart following myocardial infarction.Int J Cardiol. 2017 Jan 15;227:239-246. doi: 10.1016/j.ijcard.2016.11.127. Epub 2016 Nov 11.
642 Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPAR.Cell Physiol Biochem. 2017;42(3):876-888. doi: 10.1159/000478641. Epub 2017 Jun 23.
643 Efficacy and Safety of Zofenopril Versus Ramipril in the Treatment of Myocardial Infarction and Heart Failure: A Review of the Published and Unpublished Data of the Randomized Double-Blind SMILE-4 Study.Adv Ther. 2018 May;35(5):604-618. doi: 10.1007/s12325-018-0697-x. Epub 2018 Apr 17.
644 Xin-Ji-Er-Kang Alleviates Myocardial Infarction-Induced Cardiovascular Remodeling in Rats by Inhibiting Endothelial Dysfunction.Biomed Res Int. 2019 Jun 25;2019:4794082. doi: 10.1155/2019/4794082. eCollection 2019.
645 Differential urinary proteomics analysis of myocardial infarction using iTRAQ quantification.Mol Med Rep. 2019 May;19(5):3972-3988. doi: 10.3892/mmr.2019.10088. Epub 2019 Mar 26.
646 Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model.Cardiovasc Res. 2012 Sep 1;95(4):495-506. doi: 10.1093/cvr/cvs224. Epub 2012 Aug 10.
647 Prehypertension and risk of cardiovascular diseases: a meta-analysis of 47 cohort studies.J Hypertens. 2019 Dec;37(12):2325-2332. doi: 10.1097/HJH.0000000000002191.
648 Chromosome 17q23: a locus for cardiovascular disease.Clin Exp Pharmacol Physiol. 1993 May;20(5):279-82. doi: 10.1111/j.1440-1681.1993.tb01683.x.
649 The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure.Exp Physiol. 2019 Nov;104(11):1638-1649. doi: 10.1113/EP087552. Epub 2019 Oct 10.
650 Predicted 10-year risk of cardiovascular mortality in the 40 to 69 year old general population without cardiovascular diseases in Germany.PLoS One. 2018 Jan 2;13(1):e0190441. doi: 10.1371/journal.pone.0190441. eCollection 2018.
651 Roles for endoplasmic reticulum-associated degradation and the novel endoplasmic reticulum stress response gene Derlin-3 in the ischemic heart.Circ Res. 2010 Feb 5;106(2):307-16. doi: 10.1161/CIRCRESAHA.109.203901. Epub 2009 Nov 25.
652 HASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotection.J Mol Cell Cardiol. 2014 Jan;66:157-64. doi: 10.1016/j.yjmcc.2013.11.010. Epub 2013 Nov 20.
653 Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration.Stem Cells. 2016 Nov;34(11):2693-2706. doi: 10.1002/stem.2438. Epub 2016 Jul 7.
654 Tumorous imaginal disc 1 (TID1) inhibits isoproterenol-induced cardiac hypertrophy and apoptosis by regulating c-terminus of hsc70-interacting protein (CHIP) mediated degradation of Gs.Int J Med Sci. 2018 Oct 20;15(13):1537-1546. doi: 10.7150/ijms.24296. eCollection 2018.
655 Hypoxia-induced interaction of filamin with Drp1 causes mitochondrial hyperfission-associated myocardial senescence.Sci Signal. 2018 Nov 13;11(556):eaat5185. doi: 10.1126/scisignal.aat5185.
656 Cardiovascular risks associated with dipeptidyl peptidase-4 inhibitors monotherapy compared with other antidiabetes drugs in the Japanese population: A nationwide cohort study.Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1166-1174. doi: 10.1002/pds.4847. Epub 2019 Jul 23.
657 Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction.PLoS One. 2019 Feb 21;14(2):e0212230. doi: 10.1371/journal.pone.0212230. eCollection 2019.
658 Mesenchymal stem cells-derived extracellular vesicles, via miR-210, improve infarcted cardiac function by promotion of angiogenesis.Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):2085-2092. doi: 10.1016/j.bbadis.2017.02.023. Epub 2017 Feb 27.
659 Simultaneous Assessment of Cardiac Inflammation and Extracellular Matrix Remodeling after Myocardial Infarction.Circ Cardiovasc Imaging. 2018 Nov;11(11):e007453. doi: 10.1161/CIRCIMAGING.117.007453. Epub 2018 Nov 15.
660 Automatic high-resolution infarct detection using volumetric multiphase dual-energy CT.J Cardiovasc Comput Tomogr. 2017 Jul-Aug;11(4):288-294. doi: 10.1016/j.jcct.2017.04.006. Epub 2017 Apr 18.
661 EMC10 (Endoplasmic Reticulum Membrane Protein Complex Subunit 10) Is a Bone Marrow-Derived Angiogenic Growth Factor Promoting Tissue Repair After Myocardial Infarction.Circulation. 2017 Nov 7;136(19):1809-1823. doi: 10.1161/CIRCULATIONAHA.117.029980. Epub 2017 Sep 20.
662 Thrombolytic Therapy in the Current ERA: Myocardial Infarction and Beyond.Curr Pharm Des. 2018;24(4):414-426. doi: 10.2174/1381612824666171227211623.
663 Novel association of the obesity risk-allele near Fas Apoptotic Inhibitory Molecule 2 (FAIM2) gene with heart rate and study of its effects on myocardial infarction in diabetic participants of the PREDIMED trial.Cardiovasc Diabetol. 2014 Jan 6;13:5. doi: 10.1186/1475-2840-13-5.
664 Label-free imaging of healthy and infarcted fetal sheep hearts by two-photon microscopy.J Biophotonics. 2018 Jan;11(1). doi: 10.1002/jbio.201600296. Epub 2017 May 2.
665 Endogenous muscle atrophy F-box is involved in the development of cardiac rupture after myocardial infarction.J Mol Cell Cardiol. 2019 Jan;126:1-12. doi: 10.1016/j.yjmcc.2018.11.002. Epub 2018 Nov 6.
666 Fem1a is a mitochondrial protein up-regulated upon ischemia-reperfusion injury.FEBS Lett. 2009 May 19;583(10):1625-30. doi: 10.1016/j.febslet.2009.04.035. Epub 2009 May 4.
667 The Integrin Activating Protein Kindlin-3 Is Cleaved in Human Platelets during ST-Elevation Myocardial Infarction.Int J Mol Sci. 2019 Dec 6;20(24):6154. doi: 10.3390/ijms20246154.
668 Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke.J Thromb Haemost. 2009 Mar;7(3):385-90. doi: 10.1111/j.1538-7836.2008.03266.x.
669 FGF-16 protects against adverse cardiac remodeling in the infarct diabetic heart.Am J Transl Res. 2017 Apr 15;9(4):1630-1640. eCollection 2017.
670 Inhibition of MicroRNA-9-5p Protects Against Cardiac Remodeling Following Myocardial Infarction in Mice.Hum Gene Ther. 2019 Mar;30(3):286-301. doi: 10.1089/hum.2018.059. Epub 2018 Oct 31.
671 Recombinant frizzled1 protein attenuated cardiac hypertrophy after myocardial infarction via the canonical Wnt signaling pathway.Oncotarget. 2017 Dec 12;9(3):3069-3080. doi: 10.18632/oncotarget.23149. eCollection 2018 Jan 9.
672 Different adaptive NO-dependent Mechanisms in Normal and Hypertensive Conditions.Molecules. 2019 Apr 30;24(9):1682. doi: 10.3390/molecules24091682.
673 Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.Rheumatology (Oxford). 2017 May 1;56(5):753-762. doi: 10.1093/rheumatology/kew482.
674 TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):451-7. doi: 10.1161/ATVBAHA.110.216333. Epub 2010 Nov 11.
675 Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.J Pathol. 2015 Jul;236(3):360-72. doi: 10.1002/path.4523. Epub 2015 Mar 30.
676 Granulysin Expression in Lymphocytes that Populate the Peripheral Blood and the Myocardium after an Acute Coronary Event.Scand J Immunol. 2012 Feb;75(2):231-42. doi: 10.1111/j.1365-3083.2011.02646.x.
677 A haplotype of the GOSR2 gene is associated with myocardial infarction in Japanese men.Genet Test Mol Biomarkers. 2013 Jun;17(6):481-8. doi: 10.1089/gtmb.2012.0379. Epub 2013 May 15.
678 The proton-sensing G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) shows cardioprotective effects against myocardial infarction.Sci Rep. 2017 Aug 10;7(1):7812. doi: 10.1038/s41598-017-07573-2.
679 Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes.Cell Death Dis. 2019 Nov 4;10(11):835. doi: 10.1038/s41419-019-2061-8.
680 Gremlin2 Regulates the Differentiation and Function of Cardiac Progenitor Cells via the Notch Signaling Pathway.Cell Physiol Biochem. 2018;47(2):579-589. doi: 10.1159/000490012. Epub 2018 May 22.
681 Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.Eur Heart J. 2019 Nov 1;40(41):3385-3392. doi: 10.1093/eurheartj/ehz384.
682 The SDF1 A/G Gene Variant: A Susceptibility Variant for Myocardial Infarction.Genet Test Mol Biomarkers. 2017 Aug;21(8):506-511. doi: 10.1089/gtmb.2017.0023. Epub 2017 Jun 26.
683 HHIPL-1 (rs2895811) gene polymorphism is associated with cardiovascular risk factors and cardiometabolic parameters in Mexicans patients with myocardial infarction.Gene. 2018 Jul 15;663:34-40. doi: 10.1016/j.gene.2018.04.030. Epub 2018 Apr 12.
684 Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.J Mol Cell Cardiol. 2019 Sep;134:119-130. doi: 10.1016/j.yjmcc.2019.07.004. Epub 2019 Jul 9.
685 Fibulin-6 regulates pro-fibrotic TGF- responses in neonatal mouse ventricular cardiac fibroblasts.Sci Rep. 2017 Feb 17;7:42725. doi: 10.1038/srep42725.
686 -Caryophyllene as a Potential Protective Agent Against Myocardial Injury: The Role of Toll-Like Receptors.Molecules. 2019 May 19;24(10):1929. doi: 10.3390/molecules24101929.
687 Association of Met439Thr substitution in heat shock protein 70 gene with postoperative atrial fibrillation and serum HSP70 protein levels.Cardiology. 2008;110(1):45-52. doi: 10.1159/000109406. Epub 2007 Oct 10.
688 HSP20-mediated cardiomyocyte exosomes improve cardiac function in mice with myocardial infarction by activating Akt signaling pathway.Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4873-4881. doi: 10.26355/eurrev_201906_18075.
689 HSPB7 prevents cardiac conduction system defect through maintaining intercalated disc integrity.PLoS Genet. 2017 Aug 21;13(8):e1006984. doi: 10.1371/journal.pgen.1006984. eCollection 2017 Aug.
690 Immediate Early Response Gene X-1 (IEX-1) Mediates Ischemic Preconditioning-Induced Cardioprotection in Rats.Oxid Med Cell Longev. 2017;2017:6109061. doi: 10.1155/2017/6109061. Epub 2017 Oct 29.
691 Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.Horm Metab Res. 2019 Feb;51(2):112-119. doi: 10.1055/a-0794-6163. Epub 2018 Nov 29.
692 Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54.Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):200-206. doi: 10.1093/ehjcvp/pvz020.
693 Interleukin-38 alleviates cardiac remodelling after myocardial infarction.J Cell Mol Med. 2020 Jan;24(1):371-384. doi: 10.1111/jcmm.14741. Epub 2019 Nov 20.
694 Interleukin-34 Levels Were Associated with Prognosis in Patients with Acute Myocardial Infarction.Int Heart J. 2019 Nov 30;60(6):1259-1267. doi: 10.1536/ihj.19-111. Epub 2019 Nov 15.
695 The rs2228145 polymorphism in the interleukin-6 receptor and its association with long-term prognosis after myocardial infarction in a pilot study.Arch Med Sci. 2017 Feb 1;13(1):93-99. doi: 10.5114/aoms.2016.58636. Epub 2016 Mar 17.
696 Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.Neuropeptides. 2011 Feb;45(1):33-42. doi: 10.1016/j.npep.2010.10.002. Epub 2010 Oct 28.
697 Association of polymorphisms of BTN2A1 and ILF3 with myocardial infarction in Japanese individuals with or without hypertension, diabetes mellitus or chronic kidney disease.Int J Mol Med. 2011 May;27(5):745-52. doi: 10.3892/ijmm.2011.623. Epub 2011 Feb 23.
698 Long-Term Risk Factor Control After Myocardial Infarction-A Need for Better Prevention Programmes.J Clin Med. 2019 Jul 27;8(8):1114. doi: 10.3390/jcm8081114.
699 ISL1 overexpression enhances the survival of transplanted human mesenchymal stem cells in a murine myocardial infarction model.Stem Cell Res Ther. 2018 Feb 26;9(1):51. doi: 10.1186/s13287-018-0803-7.
700 A functional SNP in ITIH3 is associated with susceptibility to myocardial infarction.J Hum Genet. 2007;52(3):220-229. doi: 10.1007/s10038-006-0102-5. Epub 2007 Jan 9.
701 JDP2 overexpression provokes cardiac dysfunction in mice.Sci Rep. 2018 May 16;8(1):7647. doi: 10.1038/s41598-018-26052-w.
702 Post-Myocardial Infarction T-tubules Form Enlarged Branched Structures With Dysregulation of Junctophilin-2 and Bridging Integrator 1 (BIN-1).J Am Heart Assoc. 2017 May 4;6(5):e004834. doi: 10.1161/JAHA.116.004834.
703 MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7.Cell Death Dis. 2018 Jul 10;9(7):769. doi: 10.1038/s41419-018-0805-5.
704 Neuropilin 1 ameliorates electrical remodeling at infarct border zones in rats after myocardial infarction.Auton Neurosci. 2018 Nov;214:19-23. doi: 10.1016/j.autneu.2018.08.001. Epub 2018 Aug 9.
705 Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. J Am Coll Cardiol. 2008 Jan 29;51(4):435-43. doi: 10.1016/j.jacc.2007.05.057.
706 The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis.Hereditas. 2015 Oct 22;152:3. doi: 10.1186/s41065-015-0004-7. eCollection 2015.
707 KLF9 aggravates ischemic injury in cardiomyocytes through augmenting oxidative stress.Life Sci. 2019 Sep 15;233:116641. doi: 10.1016/j.lfs.2019.116641. Epub 2019 Jul 8.
708 KRT1 gene silencing ameliorates myocardial ischemia-reperfusion injury via the activation of the Notch signaling pathway in mouse models.J Cell Physiol. 2019 Apr;234(4):3634-3646. doi: 10.1002/jcp.27133. Epub 2018 Sep 7.
709 Peptidylarginine Deiminase 2 Knockout Improves Survival in hemorrhagic shock.Shock. 2020 Oct;54(4):458-463. doi: 10.1097/SHK.0000000000001489.
710 Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) study.Atherosclerosis. 2009 May;204(1):165-70. doi: 10.1016/j.atherosclerosis.2008.08.006. Epub 2008 Aug 14.
711 Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.Lipids Health Dis. 2019 Apr 11;18(1):95. doi: 10.1186/s12944-019-1042-3.
712 Association between hepatic lipase -514 C/T promoter polymorphism and myocardial infarction is modified by history of hypercholesterolemia and waist circumference.Nutr Metab Cardiovasc Dis. 2010 Sep;20(7):498-504. doi: 10.1016/j.numecd.2009.05.006. Epub 2009 Aug 19.
713 TG haplotype in the LRP8 is associated with myocardial infarction in south Indian population.Gene. 2018 Feb 5;642:225-229. doi: 10.1016/j.gene.2017.10.037. Epub 2017 Oct 12.
714 Alterations of autophagic-lysosomal system in the peripheral leukocytes of patients with myocardial infarction.Clin Chim Acta. 2011 Aug 17;412(17-18):1567-71. doi: 10.1016/j.cca.2011.05.002. Epub 2011 May 7.
715 MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response.Nat Commun. 2015 Dec 16;6:10084. doi: 10.1038/ncomms10084.
716 Effect of l-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine on ischemic heart disease risk: A Mendelian randomization study.Am Heart J. 2016 Dec;182:54-61. doi: 10.1016/j.ahj.2016.07.021. Epub 2016 Aug 26.
717 Key Regulators of Cardiovascular Differentiation and Regeneration: Harnessing the Potential of Direct Reprogramming to Treat Heart Failure.J Card Fail. 2020 Jan;26(1):80-84. doi: 10.1016/j.cardfail.2019.09.005. Epub 2019 Sep 18.
718 Inhibition of Senescence-Associated Genes Rb1 and Meis2 in Adult Cardiomyocytes Results in Cell Cycle Reentry and Cardiac Repair Post-Myocardial Infarction.J Am Heart Assoc. 2019 Aug 6;8(15):e012089. doi: 10.1161/JAHA.119.012089. Epub 2019 Jul 18.
719 Serum Bicarbonate Is Associated with Heart Failure in the Multi-Ethnic Study of Atherosclerosis.Am J Nephrol. 2017;45(2):118-126. doi: 10.1159/000454783. Epub 2016 Dec 10.
720 MRE11A Polymorphisms Are Associated With Subclinical Atherosclerosis and Cardiovascular Risk Factors. A Case-Control Study of the GEA Mexican Project.Front Genet. 2019 May 31;10:530. doi: 10.3389/fgene.2019.00530. eCollection 2019.
721 Megakaryocytic Leukemia 1 Bridges Epigenetic Activation of NADPH Oxidase in Macrophages to Cardiac Ischemia-Reperfusion Injury.Circulation. 2018 Dec 11;138(24):2820-2836. doi: 10.1161/CIRCULATIONAHA.118.035377.
722 Effect of intravenous transplantation of hUCB-MSCs on M1/M2 subtype conversion in monocyte/macrophages of AMI mice.Biomed Pharmacother. 2019 Mar;111:624-630. doi: 10.1016/j.biopha.2018.12.095. Epub 2019 Jan 3.
723 B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris.Nutr Metab Cardiovasc Dis. 2016 Jun;26(6):495-501. doi: 10.1016/j.numecd.2015.12.009. Epub 2015 Dec 23.
724 MYBL2 protects against H9c2 injury induced by hypoxia via AKT and NFB pathways.Mol Med Rep. 2018 Mar;17(3):4832-4838. doi: 10.3892/mmr.2018.8387. Epub 2018 Jan 8.
725 Impact of cardiac-specific expression of CD39 on myocardial infarct size in mice.Life Sci. 2017 Jun 15;179:54-59. doi: 10.1016/j.lfs.2016.10.016. Epub 2016 Oct 15.
726 LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription.Nat Commun. 2018 Jan 2;9(1):29. doi: 10.1038/s41467-017-02280-y.
727 Regulation of macrophage migration in ischemic mouse hearts via an AKT2/NBA1/SPK1 pathway.Oncotarget. 2017 Dec 15;8(70):115345-115359. doi: 10.18632/oncotarget.23263. eCollection 2017 Dec 29.
728 Whole Exome Sequencing to Identify Genetic Variants Associated with Raised Atherosclerotic Lesions in Young Persons.Sci Rep. 2017 Jun 22;7(1):4091. doi: 10.1038/s41598-017-04433-x.
729 Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.Clin Lymphoma Myeloma Leuk. 2020 Jan;20(1):18-23. doi: 10.1016/j.clml.2019.08.008. Epub 2019 Aug 26.
730 Effect of neuron-derived neurotrophic factor on rejuvenation of human adipose-derived stem cells for cardiac repair after myocardial infarction.J Cell Mol Med. 2019 Sep;23(9):5981-5993. doi: 10.1111/jcmm.14456. Epub 2019 Jul 9.
731 Arctigenin alleviates myocardial infarction injury through inhibition of the NFAT5-related inflammatory phenotype of cardiac macrophages/monocytes in mice.Lab Invest. 2020 Apr;100(4):527-541. doi: 10.1038/s41374-019-0340-8. Epub 2019 Dec 2.
732 Cytoprotective effects of transgenic neuroglobin overexpression in an acute and chronic mouse model of ischemic heart disease.Heart Vessels. 2018 Jan;33(1):80-88. doi: 10.1007/s00380-017-1065-5. Epub 2017 Nov 2.
733 Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.Sci Rep. 2018 Mar 15;8(1):4611. doi: 10.1038/s41598-018-22830-8.
734 NOX5 expression is increased in intramyocardial blood vessels and cardiomyocytes after acute myocardial infarction in humans.Am J Pathol. 2012 Jun;180(6):2222-9. doi: 10.1016/j.ajpath.2012.02.018. Epub 2012 Apr 10.
735 Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF-B pathway in a rat model of myocardial infarction.Cardiovasc Ther. 2018 Apr;36(2). doi: 10.1111/1755-5922.12320. Epub 2018 Feb 8.
736 Receptor-interacting protein 140 overexpression impairs cardiac mitochondrial function and accelerates the transition to heart failure in chronically infarcted rats.Transl Res. 2017 Feb;180:91-102.e1. doi: 10.1016/j.trsl.2016.08.005. Epub 2016 Aug 31.
737 Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection.Exp Cell Res. 2017 Jul 1;356(1):74-84. doi: 10.1016/j.yexcr.2017.04.012. Epub 2017 Apr 12.
738 Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.Circ Res. 2015 Jan 30;116(3):425-36. doi: 10.1161/CIRCRESAHA.116.304599. Epub 2014 Dec 17.
739 Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.Cell Death Dis. 2018 May 1;9(5):556. doi: 10.1038/s41419-018-0579-9.
740 A New Secretory Peptide of Natriuretic Peptide Family, Osteocrin, Suppresses the Progression of Congestive Heart Failure After Myocardial Infarction.Circ Res. 2018 Mar 2;122(5):742-751. doi: 10.1161/CIRCRESAHA.117.312624. Epub 2018 Jan 11.
741 The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism.Thromb Res. 2000 Aug 1;99(3):223-30. doi: 10.1016/s0049-3848(00)00236-x.
742 Variations of specific non-candidate genes and risk of myocardial infarction: a replication study.Int J Cardiol. 2011 Feb 17;147(1):38-41. doi: 10.1016/j.ijcard.2009.07.028. Epub 2009 Aug 25.
743 Role of the CDKN1A/p21, CDKN1C/p57, and CDKN2A/p16 genes in the risk of atherosclerosis and myocardial infarction.Cell Cycle. 2007 Mar 1;6(5):620-5. doi: 10.4161/cc.6.5.3927. Epub 2007 Mar 31.
744 Gene expression profile analysis of aortic vascular smooth muscle cells reveals upregulation of cadherin genes in myocardial infarction patients.Physiol Genomics. 2018 Aug 1;50(8):648-657. doi: 10.1152/physiolgenomics.00042.2017. Epub 2018 May 18.
745 The phosphodiesterase 8B gene rs4704397 is associated with thyroid function, risk of myocardial infarction, and body height: the Troms study.Thyroid. 2014 Feb;24(2):215-22. doi: 10.1089/thy.2013.0177. Epub 2013 Nov 13.
746 Variation of PEAR1 DNA methylation influences platelet and leukocyte function.Clin Epigenetics. 2019 Oct 29;11(1):151. doi: 10.1186/s13148-019-0744-8.
747 Disruption of VEGF Mediated Flk-1 Signaling Leads to a Gradual Loss of Vessel Health and CardiacFunction During Myocardial Infarction: Potential Therapy With Pellino-1.J Am Heart Assoc. 2018 Sep 18;7(18):e007601. doi: 10.1161/JAHA.117.007601.
748 Period3 VNTR polymorphism influences the time-of-day pain onset of acute myocardial infarction with ST elevation.Chronobiol Int. 2014 Oct;31(8):878-90. doi: 10.3109/07420528.2014.921790. Epub 2014 May 27.
749 Expression of profilin-1 in endothelial cells of rats with acute myocardial infarction.Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1318-1322.
750 PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.Chem Biol Interact. 2019 Dec 1;314:108848. doi: 10.1016/j.cbi.2019.108848. Epub 2019 Oct 11.
751 Stretch-activated channel Piezo1 is up-regulated in failure heart and cardiomyocyte stimulated by AngII.Am J Transl Res. 2017 Jun 15;9(6):2945-2955. eCollection 2017.
752 Overexpression of CKIP-1 alleviates hypoxia-induced cardiomyocyte injury by up-regulating Nrf2 antioxidant signaling via Keap1 inhibition.Biochimie. 2019 Aug;163:163-170. doi: 10.1016/j.biochi.2019.06.008. Epub 2019 Jun 12.
753 Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1.Nat Commun. 2017 Sep 18;8(1):578. doi: 10.1038/s41467-017-00654-w.
754 A CRM1 Inhibitor Alleviates Cardiac Hypertrophy and Increases the Nuclear Distribution of NT-PGC-1 in NRVMs.Front Pharmacol. 2019 May 7;10:465. doi: 10.3389/fphar.2019.00465. eCollection 2019.
755 Phosphatase PPM1L Prevents Excessive Inflammatory Responses and Cardiac Dysfunction after Myocardial Infarction by Inhibiting IKK Activation.J Immunol. 2019 Sep 1;203(5):1338-1347. doi: 10.4049/jimmunol.1900148. Epub 2019 Jul 22.
756 AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.Circ Heart Fail. 2013 Mar;6(2):310-7. doi: 10.1161/CIRCHEARTFAILURE.112.971325. Epub 2012 Dec 27.
757 Are we ever too old?: Characteristics and outcome of octogenarians admitted to a medical intensive care unit.Medicine (Baltimore). 2017 Sep;96(37):e7776. doi: 10.1097/MD.0000000000007776.
758 Discriminatory power of scoring systems for outcome prediction in patients with extracorporeal membrane oxygenation following cardiovascular surgery?"Schrutka L. Binder C
759 Construction of CNA35 Collagen-Targeted Phase-Changeable Nanoagents for Low-Intensity Focused Ultrasound-Triggered Ultrasound Molecular Imaging of Myocardial Fibrosis in Rabbits.ACS Appl Mater Interfaces. 2019 Jul 3;11(26):23006-23017. doi: 10.1021/acsami.9b05999. Epub 2019 Jun 24.
760 Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction.J Mol Cell Cardiol. 2012 Jan;52(1):154-64. doi: 10.1016/j.yjmcc.2011.09.011. Epub 2011 Sep 19.
761 BDNF contributes to the skeletal muscle anti-atrophic effect of exercise training through AMPK-PGC1 signaling in heart failure mice.Arch Med Sci. 2019 Jan;15(1):214-222. doi: 10.5114/aoms.2018.81037. Epub 2018 Dec 30.
762 Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.PLoS One. 2017 Mar 23;12(3):e0173927. doi: 10.1371/journal.pone.0173927. eCollection 2017.
763 Association between functional variant of inflammatory system gene (PSMA6) and end-stage kidney disease.Int Urol Nephrol. 2016 Dec;48(12):2083-2087. doi: 10.1007/s11255-016-1420-y. Epub 2016 Sep 26.
764 Automated detection and localization system of myocardial infarction in single-beat ECG using Dual-Q TQWT and wavelet packet tensor decomposition.Comput Methods Programs Biomed. 2020 Feb;184:105120. doi: 10.1016/j.cmpb.2019.105120. Epub 2019 Oct 5.
765 Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):313-322. doi: 10.1177/2048872619846334. Epub 2019 Apr 24.
766 Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction.Redox Biol. 2019 Apr;22:101151. doi: 10.1016/j.redox.2019.101151. Epub 2019 Feb 27.
767 Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium.PLoS One. 2016 Mar 7;11(3):e0144997. doi: 10.1371/journal.pone.0144997. eCollection 2016.
768 Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction.Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12248.
769 Blockade of NKG2D/NKG2D ligand interaction attenuated cardiac remodelling after myocardial infarction.Cardiovasc Res. 2019 Mar 15;115(4):765-775. doi: 10.1093/cvr/cvy254.
770 Exome Sequencing in a Family Identifies RECQL5 Mutation Resulting in Early Myocardial Infarction.Medicine (Baltimore). 2016 Feb;95(5):e2737. doi: 10.1097/MD.0000000000002737.
771 Gene Expression Profiles Link Respiratory Viral Infection, Platelet Response to Aspirin, and Acute Myocardial Infarction.PLoS One. 2015 Jul 20;10(7):e0132259. doi: 10.1371/journal.pone.0132259. eCollection 2015.
772 New antihyperglycaemic agents and cardiovascular disease: let's be optimistic.Curr Opin Cardiol. 2018 Jul;33(4):444-454. doi: 10.1097/HCO.0000000000000524.
773 Regulator of G-protein signalling 5 deficiency impairs ventricular remodelling after myocardial infarction by promoting NF-B and MAPK signalling in mice.Biochem Biophys Res Commun. 2018 May 5;499(2):143-149. doi: 10.1016/j.bbrc.2018.03.082. Epub 2018 Mar 24.
774 Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic properties.Int J Cardiol. 2018 Jan 1;250:21-28. doi: 10.1016/j.ijcard.2017.09.017.
775 Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice.J Am Heart Assoc. 2017 Jun 21;6(6):e004541. doi: 10.1161/JAHA.116.004541.
776 Identification of key genes involved in myocardial infarction.Eur J Med Res. 2019 Jul 3;24(1):22. doi: 10.1186/s40001-019-0381-x.
777 Impact of platelet turnover on long-term adverse cardiovascular outcomes in patients undergoing percutaneous coronary intervention.Eur J Clin Invest. 2019 Sep;49(9):e13157. doi: 10.1111/eci.13157. Epub 2019 Aug 19.
778 RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.Pharmacogenomics J. 2013 Aug;13(4):330-4. doi: 10.1038/tpj.2012.22. Epub 2012 Jun 5.
779 Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.Basic Res Cardiol. 2012 Jan;107(1):239. doi: 10.1007/s00395-011-0239-z. Epub 2011 Dec 28.
780 Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery.BMJ Open. 2015 May 6;5(5):e006920. doi: 10.1136/bmjopen-2014-006920.
781 Selenoprotein P in Myocardial Infarction With Cardiogenic Shock.Shock. 2020 Jan;53(1):58-62. doi: 10.1097/SHK.0000000000001342.
782 National Performance on the Medicare SEP-1 Sepsis Quality Measure.Crit Care Med. 2019 Aug;47(8):1026-1032. doi: 10.1097/CCM.0000000000003613.
783 Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction.Blood. 2011 Jun 16;117(24):6694-701. doi: 10.1182/blood-2010-11-320325. Epub 2011 Apr 19.
784 Insights from molecular signature of in vivo cardiac c-Kit(+) cells following cardiac injury and -catenin inhibition.J Mol Cell Cardiol. 2018 Oct;123:64-74. doi: 10.1016/j.yjmcc.2018.08.024. Epub 2018 Aug 29.
785 Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia.Mol Cell. 2011 Nov 18;44(4):532-44. doi: 10.1016/j.molcel.2011.08.045.
786 Amelioration of myocardial ischemia-reperfusion injury by SIRT4 involves mitochondrial protection and reduced apoptosis.Biochem Biophys Res Commun. 2018 Jul 7;502(1):15-21. doi: 10.1016/j.bbrc.2018.05.113. Epub 2018 May 24.
787 RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.Biomed Pharmacother. 2017 May;89:297-304. doi: 10.1016/j.biopha.2017.02.029. Epub 2017 Feb 24.
788 A haplotype of the SMTN gene associated with myocardial infarction in Japanese women.Genet Test Mol Biomarkers. 2012 Sep;16(9):1019-26. doi: 10.1089/gtmb.2012.0034.
789 SNX17 produces anti-arrhythmic effects by preserving functional SERCA2a protein in myocardial infarction.Int J Cardiol. 2018 Dec 1;272:298-305. doi: 10.1016/j.ijcard.2018.07.025. Epub 2018 Jul 4.
790 Analytical performance evaluation of the Elecsys Troponin T Gen 5 STAT assay.Clin Chim Acta. 2019 Aug;495:522-528. doi: 10.1016/j.cca.2019.05.026. Epub 2019 May 30.
791 Independent Modular Filter for Embolic Protection in Carotid Stenting.Circ Cardiovasc Interv. 2017 Mar;10(3):e004244. doi: 10.1161/CIRCINTERVENTIONS.116.004244.
792 STAT1-avtiviated LINC00961 regulates myocardial infarction by the PI3K/AKT/GSK3 signaling pathway.J Cell Biochem. 2019 Aug;120(8):13226-13236. doi: 10.1002/jcb.28596. Epub 2019 Mar 19.
793 Increased de novo ceramide synthesis and accumulation in failing myocardium.JCI Insight. 2017 May 4;2(9):e82922. doi: 10.1172/jci.insight.82922. eCollection 2017 May 4.
794 Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction.Circ Res. 2019 Jul 5;125(2):170-183. doi: 10.1161/CIRCRESAHA.118.314515. Epub 2019 May 30.
795 Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice.Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3735-3745. doi: 10.1016/j.bbadis.2018.09.029. Epub 2018 Sep 24.
796 Sialyltransferase7A, a Klf4-responsive gene, promotes cardiomyocyte apoptosis during myocardial infarction.Basic Res Cardiol. 2015 May;110(3):28. doi: 10.1007/s00395-015-0484-7. Epub 2015 Apr 10.
797 Early inhibition of endothelial retinoid uptake upon myocardial infarction restores cardiac function and prevents cell, tissue, and animal death.J Mol Cell Cardiol. 2019 Jan;126:105-117. doi: 10.1016/j.yjmcc.2018.11.012. Epub 2018 Nov 23.
798 Over-expression of microRNA-1 causes arrhythmia by disturbing intracellular trafficking system.Sci Rep. 2017 Apr 11;7:46259. doi: 10.1038/srep46259.
799 Identification of STXBP2 as a novel susceptibility locus for myocardial infarction in Japanese individuals by an exome-wide association study.Oncotarget. 2017 May 16;8(20):33527-33535. doi: 10.18632/oncotarget.16536.
800 Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice.Toxicol Appl Pharmacol. 2018 Apr 15;345:1-9. doi: 10.1016/j.taap.2018.03.006. Epub 2018 Mar 7.
801 SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era.Korean Circ J. 2020 Jan;50(1):22-34. doi: 10.4070/kcj.2019.0097. Epub 2019 Sep 30.
802 Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair.Circ Res. 2014 Apr 25;114(9):1422-34. doi: 10.1161/CIRCRESAHA.114.302530. Epub 2014 Mar 20.
803 Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location.Stroke. 2012 Aug;43(8):2036-41. doi: 10.1161/STROKEAHA.111.648725. Epub 2012 May 24.
804 Promotion of CHIP-mediated p53 degradation protects the heart from ischemic injury.Circ Res. 2010 Jun 11;106(11):1692-702. doi: 10.1161/CIRCRESAHA.109.214346. Epub 2010 Apr 22.
805 Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression.Circulation. 2012 Jul 24;126(4):430-9. doi: 10.1161/CIRCULATIONAHA.111.087684. Epub 2012 Jul 5.
806 THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.Am J Physiol Heart Circ Physiol. 2009 Aug;297(2):H643-53. doi: 10.1152/ajpheart.00234.2009. Epub 2009 Jun 5.
807 The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.Exp Gerontol. 2019 May;119:193-202. doi: 10.1016/j.exger.2019.02.008. Epub 2019 Feb 11.
808 Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after myocardial infarction: effects on left ventricular remodeling.Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H814-H825. doi: 10.1152/ajpheart.00076.2018. Epub 2018 Jul 6.
809 Association of rs2781666 G/T polymorphism of arginase I gene with myocardial infarction in Tunisian male population.Clin Biochem. 2010 Jan;43(1-2):106-9. doi: 10.1016/j.clinbiochem.2009.10.058. Epub 2009 Nov 5.
810 Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties.Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13724-9. doi: 10.1073/pnas.1008117107. Epub 2010 Jul 19.
811 The Troponin-I fast skeletal muscle is reliable marker for the determination of vitality in the suicide hanging.Forensic Sci Int. 2019 Aug;301:284-288. doi: 10.1016/j.forsciint.2019.05.055. Epub 2019 Jun 4.
812 Aberrant expression of TNRC6a and miR-21 during myocardial infarction.3 Biotech. 2019 Jul;9(7):285. doi: 10.1007/s13205-019-1812-7. Epub 2019 Jun 25.
813 Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events.Med Hypotheses. 2013 Sep;81(3):443-7. doi: 10.1016/j.mehy.2013.06.005. Epub 2013 Jul 3.
814 Melatonin attenuates postmyocardial infarction injury via increasing Tom70 expression.J Pineal Res. 2017 Jan;62(1). doi: 10.1111/jpi.12371. Epub 2016 Nov 1.
815 Plasma CXCL1 levels and TRAF3IP2 variants in patients with myocardial infarction.J Clin Lab Anal. 2018 Jul;32(6):e22402. doi: 10.1002/jcla.22402. Epub 2018 Feb 12.
816 The role of GILZ in modulation of adaptive immunity in a murine model of myocardial infarction.Exp Mol Pathol. 2017 Jun;102(3):408-414. doi: 10.1016/j.yexmp.2017.05.002. Epub 2017 May 10.
817 Circular RNA Ttc3 regulates cardiac function after myocardial infarction by sponging miR-15b.J Mol Cell Cardiol. 2019 May;130:10-22. doi: 10.1016/j.yjmcc.2019.03.007. Epub 2019 Mar 12.
818 Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.Ann Med. 2008;40(3):232-9. doi: 10.1080/07853890701842988.
819 Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.Am Heart J. 2006 Aug;152(2):312-20. doi: 10.1016/j.ahj.2005.12.015.
820 Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.Lipids Health Dis. 2008 Nov 17;7:46. doi: 10.1186/1476-511X-7-46.
821 Restriction fragment length polymorphisms in the apolipoprotein B gene in survivors of myocardial infarction.Med Sci Monit. 2000 Sep-Oct;6(5):882-6.
822 Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility.Nat Genet. 2005 Apr;37(4):365-72. doi: 10.1038/ng1524. Epub 2005 Mar 6.
823 Plasma mitochondrial coupling factor 6 in patients with acute myocardial infarction.Hypertens Res. 2004 Oct;27(10):717-22. doi: 10.1291/hypres.27.717.
824 Association of polymorphisms of platelet membrane integrins alpha IIb(beta)3 (HPA-1b/Pl) and alpha2(beta)1 (alpha807TT) with premature myocardial infarction.J Thromb Haemost. 2005 Jul;3(7):1522-9. doi: 10.1111/j.1538-7836.2005.01432.x.
825 XbaI polymorphism in DNA at the apolipoprotein B locus is associated with myocardial infarction (MI).Clin Genet. 1993 Nov;44(5):241-8. doi: 10.1111/j.1399-0004.1993.tb03890.x.
826 Admixture Mapping of Subclinical Atherosclerosis and Subsequent Clinical Events Among African Americans in 2 Large Cohort Studies.Circ Cardiovasc Genet. 2017 Apr;10(2):e001569. doi: 10.1161/CIRCGENETICS.116.001569.
827 Altered detection of molecules associated with leukocyte traffic in HUVECs derived from newborns with a strong family history of myocardial infarction.Acta Histochem. 2008;110(1):42-52. doi: 10.1016/j.acthis.2007.05.007. Epub 2007 Aug 31.
828 The II genotype of the angiotensin-converting enzyme gene delays the onset of acute coronary syndromes.Arterioscler Thromb Vasc Biol. 1997 Sep;17(9):1730-3. doi: 10.1161/01.atv.17.9.1730.
829 Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men.J Thromb Thrombolysis. 2008 Oct;26(2):91-6. doi: 10.1007/s11239-007-0072-2. Epub 2007 Jul 11.
830 Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability.Cancer Res. 1998 Feb 15;58(4):594-8.
831 Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle.Atherosclerosis. 2001 Mar;155(1):149-56. doi: 10.1016/s0021-9150(00)00521-9.
832 Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study.Atherosclerosis. 1999 Aug;145(2):381-8. doi: 10.1016/s0021-9150(99)00069-6.
833 Smad1 protects cardiomyocytes from ischemia-reperfusion injury.Circulation. 2005 May 31;111(21):2752-9. doi: 10.1161/CIRCULATIONAHA.104.490946. Epub 2005 May 23.
834 Variation in GYS1 interacts with exercise and gender to predict cardiovascular mortality.PLoS One. 2007 Mar 14;2(3):e285. doi: 10.1371/journal.pone.0000285.
835 Association of a polymorphic variant of the Werner helicase gene with myocardial infarction in a Japanese population.Am J Med Genet. 1997 Feb 11;68(4):494-8. doi: 10.1002/(sici)1096-8628(19970211)68:4<494::aid-ajmg30>3.0.co;2-l.
836 Gene variants of VAMP8 and HNRPUL1 are associated with early-onset myocardial infarction.Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1613-8. doi: 10.1161/01.ATV.0000226543.77214.e4. Epub 2006 May 11.
837 The histidin-rich glycoprotein Pro186/Ser polymorphism is not related to myocardial infarction in the ECTIM study.Thromb Haemost. 1998 Feb;79(2):359-61.
838 A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile.Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):932-8. doi: 10.1161/01.atv.19.4.932.
839 The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats.J Vasc Res. 2001 May-Jun;38(3):288-300. doi: 10.1159/000051057.
840 ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells.Biochem Biophys Res Commun. 1999 Sep 16;263(1):224-9. doi: 10.1006/bbrc.1999.1349.
841 The association between SCN5A, KCNQ1 and KCNE1 gene polymorphisms and complex ventricular arrhythmias in survivors of myocardial infarction.Kardiol Pol. 2008 Aug;66(8):845-53; discussion 854-5.
842 The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction.Diabetes. 2005 Oct;54(10):3021-5. doi: 10.2337/diabetes.54.10.3021.
843 Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo.J Biol Chem. 2005 Jan 7;280(1):669-76. doi: 10.1074/jbc.M406690200. Epub 2004 Oct 18.
844 Association of a 5178C-->A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals.Atherosclerosis. 2004 Aug;175(2):281-6. doi: 10.1016/j.atherosclerosis.2004.03.008.
845 Multicenter comparison of five functional and two immunological assays for protein C.Thromb Haemost. 1987 Feb 3;57(1):44-8.
846 Elafin-overexpressing mice have improved cardiac function after myocardial infarction.Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H286-92. doi: 10.1152/ajpheart.00479.2002. Epub 2003 Dec 23.
847 The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans.Chest. 1999 Oct;116(4):880-6. doi: 10.1378/chest.116.4.880.
848 Low-density lipoprotein receptor-related protein in atherosclerosis development: up-regulation of gene expression in patients with coronary obstruction.J Mol Med (Berl). 1998 Jul;76(8):596-600. doi: 10.1007/s001090050255.
849 Unaltered mRNA expression of calcitonin-like receptor and receptor activity modifying proteins in human arteries in stroke and myocardial infarction.Ideggyogy Sz. 2007 Nov 30;60(11-12):459-66.
850 MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.Circ Res. 2004 Feb 20;94(3):e18-26. doi: 10.1161/01.RES.0000118597.54416.00. Epub 2004 Jan 22.
851 Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury.Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1517-23. doi: 10.1161/01.ATV.0000224324.52466.e6. Epub 2006 Apr 27.
852 Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.Hum Gene Ther. 2006 Dec;17(12):1201-13. doi: 10.1089/hum.2006.17.1201.
853 Angiotensin II type I receptor gene and myocardial infarction: tagging SNPs and haplotype based association study. The Beijing atherosclerosis study.Pharmacogenetics. 2004 Oct;14(10):673-81. doi: 10.1097/00008571-200410000-00005.
854 The t-PA -7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid.Blood. 2005 Feb 1;105(3):1060-7. doi: 10.1182/blood-2003-12-4383. Epub 2004 Oct 5.
855 TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells.Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1355-60. doi: 10.1161/ATVBAHA.108.162883. Epub 2008 Apr 24.
856 Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies.Stroke. 2004 Apr;35(4):819-24. doi: 10.1161/01.STR.0000121646.23955.0f. Epub 2004 Mar 4.